BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Adam R, Delvart V, Pascal G, Valeanu A, Castaing D, Azoulay D, Giacchetti S, Paule B, Kunstlinger F, Ghémard O, Levi F, Bismuth H. Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival. Ann Surg 2004;240:644-57; discussion 657-8. [PMID: 15383792 DOI: 10.1097/01.sla.0000141198.92114.f6] [Cited by in Crossref: 236] [Cited by in F6Publishing: 493] [Article Influence: 13.1] [Reference Citation Analysis]
Number Citing Articles
1 Govaert KM, van Kessel CS, Lolkema M, Ruers TJ, Borel Rinkes IH. Does Radiofrequency Ablation Add to Chemotherapy for Unresectable Liver Metastases? Curr Colorectal Cancer Rep. 2012;8:130-137. [PMID: 22611343 DOI: 10.1007/s11888-012-0122-9] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
2 Zdenkowski N, Chen S, van der Westhuizen A, Ackland S. Curative strategies for liver metastases from colorectal cancer: a review. Oncologist. 2012;17:201-211. [PMID: 22234631 DOI: 10.1634/theoncologist.2011-0300] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
3 Wicherts DA, de Haas RJ, Salloum C, Andreani P, Pascal G, Sotirov D, Adam R, Castaing D, Azoulay D. Repeat hepatectomy for recurrent colorectal metastases. Br J Surg. 2013;100:808-818. [PMID: 23494765 DOI: 10.1002/bjs.9088] [Cited by in Crossref: 93] [Cited by in F6Publishing: 86] [Article Influence: 10.3] [Reference Citation Analysis]
4 Rohatgi S, Harrison EM, Powell JJ, Wigmore SJ. ALPPS: Adverse Outcomes Demand Clear Justification in an Era of Improving Survival for Colorectal Liver Metastases. World J Surg. 2015;39:1848-1849. [PMID: 25145819 DOI: 10.1007/s00268-014-2726-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
5 Sabbagh C, Chatelain D, Attencourt C, Joly JP, Chauffert B, Cosse C, Regimbeau JM. Impact of homogeneous pathologic response to preoperative chemotherapy in patients with multiple colorectal liver metastases. World J Gastroenterol 2017; 23(45): 8027-8034 [PMID: 29259378 DOI: 10.3748/wjg.v23.i45.8027] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Schwarz RE, Berlin JD, Lenz HJ, Nordlinger B, Rubbia-Brandt L, Choti MA. Systemic cytotoxic and biological therapies of colorectal liver metastases: expert consensus statement. HPB (Oxford). 2013;15:106-115. [PMID: 23297721 DOI: 10.1111/j.1477-2574.2012.00558] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Adam R, Haller DG, Poston G, Raoul JL, Spano JP, Tabernero J, Van Cutsem E. Toward optimized front-line therapeutic strategies in patients with metastatic colorectal cancer--an expert review from the International Congress on Anti-Cancer Treatment (ICACT) 2009. Ann Oncol. 2010;21:1579-1584. [PMID: 20219759 DOI: 10.1093/annonc/mdq043] [Cited by in Crossref: 38] [Cited by in F6Publishing: 40] [Article Influence: 3.2] [Reference Citation Analysis]
8 Villard C, Habib M, Nordenvall C, Nilsson PJ, Jorns C, Sparrelid E. Conversion therapy in patients with colorectal liver metastases. Eur J Surg Oncol 2021;47:2038-45. [PMID: 33640172 DOI: 10.1016/j.ejso.2021.02.019] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Fan CQ, Crawford JM. Sinusoidal obstruction syndrome (hepatic veno-occlusive disease). J Clin Exp Hepatol. 2014;4:332-346. [PMID: 25755580 DOI: 10.1016/j.jceh.2014.10.002] [Cited by in Crossref: 128] [Cited by in F6Publishing: 112] [Article Influence: 16.0] [Reference Citation Analysis]
10 Lordick F, Ricke J, Mohnike K, Hacker U. How to Create Evidence for the Integration of Local and Locoregional Treatments in Future Oncological Treatment Concepts? Viszeralmedizin 2014;30:261-8. [PMID: 26288599 DOI: 10.1159/000365313] [Reference Citation Analysis]
11 Macera A, Lario C, Petracchini M, Gallo T, Regge D, Floriani I, Ribero D, Capussotti L, Cirillo S. Staging of colorectal liver metastases after preoperative chemotherapy. Diffusion-weighted imaging in combination with Gd-EOB-DTPA MRI sequences increases sensitivity and diagnostic accuracy. Eur Radiol. 2013;23:739-747. [PMID: 22976920 DOI: 10.1007/s00330-012-2658-0] [Cited by in Crossref: 36] [Cited by in F6Publishing: 30] [Article Influence: 3.6] [Reference Citation Analysis]
12 Zarate R, Rodríguez J, Bandres E, Patiño-Garcia A, Ponz-Sarvise M, Viudez A, Ramirez N, Bitarte N, Chopitea A, Gacía-Foncillas J. Oxaliplatin, irinotecan and capecitabine as first-line therapy in metastatic colorectal cancer (mCRC): a dose-finding study and pharmacogenomic analysis. Br J Cancer 2010;102:987-94. [PMID: 20216541 DOI: 10.1038/sj.bjc.6605595] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 2.8] [Reference Citation Analysis]
13 Carrasco J, Gizzi M, Pairet G, Lannoy V, Lefesvre P, Gigot JF, Hubert C, Jouret-Mourin A, Humblet Y, Canon JL, Sempoux C, Chapaux X, Danse E, Tinton N, Navez B, Van den Eynde M. Pathological responses after angiogenesis or EGFR inhibitors in metastatic colorectal cancer depend on the chemotherapy backbone. Br J Cancer 2015;113:1298-304. [PMID: 26461062 DOI: 10.1038/bjc.2015.321] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
14 Wang K, Liu W, Yan XL, Li J, Xing BC. Long-term postoperative survival prediction in patients with colorectal liver metastasis. Oncotarget. 2017;8:79927-79934. [PMID: 29108374 DOI: 10.18632/oncotarget.20322] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 4.2] [Reference Citation Analysis]
15 Adam R, Kitano Y, Abdelrafee A, Allard MA, Baba H. Debulking surgery for colorectal liver metastases: Foolish or chance? Surg Oncol 2020;33:266-9. [PMID: 32561091 DOI: 10.1016/j.suronc.2020.02.008] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
16 Durán Giménez-Rico H, García-Aguilar J, Warren RS, Iborra P, Guerrero V. [Liver metastases from colorectal cancer. Is the practice of surgery based on the best clinical evidence possible?]. Cir Esp 2005;78:75-85. [PMID: 16420801 DOI: 10.1016/s0009-739x(05)70894-0] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
17 Sugarbaker PH, Liang J. Ovarian metastases from right colon cancer treated with systemic cancer chemotherapy, a case report. Int J Surg Case Rep 2018;47:25-9. [PMID: 29705675 DOI: 10.1016/j.ijscr.2018.04.017] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
18 Seeberg LT, Brunborg C, Waage A, Hugenschmidt H, Renolen A, Stav I, Bjørnbeth BA, Borgen E, Naume B, Brudvik KW, Wiedswang G. Survival Impact of Primary Tumor Lymph Node Status and Circulating Tumor Cells in Patients with Colorectal Liver Metastases. Ann Surg Oncol 2017;24:2113-21. [PMID: 28258416 DOI: 10.1245/s10434-017-5818-2] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 2.2] [Reference Citation Analysis]
19 Popescu I, Alexandrescu ST. Surgical options for initially unresectable colorectal liver metastases. HPB Surg 2012;2012:454026. [PMID: 23082042 DOI: 10.1155/2012/454026] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
20 Poultsides GA, Schulick RD, Pawlik TM. Hepatic resection for colorectal metastases: the impact of surgical margin status on outcome. HPB (Oxford). 2010;12:43-49. [PMID: 20495644 DOI: 10.1111/j.1477-2574.2009.00121.x] [Cited by in Crossref: 43] [Cited by in F6Publishing: 34] [Article Influence: 3.6] [Reference Citation Analysis]
21 Molla M, Fernandez-Plana J, Albiol S, Fondevila C, Vollmer I, Cases C, Garcia-Criado A, Capdevila J, Conill C, Fundora Y, Fernandez-Martos C, Pineda E. Limited Liver or Lung Colorectal Cancer Metastases. Systemic Treatment, Surgery, Ablation or SBRT. J Clin Med 2021;10:2131. [PMID: 34069240 DOI: 10.3390/jcm10102131] [Reference Citation Analysis]
22 Macedo FIB, Makarawo T. Colorectal hepatic metastasis: Evolving therapies. World J Hepatol 2014; 6(7): 453-463 [PMID: 25067997 DOI: 10.4254/wjh.v6.i7.453] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
23 Xu J, Qin X, Wang J, Zhang S, Zhong Y, Ren L, Wei Y, Zeng S, Wan D, Zheng S; Society of Surgery; Chinese Medical Association; Committee of Colorectal Cancer, Chinese Anti-cancer Association. Chinese guidelines for the diagnosis and comprehensive treatment of hepatic metastasis of colorectal cancer. J Cancer Res Clin Oncol. 2011;137:1379-1396. [PMID: 21796415 DOI: 10.1007/s00432-011-0999-8] [Cited by in Crossref: 17] [Cited by in F6Publishing: 21] [Article Influence: 1.5] [Reference Citation Analysis]
24 Aranda E, Abad A, Carrato A, Cervantes A, García-Foncillas J, García Alfonso P, García Carbonero R, Gómez España A, Tabernero JM, Díaz-Rubio E. Treatment recommendations for metastatic colorectal cancer. Clin Transl Oncol 2011;13:162-78. [PMID: 21421461 DOI: 10.1007/s12094-011-0636-7] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 1.6] [Reference Citation Analysis]
25 Heinrich S, Watzka F, Lang H. Integrative Concepts for Liver Surgery. Visc Med 2020;36:351-8. [PMID: 33178731 DOI: 10.1159/000511043] [Reference Citation Analysis]
26 Ayav A, Habib N, Jiao LR. Portal Hypertension Secondary to 90 Yttrium Microspheres: An Unknown Complication. JCO 2005;23:8275-6. [DOI: 10.1200/jco.2005.03.7820] [Cited by in Crossref: 23] [Cited by in F6Publishing: 4] [Article Influence: 1.4] [Reference Citation Analysis]
27 Van Cutsem E, Cervantes A, Adam R, Sobrero A, Van Krieken J, Aderka D, Aranda Aguilar E, Bardelli A, Benson A, Bodoky G, Ciardiello F, D'hoore A, Diaz-rubio E, Douillard J, Ducreux M, Falcone A, Grothey A, Gruenberger T, Haustermans K, Heinemann V, Hoff P, Köhne C, Labianca R, Laurent-puig P, Ma B, Maughan T, Muro K, Normanno N, Österlund P, Oyen W, Papamichael D, Pentheroudakis G, Pfeiffer P, Price T, Punt C, Ricke J, Roth A, Salazar R, Scheithauer W, Schmoll H, Tabernero J, Taïeb J, Tejpar S, Wasan H, Yoshino T, Zaanan A, Arnold D. ESMO consensus guidelines for the management of patients with metastatic colorectal cancer. Annals of Oncology 2016;27:1386-422. [DOI: 10.1093/annonc/mdw235] [Cited by in Crossref: 1387] [Cited by in F6Publishing: 1250] [Article Influence: 231.2] [Reference Citation Analysis]
28 Fornarini G, Guglielmi A, Sobrero A. The handling of metastatic colorectal cancer. Annals of Oncology 2005;16:ii141-3. [DOI: 10.1093/annonc/mdi710] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
29 Malik H, Hamady Z, Adair R, Finch R, Al-mukhtar A, Toogood G, Prasad K, Lodge J. Prognostic influence of multiple hepatic metastases from colorectal cancer. European Journal of Surgical Oncology (EJSO) 2007;33:468-73. [DOI: 10.1016/j.ejso.2006.09.030] [Cited by in Crossref: 44] [Cited by in F6Publishing: 35] [Article Influence: 2.9] [Reference Citation Analysis]
30 Kok END, Havenga K, Tanis PJ, de Wilt JHW, Hagendoorn J, Peters FP, Buijsen J, Rutten HJT, Kuhlmann KFD; Dutch Stage IV Rectal Cancer Group. Multicentre study of short-course radiotherapy, systemic therapy and resection/ablation for stage IV rectal cancer. Br J Surg 2020;107:537-45. [PMID: 32017049 DOI: 10.1002/bjs.11418] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
31 Bismuth H, Eshkenazy R, Arish A. Milestones in the evolution of hepatic surgery. Rambam Maimonides Med J 2011;2:e0021. [PMID: 23908793 DOI: 10.5041/RMMJ.10021] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
32 Kasuya K, Suzuki M, Nagakawa Y, Suzuki Y, Kikuchi S, Kyo B, Matsudo T, Itoi T, Tsuchida A, Aoki T. Administration of anti-vascular endothelial growth factor antibody following hepatectomy does not inhibit remnant liver regeneration or growth of remnant metastases. Exp Ther Med 2012;3:347-50. [PMID: 22969894 DOI: 10.3892/etm.2011.409] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
33 Gibbs P, Gebski V, Van Buskirk M, Thurston K, Cade DN, Van Hazel GA. Selective Internal Radiation Therapy (SIRT) with yttrium-90 resin microspheres plus standard systemic chemotherapy regimen of FOLFOX versus FOLFOX alone as first-line treatment of non-resectable liver metastases from colorectal cancer: the SIRFLOX study. BMC Cancer. 2014;14:897. [PMID: 25487708 DOI: 10.1186/1471-2407-14-897] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 4.6] [Reference Citation Analysis]
34 Blazer DG, Kishi Y, Maru DM, Kopetz S, Chun YS, Overman MJ, Fogelman D, Eng C, Chang DZ, Wang H, Zorzi D, Ribero D, Ellis LM, Glover KY, Wolff RA, Curley SA, Abdalla EK, Vauthey J. Pathologic Response to Preoperative Chemotherapy: A New Outcome End Point After Resection of Hepatic Colorectal Metastases. JCO 2008;26:5344-51. [DOI: 10.1200/jco.2008.17.5299] [Cited by in Crossref: 420] [Cited by in F6Publishing: 152] [Article Influence: 30.0] [Reference Citation Analysis]
35 Zhu J, Lian P, Liu F, Xu Y, Xu J, Guan Z, Liang L, Wang M, Cai S, Zhang Z. Phase II trial of first-line chemoradiotherapy with intensity-modulated radiation therapy followed by chemotherapy for synchronous unresectable distant metastases rectal adenocarcinoma. Radiat Oncol 2013;8:10. [PMID: 23295152 DOI: 10.1186/1748-717X-8-10] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
36 Königsrainer I, Beckert S. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: Where are we? World J Gastroenterol 2012; 18(38): 5317-5320 [PMID: 23082046 DOI: 10.3748/wjg.v18.i38.5317] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
37 Jegatheeswaran S, Jamdar S, Satyadas T, Sheen AJ, Adam R, Siriwardena AK. Use of Pharmacologic Agents for Modulation of Ischaemia-Reperfusion Injury after Hepatectomy: A Questionnaire Study of the LiverMetSurvey International Registry of Hepatic Surgery Units. HPB Surg 2014;2014:437159. [PMID: 25477707 DOI: 10.1155/2014/437159] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
38 Kuvshinoff B, Fong Y. Surgical therapy of liver metastases. Semin Oncol 2007;34:177-85. [PMID: 17560979 DOI: 10.1053/j.seminoncol.2007.03.003] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 2.0] [Reference Citation Analysis]
39 Pietrantonio F, Mazzaferro V, Miceli R, Cotsoglou C, Melotti F, Fanetti G, Perrone F, Biondani P, Muscarà C, Di Bartolomeo M, Coppa J, Maggi C, Milione M, Tamborini E, de Braud F. Pathological response after neoadjuvant bevacizumab- or cetuximab-based chemotherapy in resected colorectal cancer liver metastases. Med Oncol 2015;32:182. [PMID: 26003673 DOI: 10.1007/s12032-015-0638-3] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
40 Noji T, Nagayama M, Imai K, Kawamoto Y, Kuwatani M, Imamura M, Okamura K, Kimura Y, Hirano S. Conversion surgery for initially unresectable biliary malignancies: a multicenter retrospective cohort study. Surg Today 2020;50:1409-17. [PMID: 32468112 DOI: 10.1007/s00595-020-02031-5] [Reference Citation Analysis]
41 Pawlik TM, Choti MA. Surgical therapy for colorectal metastases to the liver. J Gastrointest Surg. 2007;11:1057-1077. [PMID: 17530336 DOI: 10.1007/s11605-006-0061-3] [Cited by in Crossref: 151] [Cited by in F6Publishing: 136] [Article Influence: 10.1] [Reference Citation Analysis]
42 Parikh AA, Ni S, Koyama T, Pawlik TM, Penson D. Trends in the multimodality treatment of resectable colorectal liver metastases: an underutilized strategy. J Gastrointest Surg 2013;17:1938-46. [PMID: 24018590 DOI: 10.1007/s11605-013-2325-z] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
43 Lv W, Zhang GQ, Jiao A, Zhao BC, Shi Y, Chen BM, Zhang JL. Chemotherapy Plus Cetuximab versus Chemotherapy Alone for Patients with KRAS Wild Type Unresectable Liver-Confined Metastases Colorectal Cancer: An Updated Meta-Analysis of RCTs. Gastroenterol Res Pract 2017;2017:8464905. [PMID: 28167959 DOI: 10.1155/2017/8464905] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
44 Symonds LK, Cohen SA. Use of perioperative chemotherapy in colorectal cancer metastatic to the liver. Gastroenterol Rep (Oxf) 2019;7:301-11. [PMID: 31687149 DOI: 10.1093/gastro/goz035] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
45 Fujitani K, Kurokawa Y, Takeno A, Kawabata R, Omori T, Imamura H, Hirao M, Endo S, Kawada J, Moon JH, Kobayashi N, Takahashi T, Yamasaki M, Takiguchi S, Mori M, Eguchi H, Doki Y; Osaka University Clinical Research Group for Gastroenterological Surgery. Prospective Multicenter Interventional Study of Surgical Resection for Liver Metastasis from Gastric Cancer: R0 Resection Rate, and Operative Morbidity and Mortality. Ann Surg Oncol 2021. [PMID: 34480277 DOI: 10.1245/s10434-021-10750-3] [Reference Citation Analysis]
46 Adam R, de Haas RJ, Wicherts DA, Aloia TA, Delvart V, Azoulay D, Bismuth H, Castaing D. Is hepatic resection justified after chemotherapy in patients with colorectal liver metastases and lymph node involvement? J Clin Oncol. 2008;26:3672-3680. [PMID: 18669451 DOI: 10.1200/jco.2007.15.7297] [Cited by in Crossref: 125] [Cited by in F6Publishing: 43] [Article Influence: 8.9] [Reference Citation Analysis]
47 Jafari A, Wehner S, Kalff JC, Manekeller S. Sinusoidal obstruction syndrome in the animal model: influence on liver surgery. Langenbecks Arch Surg 2017;402:115-22. [PMID: 27585678 DOI: 10.1007/s00423-016-1506-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
48 Marshall JL. Integrating targeted agents into therapeutic regimens for patients with resectable colorectal cancer. Clin Colorectal Cancer 2008;7 Suppl 2:S63-6. [PMID: 19064409 DOI: 10.3816/CCC.2008.s.010] [Reference Citation Analysis]
49 Asbun HJ, Straznicka M, Strong VE. The role of minimal access surgery for metastasectomy and cytoreduction. Surg Oncol Clin N Am 2007;16:607-25, ix. [PMID: 17606196 DOI: 10.1016/j.soc.2007.04.008] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
50 Oki E, Ando K, Nakanishi R, Sugiyama M, Nakashima Y, Kubo N, Kudou K, Saeki H, Nozoe T, Emi Y, Maehara Y. Recent advances in treatment for colorectal liver metastasis. Ann Gastroenterol Surg 2018;2:167-75. [PMID: 29863162 DOI: 10.1002/ags3.12071] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
51 Yoshimoto T, Morine Y, Imura S, Ikemoto T, Iwahashi S, Saito YU, Yamada S, Ishikawa D, Teraoku H, Yoshikawa M, Higashijima J, Takasu C, Shimada M. Maximum Diameter and Number of Tumors as a New Prognostic Indicator of Colorectal Liver Metastases. In Vivo. 2017;31:419-423. [PMID: 28438872 DOI: 10.21873/invivo.11076] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
52 Brouquet A, Belghiti J. Chemotherapy and its effect on liver hypertrophy: implications for portal vein embolization and resection. Semin Intervent Radiol. 2008;25:162-167. [PMID: 21326557 DOI: 10.1055/s-2008-1076682] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
53 Eadens MJ, Grothey A. Curable metastatic colorectal cancer. Curr Oncol Rep. 2011;13:168-176. [PMID: 21298372 DOI: 10.1007/s11912-011-0157-0] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 2.6] [Reference Citation Analysis]
54 Melstrom LG, Warner SG, Wong P, Sun V, Raoof M, Singh G, Chavin KD, Fong Y, Adam R, Hugh TJ. Management of disappearing colorectal liver metastases: an international survey. HPB 2021;23:506-11. [DOI: 10.1016/j.hpb.2020.10.005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
55 Dahlqvist G, Moreno C, Starkel P, Detry O, Coubeau L, Jochmans I. Innovations in liver transplantation in 2020, position of the Belgian Liver Intestine Advisory Committee (BeLIAC). Acta Gastroenterol Belg 2021;84:347-59. [PMID: 34217187 DOI: 10.51821/84.2.347] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
56 Petrelli F, Barni S; Anti-EGFR agents for liver metastases. Resectability and outcome with anti-EGFR agents in patients with KRAS wild-type colorectal liver-limited metastases: a meta-analysis. Int J Colorectal Dis. 2012;27:997-1004. [PMID: 22358385 DOI: 10.1007/s00384-012-1438-2] [Cited by in Crossref: 42] [Cited by in F6Publishing: 34] [Article Influence: 4.2] [Reference Citation Analysis]
57 Jaeck D, Oussoultzoglou E, Rosso E. Hepatectomy for colorectal metastases in the presence of extrahepatic disease. Surg Oncol Clin N Am 2007;16:507-23, viii. [PMID: 17606191 DOI: 10.1016/j.soc.2007.04.010] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
58 Kamphues C, Andreatos N, Kruppa J, Buettner S, Wang J, Sasaki K, Wagner D, Morioka D, Fitschek F, Løes IM, Imai K, Sun J, Poultsides G, Kaczirek K, Lønning PE, Endo I, Baba H, Kornprat P, Aucejo FN, Wolfgang CL, Kreis ME, Weiss MJ, Margonis GA. The optimal cut-off values for tumor size, number of lesions, and CEA levels in patients with surgically treated colorectal cancer liver metastases: An international, multi-institutional study. J Surg Oncol 2021;123:939-48. [PMID: 33400818 DOI: 10.1002/jso.26361] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
59 Chaudhury P, Hassanain M, Bouganim N, Salman A, Kavan P, Metrakos P. Perioperative chemotherapy with bevacizumab and liver resection for colorectal cancer liver metastasis. HPB (Oxford) 2010;12:37-42. [PMID: 20495643 DOI: 10.1111/j.1477-2574.2009.00119.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
60 Huh JW, Cho CK, Kim HR, Kim YJ. Impact of resection for primary colorectal cancer on outcomes in patients with synchronous colorectal liver metastases. J Gastrointest Surg 2010;14:1258-64. [PMID: 20544397 DOI: 10.1007/s11605-010-1250-7] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
61 Ongaro E, Cremolini C, Rossini D, Corti F, Pagani F, Morelli L, Urbani L, Masi G, Sposito C, Filippi B, Borelli B, Zucchelli G, Moretto R, Boccaccino A, Solaini L, de Braud F, Mazzaferro V, Falcone A, Cucchetti A, Pietrantonio F. Clinical and molecular determinants of extrahepatic disease progression in patients with metastatic colorectal cancer with liver-limited metastases deemed initially unresectable. ESMO Open 2019;4:e000496. [PMID: 31231562 DOI: 10.1136/esmoopen-2019-000496] [Reference Citation Analysis]
62 Suemitsu R, Takeo S, Kusumoto E, Hamatake M, Ikejiri K, Saitsu H. Results of a pulmonary metastasectomy in patients with colorectal cancer. Surg Today 2011;41:54-9. [DOI: 10.1007/s00595-009-4244-x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 26] [Article Influence: 1.7] [Reference Citation Analysis]
63 Castellanos JA, Merchant NB. Strategies for Management of Synchronous Colorectal Metastases. Curr Surg Rep. 2014;2:62. [PMID: 25431745 DOI: 10.1007/s40137-014-0062-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
64 Gonzalez RJ, Barnett CC Jr. A technique for safely teaching major hepatectomy to surgical residents. Am J Surg 2008;195:521-5. [PMID: 18304505 DOI: 10.1016/j.amjsurg.2007.02.028] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
65 Vega EA, Salehi O, Nicolaescu D, Dussom EM, Alarcon SV, Kozyreva O, Simonds J, Schnipper D, Conrad C. Failure to Cure Patients with Colorectal Liver Metastases: The Impact of the Liver Surgeon. Ann Surg Oncol 2021. [PMID: 33939045 DOI: 10.1245/s10434-021-10030-0] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
66 de Haas RJ, Wicherts DA, Flores E, Ducreux M, Lévi F, Paule B, Azoulay D, Castaing D, Lemoine A, Adam R. Tumor marker evolution: comparison with imaging for assessment of response to chemotherapy in patients with colorectal liver metastases. Ann Surg Oncol 2010;17:1010-23. [PMID: 20052553 DOI: 10.1245/s10434-009-0887-5] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 2.3] [Reference Citation Analysis]
67 Yamashita Y, Adachi E, Toh Y, Ohgaki K, Ikeda O, Oki E, Minami K, Sakaguchi Y, Tsujita E, Okamura T. Risk factors for early recurrence after curative hepatectomy for colorectal liver metastases. Surg Today 2011;41:526-32. [PMID: 21431486 DOI: 10.1007/s00595-010-4471-1] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.6] [Reference Citation Analysis]
68 Kepenekian V, Muller A, Valette PJ, Rousset P, Chauvenet M, Phelip G, Walter T, Adham M, Glehen O, Passot G. Evaluation of a strategy using pretherapeutic fiducial marker placement to avoid missing liver metastases. BJS Open. 2019;3:344-353. [PMID: 31183451 DOI: 10.1002/bjs5.50140] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
69 van der Pool AE, de Wilt JH, Lalmahomed ZS, Eggermont AM, Ijzermans JN, Verhoef C. Optimizing the outcome of surgery in patients with rectal cancer and synchronous liver metastases. Br J Surg. 2010;97:383-390. [PMID: 20101594 DOI: 10.1002/bjs.6947] [Cited by in Crossref: 78] [Cited by in F6Publishing: 65] [Article Influence: 6.5] [Reference Citation Analysis]
70 Neeff H, Hörth W, Makowiec F, Fischer E, Imdahl A, Hopt UT, Passlick B. Outcome after Resection of Hepatic and Pulmonary Metastases of Colorectal Cancer. J Gastrointest Surg 2009;13:1813-20. [DOI: 10.1007/s11605-009-0960-1] [Cited by in Crossref: 61] [Cited by in F6Publishing: 51] [Article Influence: 4.7] [Reference Citation Analysis]
71 Niu R, Yan TD, Zhu JC, Black D, Chu F, Morris DL. Recurrence and Survival Outcomes after Hepatic Resection with or without Cryotherapy for Liver Metastases from Colorectal Carcinoma. Ann Surg Oncol 2007;14:2078-87. [DOI: 10.1245/s10434-007-9400-1] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 2.1] [Reference Citation Analysis]
72 Oh MY, Kim H, Choi YJ, Byun Y, Han Y, Kang JS, Sohn H, Lee JM, Kwon W, Jang JY. Conversion surgery for initially unresectable extrahepatic biliary tract cancer. Ann Hepatobiliary Pancreat Surg 2021;25:349-57. [PMID: 34402435 DOI: 10.14701/ahbps.2021.25.3.349] [Reference Citation Analysis]
73 Vyas SJ, Davies N, Grant L, Imber CJ, Sharma D, Davidson BR, Malago M, Fusai G. Failure of portal venous embolization. ALPPS as salvage enabling successful resection of bilobar liver metastases. J Gastrointest Cancer. 2014;45 Suppl 1:233-236. [PMID: 25081490 DOI: 10.1007/s12029-014-9643-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
74 McMasters KM. What's new in surgical oncology. J Am Coll Surg 2005;200:937-45. [PMID: 15922209 DOI: 10.1016/j.jamcollsurg.2005.03.008] [Reference Citation Analysis]
75 Eichler K, Zangos S, Mack MG, Hammerstingl R, Gruber-Rouh T, Gallus C, Vogl TJ. First human study in treatment of unresectable liver metastases from colorectal cancer with irinotecan-loaded beads (DEBIRI). Int J Oncol. 2012;41:1213-1220. [PMID: 22842404 DOI: 10.3892/ijo.2012.1572] [Cited by in Crossref: 40] [Cited by in F6Publishing: 35] [Article Influence: 4.0] [Reference Citation Analysis]
76 Leite D, Kater FR. Conversion treatment of hepatic metastases of colon adenocarcinoma by bevacizumab and FOLFOX. Anticancer Drugs 2011;22 Suppl 2:S1-7. [PMID: 21768791 DOI: 10.1097/01.cad.0000398726.60837.27] [Reference Citation Analysis]
77 Rossi L, Zullo A, Zoratto F, Papa A, Strudel M, Colonna M, Tomao S. Chemotherapy and target therapy as neo-adjuvant approach for initially unresectable colorectal liver metastases. Oncol Rev 2012;6:e6. [PMID: 25992208 DOI: 10.4081/oncol.2012.e6] [Reference Citation Analysis]
78 Shindoh J, Loyer EM, Kopetz S, Boonsirikamchai P, Maru DM, Chun YS, Zimmitti G, Curley SA, Charnsangavej C, Aloia TA, Vauthey JN. Optimal morphologic response to preoperative chemotherapy: an alternate outcome end point before resection of hepatic colorectal metastases. J Clin Oncol. 2012;30:4566-4572. [PMID: 23150701 DOI: 10.1200/jco.2012.45.2854] [Cited by in Crossref: 138] [Cited by in F6Publishing: 58] [Article Influence: 13.8] [Reference Citation Analysis]
79 Rees M, Tekkis PP, Welsh FK, O'Rourke T, John TG. Evaluation of long-term survival after hepatic resection for metastatic colorectal cancer: a multifactorial model of 929 patients. Ann Surg. 2008;247:125-135. [PMID: 18156932 DOI: 10.1097/sla.0b013e31815aa2c2] [Cited by in Crossref: 705] [Cited by in F6Publishing: 307] [Article Influence: 50.4] [Reference Citation Analysis]
80 Nozawa H, Ishizawa T, Yasunaga H, Ishii H, Sonoda H, Emoto S, Murono K, Sasaki K, Kawai K, Akamatsu N, Kaneko J, Arita J, Hasegawa K, Ishihara S. Open and/or laparoscopic one-stage resections of primary colorectal cancer and synchronous liver metastases: An observational study. Medicine (Baltimore) 2021;100:e25205. [PMID: 33726015 DOI: 10.1097/MD.0000000000025205] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
81 Chen D, Zhang X, Gao G, Shen L, Xie J, Qian X, Wang H. Should anti-EGFR mAbs be discontinued for conversion surgery in untreated right-sided metastatic colorectal cancer? A systematic review and meta-analysis. World J Surg Oncol 2018;16:200. [PMID: 30296945 DOI: 10.1186/s12957-018-1502-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
82 Zhang Y, Huang G, Wang Y, Liang L, Peng B, Fan W, Yang J, Huang Y, Yao W, Li J. Is Salvage Liver Resection Necessary for Initially Unresectable Hepatocellular Carcinoma Patients Downstaged by Transarterial Chemoembolization? Ten Years of Experience. Oncologist 2016;21:1442-9. [PMID: 27486202 DOI: 10.1634/theoncologist.2016-0094] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
83 Benoist S, Nordlinger B. Neoadjuvant treatment before resection of liver metastases. Eur J Surg Oncol 2007;33 Suppl 2:S35-41. [PMID: 17981428 DOI: 10.1016/j.ejso.2007.09.022] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
84 Benoist S, Salabert A, Penna C, Karoui M, Julié C, Rougier P, Nordlinger B. Portal triad clamping (TC) or hepatic vascular exclusion (VE) for major liver resection after prolonged neoadjuvant chemotherapy? A case-matched study in 60 patients. Surgery 2006;140:396-403. [DOI: 10.1016/j.surg.2006.03.023] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 1.1] [Reference Citation Analysis]
85 Yasuno M, Uetake H, Ishiguro M, Mizunuma N, Komori T, Miyata G, Shiomi A, Kagimura T, Sugihara K. mFOLFOX6 plus bevacizumab to treat liver-only metastases of colorectal cancer that are unsuitable for upfront resection (TRICC0808): a multicenter phase II trial comprising the final analysis for survival. Int J Clin Oncol 2019;24:516-25. [PMID: 30612267 DOI: 10.1007/s10147-018-01393-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
86 Scheer MG, Sloots CE, van der Wilt GJ, Ruers TJ. Management of patients with asymptomatic colorectal cancer and synchronous irresectable metastases. Ann Oncol 2008;19:1829-35. [PMID: 18662955 DOI: 10.1093/annonc/mdn398] [Cited by in Crossref: 109] [Cited by in F6Publishing: 89] [Article Influence: 7.8] [Reference Citation Analysis]
87 Adam R, Bhangui P, Poston G, Mirza D, Nuzzo G, Barroso E, Ijzermans J, Hubert C, Ruers T, Capussotti L, Ouellet JF, Laurent C, Cugat E, Colombo PE, Milicevic M. Is perioperative chemotherapy useful for solitary, metachronous, colorectal liver metastases? Ann Surg. 2010;252:774-787. [PMID: 21037433 DOI: 10.1097/sla.0b013e3181fcf3e3] [Cited by in Crossref: 127] [Cited by in F6Publishing: 52] [Article Influence: 10.6] [Reference Citation Analysis]
88 Bu Z, Lu C, Yang X, Lai H, Jiang Y, Li Y, Lin Y, Qin Y, Xiao M, Cheng C, Liu Q. Partial response after treatment with Conversion chemotherapy: A case report of a patient with colon cancer and unresectable hepatic metastases. Medicine (Baltimore) 2019;98:e15239. [PMID: 31027071 DOI: 10.1097/MD.0000000000015239] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
89 Costi R, Leonardi F, Zanoni D, Violi V, Roncoroni L. Palliative care and end-stage colorectal cancer management: The surgeon meets the oncologist. World J Gastroenterol 2014; 20(24): 7602-7621 [PMID: 24976699 DOI: 10.3748/wjg.v20.i24.7602] [Cited by in CrossRef: 30] [Cited by in F6Publishing: 22] [Article Influence: 3.8] [Reference Citation Analysis]
90 Chau I, Cunningham D. Treatment in advanced colorectal cancer: what, when and how? Br J Cancer. 2009;100:1704-1719. [PMID: 19436303 DOI: 10.1038/sj.bjc.6605061] [Cited by in Crossref: 75] [Cited by in F6Publishing: 63] [Article Influence: 5.8] [Reference Citation Analysis]
91 Trarbach T, Schmoll HJ. Rectal cancer and synchronous metastases: resection of primary tumor or not? Gastroenterol Clin Biol 2009;33:1098-100. [PMID: 19945239 DOI: 10.1016/j.gcb.2009.10.011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
92 Aprile G, Zanon E, Tuniz F, Iaiza E, De Pauli F, Pella N, Pizzolitto S, Buffoli A, Piga A, Skrap M. Neurosurgical management and postoperative whole-brain radiotherapy for colorectal cancer patients with symptomatic brain metastases. J Cancer Res Clin Oncol. 2009;135:451-457. [PMID: 18779977 DOI: 10.1007/s00432-008-0468-1] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 2.1] [Reference Citation Analysis]
93 Mohammad WM, Martel G, Mimeault R, Fairfull-Smith RJ, Auer RC, Balaa FK. Evaluating agreement regarding the resectability of colorectal liver metastases: a national case-based survey of hepatic surgeons. HPB (Oxford). 2012;14:291-297. [PMID: 22487066 DOI: 10.1111/j.1477-2574.2012.00440.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 1.9] [Reference Citation Analysis]
94 Ren W, Sell NM, Ferrone CR, Tanabe KK, Lillemoe KD, Qadan M. Size of the Largest Colorectal Liver Metastasis Is an Independent Prognostic Factor in the Neoadjuvant Setting. J Surg Res 2021;259:253-60. [PMID: 33160635 DOI: 10.1016/j.jss.2020.09.039] [Reference Citation Analysis]
95 Chiappa A, Bertani E, Biffi R, Pace U, Viale G, Pruneri G, Zampino G, Fazio N, Orsi F, Bonomo G, Monfardini L, Vigna PD, Andreoni B. Resection of colorectal liver metastases following neoadjuvant chemotherapy. Ecancermedicalscience 2007;1:58. [PMID: 22275956 DOI: 10.3332/ecancer.2008.58] [Reference Citation Analysis]
96 S Hammond J, Muirhead W, Zaitoun AM, Cameron IC, Lobo DN. Comparison of liver parenchymal ablation and tissue necrosis in a cadaveric bovine model using the Harmonic Scalpel, the LigaSure, the Cavitron Ultrasonic Surgical Aspirator and the Aquamantys devices. HPB (Oxford) 2012;14:828-32. [PMID: 23134184 DOI: 10.1111/j.1477-2574.2012.00547.x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
97 Gurusamy K, Davidson BR. Trace element concentration in metastatic liver disease: a systematic review. J Trace Elem Med Biol 2007;21:169-77. [PMID: 17697955 DOI: 10.1016/j.jtemb.2007.03.003] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 1.3] [Reference Citation Analysis]
98 Okamura R, Hasegawa S, Hida K, Hoshino N, Kawada K, Sugihara K, Sakai Y; Japanese Study Group for Postoperative Follow-up of Colorectal Cancer. The role of periodic serum CA19-9 test in surveillance after colorectal cancer surgery. Int J Clin Oncol 2017;22:96-101. [PMID: 27503134 DOI: 10.1007/s10147-016-1027-4] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
99 Shao YC, Chang YY, Lin JK, Lin CC, Wang HS, Yang SH, Jiang JK, Lan YT, Lin TC, Li AF. Neoadjuvant chemotherapy can improve outcome of colorectal cancer patients with unresectable metastasis. Int J Colorectal Dis. 2013;28:1359-1365. [PMID: 23695387 DOI: 10.1007/s00384-013-1713-x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
100 López-Gómez M, Cejas P, Merino M, Fernández-Luengas D, Casado E, Feliu J. Management of colorectal cancer patients after resection of liver metastases: can we offer a tailored treatment? Clin Transl Oncol 2012;14:641-58. [PMID: 22911546 DOI: 10.1007/s12094-012-0853-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
101 Nozawa H, Sonoda H, Ishii H, Emoto S, Murono K, Kaneko M, Sasaki K, Nishikawa T, Shuno Y, Tanaka T, Kawai K, Hata K, Ishihara S. Postoperative chemotherapy is associated with prognosis of stage IV colorectal cancer treated with preoperative chemotherapy/chemoradiotherapy and curative resection. Int J Colorectal Dis 2020;35:177-80. [PMID: 31807855 DOI: 10.1007/s00384-019-03461-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
102 Kesmodel SB, Ellis LM, Lin E, Chang GJ, Abdalla EK, Kopetz S, Vauthey JN, Rodriguez-Bigas MA, Curley SA, Feig BW. Preoperative bevacizumab does not significantly increase postoperative complication rates in patients undergoing hepatic surgery for colorectal cancer liver metastases. J Clin Oncol. 2008;26:5254-5260. [PMID: 18854565 DOI: 10.1200/jco.2008.17.7857] [Cited by in Crossref: 146] [Cited by in F6Publishing: 38] [Article Influence: 10.4] [Reference Citation Analysis]
103 Goèré D, Gaujoux S, Deschamp F, Dumont F, Souadka A, Dromain C, Ducreux M, Elias D. Patients operated on for initially unresectable colorectal liver metastases with missing metastases experience a favorable long-term outcome. Ann Surg. 2011;254:114-118. [PMID: 21516034 DOI: 10.1097/sla.0b013e31821ad704] [Cited by in Crossref: 25] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
104 Baize N, Gerard B, Bleiberg H, Caroli-bosc F, Berthier F, Legendre H, Pector J, Hendlisz A. Long-term survival of patients downstaged by oxaliplatin and 5-fluorouracil combination followed by rescue surgery for unresectable colorectal liver metastases. Gastroentérologie Clinique et Biologique 2006;30:1349-53. [DOI: 10.1016/s0399-8320(06)73553-9] [Cited by in Crossref: 15] [Cited by in F6Publishing: 3] [Article Influence: 0.9] [Reference Citation Analysis]
105 Narasimhan V, Wright JA, Churchill M, Wang T, Rosati R, Lannagan TRM, Vrbanac L, Richardson AB, Kobayashi H, Price T, Tye GXY, Marker J, Hewett PJ, Flood MP, Pereira S, Whitney GA, Michael M, Tie J, Mukherjee S, Grandori C, Heriot AG, Worthley DL, Ramsay RG, Woods SL. Medium-throughput Drug Screening of Patient-derived Organoids from Colorectal Peritoneal Metastases to Direct Personalized Therapy. Clin Cancer Res 2020;26:3662-70. [PMID: 32376656 DOI: 10.1158/1078-0432.CCR-20-0073] [Cited by in Crossref: 21] [Cited by in F6Publishing: 12] [Article Influence: 10.5] [Reference Citation Analysis]
106 Zhou J, Liu Y, Zhang Y, Li Q, Cao Y. Modeling Tumor Evolutionary Dynamics to Predict Clinical Outcomes for Patients with Metastatic Colorectal Cancer: A Retrospective Analysis. Cancer Res 2020;80:591-601. [PMID: 31676575 DOI: 10.1158/0008-5472.CAN-19-1940] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
107 Ismaili N. Treatment of colorectal liver metastases. World J Surg Oncol. 2011;9:154. [PMID: 22115124 DOI: 10.1186/1477-7819-9-154] [Cited by in Crossref: 44] [Cited by in F6Publishing: 43] [Article Influence: 4.0] [Reference Citation Analysis]
108 McWhirter D, Kitteringham N, Jones RP, Malik H, Park K, Palmer D. Chemotherapy induced hepatotoxicity in metastatic colorectal cancer: a review of mechanisms and outcomes. Crit Rev Oncol Hematol 2013;88:404-15. [PMID: 23786843 DOI: 10.1016/j.critrevonc.2013.05.011] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 3.3] [Reference Citation Analysis]
109 Poston G, Adam R, Vauthey JN. Downstaging or downsizing: time for a new staging system in advanced colorectal cancer? J Clin Oncol 2006;24:2702-6. [PMID: 16782909 DOI: 10.1200/JCO.2006.05.8404] [Cited by in Crossref: 31] [Cited by in F6Publishing: 8] [Article Influence: 1.9] [Reference Citation Analysis]
110 Nafidi O, Désy D, Létourneau R, Côté J, Plasse M, Vandenbroucke F, Roy A, Dagenais M, Lapointe RW. Hypertrophy of the non-embolized liver after chemotherapy. HPB (Oxford) 2009;11:103-7. [PMID: 19590632 DOI: 10.1111/j.1477-2574.2009.00004.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
111 Lin YM, Paolucci I, Brock KK, Odisio BC. Image-Guided Ablation for Colorectal Liver Metastasis: Principles, Current Evidence, and the Path Forward. Cancers (Basel) 2021;13:3926. [PMID: 34439081 DOI: 10.3390/cancers13163926] [Reference Citation Analysis]
112 Morris-Stiff G, Tan YM, Vauthey JN. Hepatic complications following preoperative chemotherapy with oxaliplatin or irinotecan for hepatic colorectal metastases. Eur J Surg Oncol. 2008;34:609-614. [PMID: 17764887 DOI: 10.1016/j.ejso.2007.07.007] [Cited by in Crossref: 81] [Cited by in F6Publishing: 72] [Article Influence: 5.4] [Reference Citation Analysis]
113 Eshkenazy R, Dreznik Y, Lahat E, Zakai BB, Zendel A, Ariche A. Small for size liver remnant following resection: prevention and management. Hepatobiliary Surg Nutr 2014;3:303-12. [PMID: 25392842 DOI: 10.3978/j.issn.2304-3881.2014.09.08] [Cited by in F6Publishing: 15] [Reference Citation Analysis]
114 Tanaka K, Takakura H, Takeda K, Matsuo K, Nagano Y, Endo I. Importance of complete pathologic response to prehepatectomy chemotherapy in treating colorectal cancer metastases. Ann Surg. 2009;250:935-942. [PMID: 19953712 DOI: 10.1097/sla.0b013e3181b0c6e4] [Cited by in Crossref: 69] [Cited by in F6Publishing: 27] [Article Influence: 5.8] [Reference Citation Analysis]
115 Kozol RA, Hyman N, Strong S, Whelan RL, Cha C, Longo WE. Minimizing risk in colon and rectal surgery. Am J Surg 2007;194:576-87. [PMID: 17936417 DOI: 10.1016/j.amjsurg.2007.08.006] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
116 Idrees K, Safar B, Hawkins WG. Unresectable Colorectal Cancer Synchronous Metastases: How to Manage the Primary Tumor. Curr Colorectal Cancer Rep 2012;8:118-22. [DOI: 10.1007/s11888-012-0125-6] [Reference Citation Analysis]
117 Kim K, Kim S, Han K, Bae H, Shin J, Lim JS. Diagnostic Performance of Deep Learning-Based Lesion Detection Algorithm in CT for Detecting Hepatic Metastasis from Colorectal Cancer. Korean J Radiol 2021;22:912-21. [PMID: 33686820 DOI: 10.3348/kjr.2020.0447] [Reference Citation Analysis]
118 Bischof DA, Clary BM, Maithel SK, Pawlik TM. Surgical management of disappearing colorectal liver metastases. Br J Surg. 2013;100:1414-1420. [PMID: 24037559 DOI: 10.1002/bjs.9213] [Cited by in Crossref: 47] [Cited by in F6Publishing: 36] [Article Influence: 5.2] [Reference Citation Analysis]
119 Ishibashi K, Ishida H, Ohsawa T, Okada N, Kumamoto K, Haga N. Impact of hepatic lymph node metastasis on survival of patients with synchronous resectable or unresectable liver metastases of colorectal cancer. Tech Coloproctol 2013;17:51-7. [PMID: 22936589 DOI: 10.1007/s10151-012-0881-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
120 Huh JW, Park YA, Jung EJ, Lee KY, Kwon JE, Sohn SK. Complete remission of unresectable colon cancer after preoperative chemotherapy selected by adenosine triphosphate-based chemotherapy response assay. J Korean Med Sci 2008;23:916-9. [PMID: 18955806 DOI: 10.3346/jkms.2008.23.5.916] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
121 Dunne DF, Jones RP, Malik HZ, Fenwick SW, Poston GJ. Surgical management of colorectal liver metastases: a European perspective. Hepat Oncol. 2014;1:121-133. [PMID: 30190946 DOI: 10.2217/hep.13.3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
122 Barbaro B, Caputo F, Tebala C, Di Stasi C, Vellone M, Giuliante F, Nuzzo G, Bonomo L. Preoperative right portal vein embolisation: indications and results. Radiol Med 2009;114:553-70. [PMID: 19367466 DOI: 10.1007/s11547-009-0383-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
123 Dai S, Xu S, Ye Y, Ding K. Identification of an Immune-Related Gene Signature to Improve Prognosis Prediction in Colorectal Cancer Patients. Front Genet 2020;11:607009. [PMID: 33343640 DOI: 10.3389/fgene.2020.607009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
124 Kataoka K, Kanazawa A, Iwamoto S, Kato T, Nakajima A, Arimoto A. Does "conversion chemotherapy" really improve survival in metastatic colorectal cancer patients with liver-limited disease? World J Surg 2014;38:936-46. [PMID: 24166026 DOI: 10.1007/s00268-013-2305-1] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 2.1] [Reference Citation Analysis]
125 Frank M, Mittendorf T. Influence of pharmacogenomic profiling prior to pharmaceutical treatment in metastatic colorectal cancer on cost effectiveness : a systematic review. Pharmacoeconomics 2013;31:215-28. [PMID: 23338963 DOI: 10.1007/s40273-012-0017-2] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 2.3] [Reference Citation Analysis]
126 Komori H, Beppu T, Baba Y, Horino K, Imsung C, Masuda T, Hayashi H, Okabe H, Ootao R, Watanabe M, Takamori H, Iyama K, Baba H. Histological liver injury and surgical outcome after FOLFOX followed by a hepatectomy for colorectal liver metastases in Japanese patients. Int J Clin Oncol 2010;15:263-70. [DOI: 10.1007/s10147-010-0046-9] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 1.7] [Reference Citation Analysis]
127 Poston GJ, Figueras J, Giuliante F, Nuzzo G, Sobrero AF, Gigot JF, Nordlinger B, Adam R, Gruenberger T, Choti MA, Bilchik AJ, Van Cutsem EJ, Chiang JM, D'Angelica MI. Urgent need for a new staging system in advanced colorectal cancer. J Clin Oncol. 2008;26:4828-4833. [PMID: 18711170 DOI: 10.1200/jco.2008.17.6453] [Cited by in Crossref: 102] [Cited by in F6Publishing: 46] [Article Influence: 7.3] [Reference Citation Analysis]
128 Tsunematsu M, Takahashi N, Murakami K, Misawa T, Akiba T, Yanaga K. Successful conversion surgery for gastric cancer with multiple liver metastases treated after S-1 plus cisplatin combination chemotherapy: a case report. Surg Case Rep 2017;3:95. [PMID: 28853036 DOI: 10.1186/s40792-017-0372-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
129 Bossé D, Ng T, Ahmad C, Alfakeeh A, Alruzug I, Biagi J, Brierley J, Chaudhury P, Cleary S, Colwell B, Cripps C, Dawson LA, Dorreen M, Ferland E, Galiatsatos P, Girard S, Gray S, Halwani F, Kopek N, Mahmud A, Martel G, Robillard L, Samson B, Seal M, Siddiqui J, Sideris L, Snow S, Thirwell M, Vickers M, Goodwin R, Goel R, Hsu T, Tsvetkova E, Ward B, Asmis T. Eastern Canadian Gastrointestinal Cancer Consensus Conference 2016. Curr Oncol 2016;23:e605-14. [PMID: 28050151 DOI: 10.3747/co.23.3394] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
130 Nuzzo G, Giuliante F, Ardito F, Vellone M, Pozzo C, Cassano A, Giovannini I, Barone C. Liver resection for primarily unresectable colorectal metastases downsized by chemotherapy. J Gastrointest Surg. 2007;11:318-324. [PMID: 17458605 DOI: 10.1007/s11605-006-0070-2] [Cited by in Crossref: 41] [Cited by in F6Publishing: 37] [Article Influence: 2.7] [Reference Citation Analysis]
131 Lan YT, Jiang JK, Chang SC, Yang SH, Lin CC, Lin HH, Wang HS, Chen WS, Lin TC, Lin JK. Improved outcomes of colorectal cancer patients with liver metastases in the era of the multidisciplinary teams. Int J Colorectal Dis. 2016;31:403-411. [PMID: 26662193 DOI: 10.1007/s00384-015-2459-4] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 2.9] [Reference Citation Analysis]
132 Schmoll H, Van Cutsem E, Stein A, Valentini V, Glimelius B, Haustermans K, Nordlinger B, van de Velde C, Balmana J, Regula J, Nagtegaal I, Beets-tan R, Arnold D, Ciardiello F, Hoff P, Kerr D, Köhne C, Labianca R, Price T, Scheithauer W, Sobrero A, Tabernero J, Aderka D, Barroso S, Bodoky G, Douillard J, El Ghazaly H, Gallardo J, Garin A, Glynne-jones R, Jordan K, Meshcheryakov A, Papamichail D, Pfeiffer P, Souglakos I, Turhal S, Cervantes A. ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making. Annals of Oncology 2012;23:2479-516. [DOI: 10.1093/annonc/mds236] [78495111110.1093/annonc/mds236','', '1948-5204')">Reference Citation Analysis]
133 Ohkura Y, Shinohara H, Haruta S, Ueno M, Hashimoto M, Sakai Y, Udagawa H. Hepatectomy Offers Superior Survival Compared with Non-surgical Treatment for ≤ 3 Metastatic Tumors with Diameters < 3 cm from Gastric Cancer: A Retrospective Study. World J Surg 2015;39:2757-63. [PMID: 26148522 DOI: 10.1007/s00268-015-3151-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
134 Kuo IM, Huang SF, Chiang JM, Yeh CY, Chan KM, Chen JS, Yu MC. Clinical features and prognosis in hepatectomy for colorectal cancer with centrally located liver metastasis. World J Surg Oncol. 2015;13:92. [PMID: 25889950 DOI: 10.1186/s12957-015-0497-6] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
135 Stintzing S, van Oostrum I, Pescott CP, Ronga P, Heeg B, Heinemann V. Cost-effectiveness of FOLFIRI + cetuximab vs FOLFIRI + bevacizumab in the first-line treatment of RAS wild-type metastatic colorectal cancer in Germany: data from the FIRE-3 (AIO KRK-0306) study. J Med Econ 2020;23:448-55. [PMID: 31903807 DOI: 10.1080/13696998.2019.1709848] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
136 Kennedy A, Brown DB, Feilchenfeldt J, Marshall J, Wasan H, Fakih M, Gibbs P, Knuth A, Sangro B, Soulen MC, Pittari G, Sharma RA. Safety of selective internal radiation therapy (SIRT) with yttrium-90 microspheres combined with systemic anticancer agents: expert consensus. J Gastrointest Oncol 2017;8:1079-99. [PMID: 29299370 DOI: 10.21037/jgo.2017.09.10] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 3.2] [Reference Citation Analysis]
137 Reinacher-Schick AC, Bechstein WO. [Colorectal liver metastases. Neoadjuvant chemotherapy: aspects of medical and surgical oncology]. Internist (Berl) 2007;48:51-8. [PMID: 17160665 DOI: 10.1007/s00108-006-1770-0] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
138 Dede K, Salamon F, Landherr L, Jakab F, Bursics A. Pathologic assessment of response to chemotherapy in colorectal cancer liver metastases after hepatic resection: which method to use? Pathol Oncol Res. 2015;21:173-179. [PMID: 24898285 DOI: 10.1007/s12253-014-9803-9] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
139 Irving GR, Iwuji CO, Morgan B, Berry DP, Steward WP, Thomas A, Brown K, Howells LM. Combining curcumin (C3-complex, Sabinsa) with standard care FOLFOX chemotherapy in patients with inoperable colorectal cancer (CUFOX): study protocol for a randomised control trial. Trials 2015;16:110. [PMID: 25872567 DOI: 10.1186/s13063-015-0641-1] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 5.0] [Reference Citation Analysis]
140 Hemming AW. Heading in the right direction: improved outcome of surgery for advanced colorectal liver metastases. Ann Surg Oncol 2008;15:7-8. [PMID: 17973173 DOI: 10.1245/s10434-007-9620-4] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
141 Cig Media Group Lp. Highlights from: The 2009 American Society of Clinical Oncology Gastrointestinal Cancers Symposium. Clin Colorectal Cancer 2009;8:72-6. [PMID: 19423499 DOI: 10.3816/CCC.2009.n.012] [Reference Citation Analysis]
142 Haraldsdottir S, Wu C, Bloomston M, Goldberg RM. What is the optimal neo-adjuvant treatment for liver metastasis? Ther Adv Med Oncol. 2013;5:221-234. [PMID: 23858331 DOI: 10.1177/1758834013485111] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
143 Okuno M, Goumard C, Mizuno T, Omichi K, Tzeng CD, Chun YS, Aloia TA, Fleming JB, Lee JE, Vauthey JN, Conrad C. Operative and short-term oncologic outcomes of laparoscopic vs open liver resection for colorectal liver metastases located in the posterosuperior liver: a propensity score matching analysis. Surg Endosc. 2018;32:1776-1786. [PMID: 28917012 DOI: 10.1007/s00464-017-5861-x] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 5.6] [Reference Citation Analysis]
144 Liu W, Yan XL, Wang K, Bao Q, Sun Y, Xing BC. The outcome of liver resection and lymphadenectomy for hilar lymph node involvement in colorectal cancer liver metastases. Int J Colorectal Dis 2014;29:737-45. [PMID: 24743847 DOI: 10.1007/s00384-014-1863-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
145 Mitchell D, Puckett Y, Nguyen QN. Literature Review of Current Management of Colorectal Liver Metastasis. Cureus. 2019;11:e3940. [PMID: 30937238 DOI: 10.7759/cureus.3940] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
146 Cetin B, Bilgetekin I, Cengiz M, Ozet A. Managing Synchronous Liver Metastases in Colorectal Cancer. Indian J Surg Oncol 2018;9:461-71. [PMID: 30538373 DOI: 10.1007/s13193-018-0765-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
147 Gruenberger T, Bridgewater J, Chau I, García Alfonso P, Rivoire M, Mudan S, Lasserre S, Hermann F, Waterkamp D, Adam R. Bevacizumab plus mFOLFOX-6 or FOLFOXIRI in patients with initially unresectable liver metastases from colorectal cancer: the OLIVIA multinational randomised phase II trial. Ann Oncol. 2015;26:702-708. [PMID: 25538173 DOI: 10.1093/annonc/mdu580] [Cited by in Crossref: 154] [Cited by in F6Publishing: 128] [Article Influence: 19.3] [Reference Citation Analysis]
148 Van Buren G, Yang AD, Dallas NA, Gray MJ, Lim SJ, Xia L, Fan F, Somcio R, Wu Y, Hicklin DJ, Ellis LM. Effect of Molecular Therapeutics on Liver Regeneration in a Murine Model. JCO 2008;26:1836-42. [DOI: 10.1200/jco.2007.11.6566] [Cited by in Crossref: 46] [Cited by in F6Publishing: 20] [Article Influence: 3.3] [Reference Citation Analysis]
149 Inoue Y, Kusunoki M. Advances and directions in chemotherapy using implantable port systems for colorectal cancer: a historical review. Surg Today 2014;44:1406-14. [PMID: 23893159 DOI: 10.1007/s00595-013-0672-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
150 Faris JE, Ryan DP. Biomarker-Driven Therapy in the Neoadjuvant Treatment of Colorectal Liver Metastases. Curr Colorectal Cancer Rep 2012;8:143-51. [DOI: 10.1007/s11888-012-0123-8] [Reference Citation Analysis]
151 Jamal MH, Hassanain M, Chaudhury P, Tran TT, Wong S, Yousef Y, Jozaghi Y, Salman A, Jabbour S, Simoneau E. Staged hepatectomy for bilobar colorectal hepatic metastases. HPB (Oxford). 2012;14:782-789. [PMID: 23043668 DOI: 10.1111/j.1477-2574.2012.00543.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
152 Rong Z, Martel G, Vandenbroucke-Menu F, Adam R, Lapointe R. Impact of peri-operative bevacizumab on survival in patients with resected colorectal liver metastases: an analysis of the LiverMetSurvey. HPB (Oxford) 2014;16:342-9. [PMID: 24641317 DOI: 10.1111/hpb.12138] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
153 Saxena A, Bester L, Shan L, Perera M, Gibbs P, Meteling B, Morris DL. A systematic review on the safety and efficacy of yttrium-90 radioembolization for unresectable, chemorefractory colorectal cancer liver metastases. J Cancer Res Clin Oncol. 2014;140:537-547. [PMID: 24318568 DOI: 10.1007/s00432-013-1564-4] [Cited by in Crossref: 57] [Cited by in F6Publishing: 43] [Article Influence: 6.3] [Reference Citation Analysis]
154 Pak LM, Kemeny NE, Capanu M, Chou JF, Boucher T, Cercek A, Balachandran VP, Kingham TP, Allen PJ, DeMatteo RP. Prospective phase II trial of combination hepatic artery infusion and systemic chemotherapy for unresectable colorectal liver metastases: Long term results and curative potential. J Surg Oncol. 2018;117:634-643. [PMID: 29165816 DOI: 10.1002/jso.24898] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 5.4] [Reference Citation Analysis]
155 Robinson DBT, Powell AGMT, Waterman J, Hopkins L, James OP, Egan RJ, Lewis WG. Predictive value of Altmetric score on citation rates and bibliometric impact. BJS Open 2021;5:zraa039. [PMID: 33609373 DOI: 10.1093/bjsopen/zraa039] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
156 Kelly C, Cassidy J. Chemotherapy in metastatic colorectal cancer. Surg Oncol. 2007;16:65-70. [PMID: 17521906 DOI: 10.1016/j.suronc.2007.04.006] [Cited by in Crossref: 33] [Cited by in F6Publishing: 28] [Article Influence: 2.2] [Reference Citation Analysis]
157 Ribero D, Wang H, Donadon M, Zorzi D, Thomas MB, Eng C, Chang DZ, Curley SA, Abdalla EK, Ellis LM, Vauthey J. Bevacizumab improves pathologic response and protects against hepatic injury in patients treated with oxaliplatin-based chemotherapy for colorectal liver metastases: Colorectal Liver Metastases and Bevacizumab. Cancer 2007;110:2761-7. [DOI: 10.1002/cncr.23099] [Cited by in Crossref: 286] [Cited by in F6Publishing: 231] [Article Influence: 19.1] [Reference Citation Analysis]
158 Abdel-Misih SR, Schmidt CR, Bloomston PM. Update and review of the multidisciplinary management of stage IV colorectal cancer with liver metastases. World J Surg Oncol 2009;7:72. [PMID: 19788748 DOI: 10.1186/1477-7819-7-72] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
159 Nakamura M, Ojima T, Nakamori M, Katsuda M, Tsuji T, Hayata K, Kato T, Yamaue H. Conversion Surgery for Gastric Cancer with Peritoneal Metastasis Based on the Diagnosis of Second-Look Staging Laparoscopy. J Gastrointest Surg 2019;23:1758-66. [PMID: 30264385 DOI: 10.1007/s11605-018-3983-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
160 Neeff HP, Drognitz O, Klock A, Illerhaus G, Opitz OG, Hopt UT, Makowiec F. Impact of preoperative targeted therapy on postoperative complications after resection of colorectal liver metastases. Int J Colorectal Dis. 2012;27:635-645. [PMID: 22139030 DOI: 10.1007/s00384-011-1360-z] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
161 Nielsen K, Scheffer HJ, Volders JH, van der Vorst MJ, van Tilborg AA, Comans EF, de Lange-de Klerk ES, Sietses C, Meijer S, Meijerink MR, van den Tol MP. Radiofrequency Ablation to Improve Survival After Conversion Chemotherapy for Colorectal Liver Metastases. World J Surg 2016;40:1951-8. [PMID: 27220509 DOI: 10.1007/s00268-016-3554-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
162 Elias D, Goere D, Kohneh-Sahrhi N, de Baere T. Strategies for resection using portal vein embolization: metastatic liver cancer. Semin Intervent Radiol 2008;25:123-31. [PMID: 21326553 DOI: 10.1055/s-2008-1076680] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
163 Shimada H, Tanaka K, Endou I, Ichikawa Y. Treatment for colorectal liver metastases: a review. Langenbecks Arch Surg. 2009;394:973-983. [PMID: 19582473 DOI: 10.1007/s00423-009-0530-8] [Cited by in Crossref: 40] [Cited by in F6Publishing: 38] [Article Influence: 3.1] [Reference Citation Analysis]
164 Studer P, Horn T, Haynes A, Candinas D, Banz VM. Quality of life after hepatic resection. British Journal of Surgery 2018;105:237-43. [DOI: 10.1002/bjs.10735] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
165 Zaniboni A, Savelli G, Pizzocaro C, Basile P, Massetti V. Positron Emission Tomography for the Response Evaluation following Treatment with Chemotherapy in Patients Affected by Colorectal Liver Metastases: A Selected Review. Gastroenterol Res Pract. 2015;2015:706808. [PMID: 26078753 DOI: 10.1155/2015/706808] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
166 Cohen R, Stebbing J, Windsor A. Bevacizumab and surgery: what is the real risk? Future Oncol 2009;5:915-7. [PMID: 19792957 DOI: 10.2217/fon.09.63] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
167 Montalti R, Tomassini F, Laurent S, Smeets P, De Man M, Geboes K, Libbrecht LJ, Troisi RI. Impact of surgical margins on overall and recurrence-free survival in parenchymal-sparing laparoscopic liver resections of colorectal metastases. Surg Endosc. 2015;29:2736-2747. [PMID: 25427420 DOI: 10.1007/s00464-014-3999-3] [Cited by in Crossref: 35] [Cited by in F6Publishing: 29] [Article Influence: 4.4] [Reference Citation Analysis]
168 Vyas S, Bent C, Partelli S, Abraham AT, Hutchins RR, Bhattacharya S, Low D, Fotheringham T, Kocher HM. Portal Vein Embolisation for Extended Hepatectomy: Single-Centre Experience. J Gastrointest Canc 2012;43:413-9. [DOI: 10.1007/s12029-011-9321-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
169 Petrelli F, Barni S. Correlation of progression-free and post-progression survival with overall survival in advanced colorectal cancer. Ann Oncol. 2013;24:186-192. [PMID: 22898038 DOI: 10.1093/annonc/mds289] [Cited by in Crossref: 47] [Cited by in F6Publishing: 50] [Article Influence: 4.7] [Reference Citation Analysis]
170 Patterson NH, Alabdulkarim B, Lazaris A, Thomas A, Marcinkiewicz MM, Gao ZH, Vermeulen PB, Chaurand P, Metrakos P. Assessment of pathological response to therapy using lipid mass spectrometry imaging. Sci Rep 2016;6:36814. [PMID: 27841360 DOI: 10.1038/srep36814] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 4.5] [Reference Citation Analysis]
171 Imai K, Allard MA, Benitez CC, Vibert E, Sa Cunha A, Cherqui D, Castaing D, Bismuth H, Baba H, Adam R. Early Recurrence After Hepatectomy for Colorectal Liver Metastases: What Optimal Definition and What Predictive Factors? Oncologist. 2016;21:887-894. [PMID: 27125753 DOI: 10.1634/theoncologist.2015-0468] [Cited by in Crossref: 42] [Cited by in F6Publishing: 37] [Article Influence: 7.0] [Reference Citation Analysis]
172 Degeling K, Vu M, Koffijberg H, Wong HL, Koopman M, Gibbs P, IJzerman M. Health Economic Models for Metastatic Colorectal Cancer: A Methodological Review. Pharmacoeconomics 2020;38:683-713. [PMID: 32319026 DOI: 10.1007/s40273-020-00908-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
173 Stewart CL, Warner S, Ito K, Raoof M, Wu GX, Kessler J, Kim JY, Fong Y. Cytoreduction for colorectal metastases: liver, lung, peritoneum, lymph nodes, bone, brain. When does it palliate, prolong survival, and potentially cure? Curr Probl Surg 2018;55:330-79. [PMID: 30526930 DOI: 10.1067/j.cpsurg.2018.08.004] [Cited by in Crossref: 38] [Cited by in F6Publishing: 33] [Article Influence: 9.5] [Reference Citation Analysis]
174 Elsamany S, Elsisi GH, Mohamed Hassanin FA, Saleh K, Tashkandi E. Cost-Effectiveness of First-Line Cetuximab in Metastatic Colorectal Cancer in Saudi Arabia. Value Health Reg Issues 2021;28:67-75. [PMID: 34801961 DOI: 10.1016/j.vhri.2021.07.001] [Reference Citation Analysis]
175 Asiyanbola B, Chang D, Gleisner AL, Nathan H, Choti MA, Schulick RD, Pawlik TM. Operative mortality after hepatic resection: are literature-based rates broadly applicable? J Gastrointest Surg. 2008;12:842-851. [PMID: 18266046 DOI: 10.1007/s11605-008-0494-y] [Cited by in Crossref: 114] [Cited by in F6Publishing: 111] [Article Influence: 8.1] [Reference Citation Analysis]
176 Hadaki M, Praseedom R, Brais R, See TC, Balan K, Wilson CB. Selective internal radiation therapy with 90Y-SIR-Spheres microspheres for non-resectable colorectal metastases in the liver. BMJ Case Rep 2011;2011:bcr0120113793. [PMID: 22696750 DOI: 10.1136/bcr.01.2011.3793] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
177 Huh JW, Lee WY, Park YA, Cho YB, Yun SH, Kim HC, Chun HK. Prognostic factors associated with primary cancer in curatively resected stage IV colorectal cancer. J Cancer Res Clin Oncol 2014;140:435-41. [PMID: 24414039 DOI: 10.1007/s00432-013-1580-4] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
178 Sobrero A, De Cian F, Andretta V, Pessino A. Objectives of chemotherapy for unresectable liver metastases: Best response or resection? European Journal of Cancer Supplements 2007;5:317-21. [DOI: 10.1016/s1359-6349(07)70059-9] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
179 Okines A, Puerto OD, Cunningham D, Chau I, Van Cutsem E, Saltz L, Cassidy J. Surgery with curative-intent in patients treated with first-line chemotherapy plus bevacizumab for metastatic colorectal cancer First BEAT and the randomised phase-III NO16966 trial. Br J Cancer 2009;101:1033-8. [PMID: 19789532 DOI: 10.1038/sj.bjc.6605259] [Cited by in Crossref: 128] [Cited by in F6Publishing: 106] [Article Influence: 9.8] [Reference Citation Analysis]
180 Giakoustidis A, Neofytou K, Khan A, Mudan S. Addition of bevacizumab to preoperative chemotherapy for colorectal liver metastases does not increase perioperative morbidity and mortality. Hepat Oncol 2014;1:363-75. [PMID: 30190972 DOI: 10.2217/hep.14.17] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
181 Fong Y. Primary Tumor Resection and Patients With Asymptomatic Colorectal Cancer and Nonresectable Metastases: Results of Recent Randomized Trials. JAMA Surg 2021;156:1101-2. [PMID: 34613343 DOI: 10.1001/jamasurg.2021.5023] [Reference Citation Analysis]
182 Fioole B, Jansen MC, van Duijnhoven FH, van Hillegersberg R, van Gulik TM, Borel Rinkes IH. Combining partial liver resection and local ablation of liver tumours: a preliminary Dutch experience. World J Surg Oncol 2006;4:46. [PMID: 16846515 DOI: 10.1186/1477-7819-4-46] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
183 Takemura N, Saiura A, Koga R, Arita J, Yoshioka R, Ono Y, Hiki N, Sano T, Yamamoto J, Kokudo N, Yamaguchi T. Long-term outcomes after surgical resection for gastric cancer liver metastasis: an analysis of 64 macroscopically complete resections. Langenbecks Arch Surg 2012;397:951-7. [PMID: 22615045 DOI: 10.1007/s00423-012-0959-z] [Cited by in Crossref: 83] [Cited by in F6Publishing: 81] [Article Influence: 8.3] [Reference Citation Analysis]
184 Homayounfar K, Liersch T, Schuetze G, Niessner M, Goralczyk A, Meller J, Langer C, Ghadimi BM, Becker H, Lorf T. Two-stage hepatectomy (R0) with portal vein ligation--towards curing patients with extended bilobular colorectal liver metastases. Int J Colorectal Dis. 2009;24:409-418. [PMID: 19084973 DOI: 10.1007/s00384-008-0620-z] [Cited by in Crossref: 41] [Cited by in F6Publishing: 33] [Article Influence: 2.9] [Reference Citation Analysis]
185 Luz JHM, Veloso Gomes F, Costa NV, Vasco I, Coimbra E, Luz PM, Marques HP, Coelho JS, Mega RMA, Ribeiro VNTV, da Costa Lamelas JTR, de Sampaio Nunes E Sobral MM, da Silva SRG, de Teixeira Carrelha AS, Rodrigues SCC, de Figueiredo AAFP, Santos MV, Bilhim T. BestFLR Trial: Liver Regeneration at CT before Major Hepatectomies for Liver Cancer-A Randomized Controlled Trial Comparing Portal Vein Embolization with N-Butyl-Cyanoacrylate Plus Iodized Oil versus Polyvinyl Alcohol Particles Plus Coils. Radiology 2021;299:715-24. [PMID: 33825512 DOI: 10.1148/radiol.2021204055] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
186 Garufi C, Torsello A, Tumolo S, Ettorre GM, Zeuli M, Campanella C, Vennarecci G, Mottolese M, Sperduti I, Cognetti F. Cetuximab plus chronomodulated irinotecan, 5-fluorouracil, leucovorin and oxaliplatin as neoadjuvant chemotherapy in colorectal liver metastases: POCHER trial. Br J Cancer. 2010;103:1542-1547. [PMID: 20959822 DOI: 10.1038/sj.bjc.6605940] [Cited by in Crossref: 119] [Cited by in F6Publishing: 113] [Article Influence: 9.9] [Reference Citation Analysis]
187 Pulitanò C, Castillo F, Aldrighetti L, Bodingbauer M, Parks RW, Ferla G, Wigmore SJ, Garden OJ. What defines 'cure' after liver resection for colorectal metastases? Results after 10 years of follow-up. HPB (Oxford) 2010;12:244-9. [PMID: 20590894 DOI: 10.1111/j.1477-2574.2010.00155.x] [Cited by in Crossref: 69] [Cited by in F6Publishing: 63] [Article Influence: 5.8] [Reference Citation Analysis]
188 Robles-campos R, Lopez-lopez V, Brusadin R, Lopez-conesa A, Gil-vazquez PJ, Navarro-barrios Á, Parrilla P. Open versus minimally invasive liver surgery for colorectal liver metastases (LapOpHuva): a prospective randomized controlled trial. Surg Endosc 2019;33:3926-36. [DOI: 10.1007/s00464-019-06679-0] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 7.7] [Reference Citation Analysis]
189 Gurusamy KS, Imber C, Davidson BR. Management of the hepatic lymph nodes during resection of liver metastases from colorectal cancer: a systematic review. HPB Surg 2008;2008:684150. [PMID: 18475315 DOI: 10.1155/2008/684150] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 1.7] [Reference Citation Analysis]
190 Assenat E, Desseigne F, Thezenas S, Viret F, Mineur L, Kramar A, Samalin E, Portales F, Bibeau F, Crapez-Lopez E. Cetuximab plus FOLFIRINOX (ERBIRINOX) as first-line treatment for unresectable metastatic colorectal cancer: a phase II trial. Oncologist. 2011;16:1557-1564. [PMID: 22016477 DOI: 10.1634/theoncologist.2011-0141] [Cited by in Crossref: 52] [Cited by in F6Publishing: 53] [Article Influence: 4.7] [Reference Citation Analysis]
191 Requejo AS, Estella VB, Azcárate CH, Muniain JE. [Prognostic factors of colorectal cancer liver metastasis after hepatic resection: Is this a uniform series? Are we talking of the same cases?]. Cir Esp 2009;86:263-4; author reply 264-5. [PMID: 19683223 DOI: 10.1016/j.ciresp.2009.05.014] [Reference Citation Analysis]
192 Stremitzer S, Sunakawa Y, Zhang W, Yang D, Ning Y, Stintzing S, Sebio A, Yamauchi S, Matsusaka S, El-Khoueiry R, Stift J, Wrba F, Gruenberger T, Lenz HJ. Variations in genes involved in immune response checkpoints and association with outcomes in patients with resected colorectal liver metastases. Pharmacogenomics J 2015;15:521-9. [PMID: 25752522 DOI: 10.1038/tpj.2015.14] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
193 Okuno M, Hatano E, Toda R, Nishino H, Nakamura K, Ishii T, Seo S, Taura K, Yasuchika K, Yazawa T, Zaima M, Kanazawa A, Terajima H, Kaihara S, Adachi Y, Inoue N, Furumoto K, Manaka D, Tokuka A, Furuyama H, Doi K, Hirose T, Horimatsu T, Hasegawa S, Matsumoto S, Sakai Y, Uemoto S. Conversion to complete resection with mFOLFOX6 with bevacizumab or cetuximab based on K-RAS status for unresectable colorectal liver metastasis (BECK study): Long-term results of survival. J Hepatobiliary Pancreat Sci 2020;27:496-509. [PMID: 32362018 DOI: 10.1002/jhbp.747] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
194 Soykan EA, Aarts BM, Lopez-Yurda M, Kuhlmann KFD, Erdmann JI, Kok N, van Lienden KP, Wilthagen EA, Beets-Tan RGH, van Delden OM, Gomez FM, Klompenhouwer EG. Predictive Factors for Hypertrophy of the Future Liver Remnant After Portal Vein Embolization: A Systematic Review. Cardiovasc Intervent Radiol 2021;44:1355-66. [PMID: 34142192 DOI: 10.1007/s00270-021-02877-3] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
195 Takahashi S, Konishi M, Kinoshita T, Gotohda N, Kato Y, Saito N, Sugito M, Yoshino T. Predictors for early recurrence after hepatectomy for initially unresectable colorectal liver metastasis. J Gastrointest Surg. 2013;17:939-948. [PMID: 23400510 DOI: 10.1007/s11605-013-2162-0] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
196 Qadan M, D'Angelica MI. Complex Surgical Strategies to Improve Resectability in Borderline-Resectable Disease. Curr Colorectal Cancer Rep. 2015;11:369-377. [PMID: 28090195 DOI: 10.1007/s11888-015-0290-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
197 Lazaris A, Amri A, Petrillo SK, Zoroquiain P, Ibrahim N, Salman A, Gao ZH, Vermeulen PB, Metrakos P. Vascularization of colorectal carcinoma liver metastasis: insight into stratification of patients for anti-angiogenic therapies. J Pathol Clin Res 2018;4:184-92. [PMID: 29654716 DOI: 10.1002/cjp2.100] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 5.8] [Reference Citation Analysis]
198 van Kessel CS, Buckens CF, van den Bosch MA, van Leeuwen MS, van Hillegersberg R, Verkooijen HM. Preoperative imaging of colorectal liver metastases after neoadjuvant chemotherapy: a meta-analysis. Ann Surg Oncol. 2012;19:2805-2813. [PMID: 22396005 DOI: 10.1245/s10434-012-2300-z] [Cited by in Crossref: 109] [Cited by in F6Publishing: 82] [Article Influence: 10.9] [Reference Citation Analysis]
199 Coimbra FJ, Ribeiro HS, Marques MC, Herman P, Chojniak R, Kalil AN, Wiermann EG, Cavallero SR, Coelho FF, Fernandes PH, Silvestrini AA, Almeida MF, de Araújo AL, Pitombo M, Teixeira HM, Waechter FL, Ferreira FG, Diniz AL, D'Ippolito G, D'Ippolito G, Begnami MD, Prolla G, Balzan SM, de Oliveira TB, Szultan LA, Lendoire J, Torres OJ. FIRST BRAZILIAN CONSENSUS ON MULTIMODAL TREATMENT OF COLORECTAL LIVER METASTASES. MODULE 1: PRE-TREATMENT EVALUATION. Arq Bras Cir Dig 2015;28:222-30. [PMID: 26734788 DOI: 10.1590/S0102-6720201500040002] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
200 Cauchy F, Aussilhou B, Dokmak S, Fuks D, Gaujoux S, Farges O, Faivre S, Lepillé D, Belghiti J. Reappraisal of the risks and benefits of major liver resection in patients with initially unresectable colorectal liver metastases. Ann Surg 2012;256:746-52; discussion 752-4. [PMID: 23095618 DOI: 10.1097/SLA.0b013e3182738204] [Cited by in Crossref: 52] [Cited by in F6Publishing: 15] [Article Influence: 5.8] [Reference Citation Analysis]
201 Hashizume R, Kawahara H, Ogawa M, Suwa K, Eto K, Yanaga K. CA19-9 Concentration After First-line Chemotherapy Is Prognostic Predictor of Metastatic Colon Cancer. In Vivo 2019;33:2087-93. [PMID: 31662542 DOI: 10.21873/invivo.11708] [Reference Citation Analysis]
202 Schwarz RE, Berlin JD, Lenz HJ, Nordlinger B, Rubbia-Brandt L, Choti MA. Systemic cytotoxic and biological therapies of colorectal liver metastases: expert consensus statement. HPB (Oxford) 2013;15:106-15. [PMID: 23297721 DOI: 10.1111/j.1477-2574.2012.00558.x] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 3.3] [Reference Citation Analysis]
203 Parmar KL, O'Reilly D, Valle JW, Braun M, Naish JH, Williams SR, Lloyd WK, Malcomson L, Cresswell K, Bamford C, Renehan AG. Prospective study of change in liver function and fat in patients with colorectal liver metastases undergoing preoperative chemotherapy: protocol for the CLiFF Study. BMJ Open 2020;10:e027630. [PMID: 32967864 DOI: 10.1136/bmjopen-2018-027630] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
204 Konishi T, Yoshidome H, Shimizu H, Yoshitomi H, Furukawa K, Takayashiki T, Kuboki S, Takano S, Miyazaki M, Ohtsuka M. Splenic enlargement induced by preoperative chemotherapy is a useful indicator for predicting liver regeneration after resection for colorectal liver metastases. World J Surg Oncol 2020;18:139. [PMID: 32576191 DOI: 10.1186/s12957-020-01918-4] [Reference Citation Analysis]
205 García-Alfonso P, Ferrer A, Gil S, Dueñas R, Pérez MT, Molina R, Capdevila J, Safont MJ, Castañón C, Cano JM, Lara R. Neoadjuvant and conversion treatment of patients with colorectal liver metastasis: the potential role of bevacizumab and other antiangiogenic agents. Target Oncol 2015;10:453-65. [PMID: 25752908 DOI: 10.1007/s11523-015-0362-0] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
206 Hou RM, Chu F, Zhao J, Morris DL. The effects of surgical margin and edge cryotherapy after liver resection for colorectal cancer metastases. HPB (Oxford) 2007;9:201-7. [PMID: 18333223 DOI: 10.1080/13651820701275113] [Cited by in Crossref: 13] [Cited by in F6Publishing: 4] [Article Influence: 1.1] [Reference Citation Analysis]
207 Schmoll HJ, Van Cutsem E, Stein A, Valentini V, Glimelius B, Haustermans K, Nordlinger B, van de Velde CJ, Balmana J, Regula J. ESMO Consensus Guidelines for management of patients with colon and rectal cancer. a personalized approach to clinical decision making. Ann Oncol. 2012;23:2479-2516. [PMID: 23012255 DOI: 10.1093/annonc/mds236] [Cited by in Crossref: 877] [Cited by in F6Publishing: 791] [Article Influence: 97.4] [Reference Citation Analysis]
208 Boilève A, Maillard A, Wagner M, Dromain C, Laurent C, Dupont Bierre E, Le Sourd S, Audemar F, Ulusakarya A, Guerin-Meyer V, Smisth D, Pezzella V, De Baere T, Goere D, Gelli M, Taieb J, Boige V. Treatment intensification with hepatic arterial infusion chemotherapy in patients with liver-only colorectal metastases still unresectable after systemic induction chemotherapy - a randomized phase II study -- SULTAN UCGI 30/PRODIGE 53 (NCT03164655)- study protocol. BMC Cancer 2020;20:74. [PMID: 32000724 DOI: 10.1186/s12885-020-6571-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
209 Miura S, Ito K, Takemura N, Mihara F, Kiyomatsu T, Kokudo N. Complete remission of multiple liver metastases with only partial response of the primary rectal cancer after neoadjuvant chemotherapy. Surg Case Rep 2020;6:46. [PMID: 32107670 DOI: 10.1186/s40792-020-00807-y] [Reference Citation Analysis]
210 Wong R, Cunningham D, Barbachano Y, Saffery C, Valle J, Hickish T, Mudan S, Brown G, Khan A, Wotherspoon A, Strimpakos AS, Thomas J, Compton S, Chua YJ, Chau I. A multicentre study of capecitabine, oxaliplatin plus bevacizumab as perioperative treatment of patients with poor-risk colorectal liver-only metastases not selected for upfront resection. Ann Oncol. 2011;22:2042-2048. [PMID: 21285134 DOI: 10.1093/annonc/mdq714] [Cited by in Crossref: 144] [Cited by in F6Publishing: 119] [Article Influence: 13.1] [Reference Citation Analysis]
211 Goéré D, Deshaies I, de Baere T, Boige V, Malka D, Dumont F, Dromain C, Ducreux M, Elias D. Prolonged survival of initially unresectable hepatic colorectal cancer patients treated with hepatic arterial infusion of oxaliplatin followed by radical surgery of metastases. Ann Surg. 2010;251:686-691. [PMID: 20224373 DOI: 10.1097/sla.0b013e3181d35983] [Cited by in Crossref: 92] [Cited by in F6Publishing: 29] [Article Influence: 7.7] [Reference Citation Analysis]
212 Karakousis G, Fong Y. The case for selective use of pre-operative chemotherapy for hepatic colorectal metastases: more is not always better. Ann Surg Oncol 2009;16:2086-8. [PMID: 19513600 DOI: 10.1245/s10434-009-0539-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
213 Gallinger S, Biagi JJ, Fletcher GG, Nhan C, Ruo L, McLeod RS. Liver resection for colorectal cancer metastases. Curr Oncol. 2013;20:e255-e265. [PMID: 23737695 DOI: 10.3747/co.20.1341] [Cited by in Crossref: 39] [Cited by in F6Publishing: 39] [Article Influence: 4.3] [Reference Citation Analysis]
214 Wang Y, Wang ZQ, Wang FH, Yuan YF, Li BK, Ding PR, Chen G, Wu XJ, Lu ZH, Pan ZZ. The Role of Adjuvant Chemotherapy for Colorectal Liver Metastasectomy after Pre-Operative Chemotherapy: Is the Treatment Worthwhile? J Cancer. 2017;8:1179-1186. [PMID: 28607592 DOI: 10.7150/jca.18091] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
215 Hallet J, Sa Cunha A, Adam R, Goéré D, Bachellier P, Azoulay D, Ayav A, Grégoire E, Navarro F, Pessaux P; French Colorectal Liver Metastases Working Group, Association Française de Chirurgie (AFC). Factors influencing recurrence following initial hepatectomy for colorectal liver metastases. Br J Surg 2016;103:1366-76. [PMID: 27306949 DOI: 10.1002/bjs.10191] [Cited by in Crossref: 38] [Cited by in F6Publishing: 33] [Article Influence: 6.3] [Reference Citation Analysis]
216 Terashima M. Conversion therapy for gastric cancer: who can make conversion as successful as Goromaru? Gastric Cancer 2016;19:685-6. [PMID: 27055560 DOI: 10.1007/s10120-016-0609-1] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
217 Arnold D, Siewczynski R, Schmoll H. The integration of targeted agents into systemic therapy of metastatic colorectal cancer. Annals of Oncology 2006;17:x122-8. [DOI: 10.1093/annonc/mdl249] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
218 Moris D, Ronnekleiv-Kelly S, Rahnemai-Azar AA, Felekouras E, Dillhoff M, Schmidt C, Pawlik TM. Parenchymal-Sparing Versus Anatomic Liver Resection for Colorectal Liver Metastases: a Systematic Review. J Gastrointest Surg. 2017;21:1076-1085. [PMID: 28364212 DOI: 10.1007/s11605-017-3397-y] [Cited by in Crossref: 56] [Cited by in F6Publishing: 46] [Article Influence: 11.2] [Reference Citation Analysis]
219 Zeng X, Ward SE, Zhou J, Cheng ASL. Liver Immune Microenvironment and Metastasis from Colorectal Cancer-Pathogenesis and Therapeutic Perspectives. Cancers (Basel) 2021;13:2418. [PMID: 34067719 DOI: 10.3390/cancers13102418] [Reference Citation Analysis]
220 Kardassis D, Ntinas A, Miliaras D, Kofokotsios A, Papazisis K, Vrochides D. Patients with multiple synchronous colonic cancer hepatic metastases benefit from enrolment in a “liver first” approach protocol. World J Hepatol 2014; 6(7): 513-519 [PMID: 25068003 DOI: 10.4254/wjh.v6.i7.513] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
221 Torres OJ, Marques MC, Santos FN, Farias IC, Coutinho AK, Oliveira CV, Kalil AN, Mello CA, Kruger JA, Fernandes GD, Quireze C Jr, Murad AM, Silva MJ, Zurstrassen CE, Freitas HC, Cruz MR, Weschenfelder R, Linhares MM, Castro LD, Vollmer C, Dixon E, Ribeiro HS, Coimbra FJ. BRAZILIAN CONSENSUS FOR MULTIMODAL TREATMENT OF COLORECTAL LIVER METASTASES. MODULE 3: CONTROVERSIES AND UNRESECTABLE METASTASES. Arq Bras Cir Dig 2016;29:173-9. [PMID: 27759781 DOI: 10.1590/0102-6720201600030011] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
222 Lalmahomed ZS, Ayez N, van der Pool AE, Verheij J, IJzermans JN, Verhoef C. Anatomical versus nonanatomical resection of colorectal liver metastases: is there a difference in surgical and oncological outcome? World J Surg. 2011;35:656-661. [PMID: 21161655 DOI: 10.1007/s00268-010-0890-9] [Cited by in Crossref: 37] [Cited by in F6Publishing: 35] [Article Influence: 3.4] [Reference Citation Analysis]
223 Nguyen-Khac E, Lobry C, Chatelain D, Fuks D, Joly JP, Brevet M, Tramier B, Mouly C, Hautefeuille V, Chauffert B, Regimbeau JM. A Reappraisal of Chemotherapy-Induced Liver Injury in Colorectal Liver Metastases before the Era of Antiangiogenics. Int J Hepatol 2013;2013:314868. [PMID: 23533786 DOI: 10.1155/2013/314868] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
224 Vyas S, Markar S, Partelli S, Fotheringham T, Low D, Imber C, Malago M, Kocher HM. Portal vein embolization and ligation for extended hepatectomy. Indian J Surg Oncol. 2014;5:30-42. [PMID: 24669163 DOI: 10.1007/s13193-013-0279-y] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
225 Lubezky N, Winograd E, Papoulas M, Lahat G, Shacham-Shmueli E, Geva R, Nakache R, Klausner J, Ben-Haim M. Perioperative complications after neoadjuvant chemotherapy with and without bevacizumab for colorectal liver metastases. J Gastrointest Surg. 2013;17:527-532. [PMID: 23299220 DOI: 10.1007/s11605-012-2108-y] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
226 Abdalla EK, Bauer TW, Chun YS, D’Angelica M, Kooby DA, Jarnagin WR. Locoregional surgical and interventional therapies for advanced colorectal cancer liver metastases: expert consensus statements. HPB (Oxford). 2013;15:119-130. [PMID: 23297723 DOI: 10.1111/j.1477-2574.2012.00597.x] [Cited by in Crossref: 58] [Cited by in F6Publishing: 54] [Article Influence: 6.4] [Reference Citation Analysis]
227 de Wilt JH, Vermaas M, Ferenschild FT, Verhoef C. Management of locally advanced primary and recurrent rectal cancer. Clin Colon Rectal Surg 2007;20:255-63. [PMID: 20011207 DOI: 10.1055/s-2007-984870] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 2.0] [Reference Citation Analysis]
228 Kim YW, Kim IY. The Role of Surgery for Asymptomatic Primary Tumors in Unresectable Stage IV Colorectal Cancer. Ann Coloproctol 2013;29:44-54. [PMID: 23700570 DOI: 10.3393/ac.2013.29.2.44] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
229 Kanas GP, Taylor A, Primrose JN, Langeberg WJ, Kelsh MA, Mowat FS, Alexander DD, Choti MA, Poston G. Survival after liver resection in metastatic colorectal cancer: review and meta-analysis of prognostic factors. Clin Epidemiol. 2012;4:283-301. [PMID: 23152705 DOI: 10.2147/clep.s34285] [Cited by in Crossref: 67] [Cited by in F6Publishing: 154] [Article Influence: 6.7] [Reference Citation Analysis]
230 Vreuls CP, Olde Damink SW, Koek GH, Winstanley A, Wisse E, Cloots RH, van den Broek MA, Dejong CH, Bosman FT, Driessen A. Glutathione S-transferase M1-null genotype as risk factor for SOS in oxaliplatin-treated patients with metastatic colorectal cancer. Br J Cancer 2013;108:676-80. [PMID: 23287989 DOI: 10.1038/bjc.2012.590] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
231 Horton PJ, Chaudhury PK, Znajda TL, Martinie JB, Rochon C, Tzimas GN, Metrakos P. Novel two-step resection for lesions between the middle hepatic vein and vena cava which allows the middle hepatic vein to be preserved. J Gastrointest Surg 2006;10:69-76. [PMID: 16368493 DOI: 10.1016/j.gassur.2005.07.023] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
232 Wee IJY, Syn N, Lee LS, Tan SS, Chiow AKH. A systematic review and meta-analysis on the quality of life after hepatic resection. HPB (Oxford). 2020;22:177-186. [PMID: 32008917 DOI: 10.1016/j.hpb.2019.11.016] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
233 Imai K, Benitez CC, Allard M, Vibert E, Cunha AS, Cherqui D, Castaing D, Bismuth H, Baba H, Adam R. Impact of Surgical Treatment for Recurrence After 2-Stage Hepatectomy for Colorectal Liver Metastases, on Patient Outcome. Annals of Surgery 2019;269:322-30. [DOI: 10.1097/sla.0000000000002472] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 4.7] [Reference Citation Analysis]
234 Ramírez-Plaza CP, Moreno-Ruiz FJ, Pérez-Daga JA. A multidisciplinary approach for peritoneal carcinomatosis and bilobar liver metastases from colorectal cancer: case report and review of the literature. World J Surg Oncol 2015;13:233. [PMID: 26231227 DOI: 10.1186/s12957-015-0654-y] [Reference Citation Analysis]
235 Gueorguiev AL, Mackey R, Kowdley GC, Esquivel J, Cunningham SC. Minimally invasive evaluation and treatment of colorectal liver metastases. Int J Surg Oncol 2011;2011:686030. [PMID: 22312518 DOI: 10.1155/2011/686030] [Reference Citation Analysis]
236 Fong Y, Bentrem DJ. CASH (Chemotherapy-Associated Steatohepatitis) costs. Ann Surg. 2006;243:8-9. [PMID: 16371729 DOI: 10.1097/01.sla.0000193599.57858.9b] [Cited by in Crossref: 80] [Cited by in F6Publishing: 70] [Article Influence: 5.0] [Reference Citation Analysis]
237 Farquharson MJ, Al-ebraheem A, Theodorakou C, Ryan E, Bradley DA, Gurusamy K, Davidson B. Measurement of K, Fe, Cu and Zn levels in secondary colorectal liver cancer and surrounding normal liver tissue, and their potential as a tissue classifier. X-Ray Spectrom 2009;38:81-8. [DOI: 10.1002/xrs.1121] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
238 Xu D, Liu XF, Yan XL, Wang K, Xing BC. Survival prediction in patients with resectable colorectal liver metastases: Clinical risk scores and tumor response to chemotherapy. Oncol Lett 2017;14:8051-9. [PMID: 29344248 DOI: 10.3892/ol.2017.7191] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
239 Kitano Y, Hayashi H, Matsumoto T, Kinoshita S, Sato H, Shiraishi Y, Nakao Y, Kaida T, Imai K, Yamashita YI, Baba H. Borderline resectable for colorectal liver metastases: Present status and future perspective. World J Gastrointest Surg 2021; 13(8): 756-763 [PMID: 34512899 DOI: 10.4240/wjgs.v13.i8.756] [Reference Citation Analysis]
240 Spatz H, Anthuber M. Surgery of colon cancer (conventional open and laparoscopic surgery). Eur Surg 2010;42:260-6. [DOI: 10.1007/s10353-010-0572-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
241 Shen P, Stewart JH, Levine EA. The Role of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Metastatic Colorectal Cancer with Peritoneal Surface Disease. Current Problems in Cancer 2009;33:154-67. [DOI: 10.1016/j.currproblcancer.2009.06.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
242 Kim CW, Lee JL, Yoon YS, Park IJ, Lim SB, Yu CS, Kim TW, Kim JC. Resection after preoperative chemotherapy versus synchronous liver resection of colorectal cancer liver metastases: A propensity score matching analysis. Medicine (Baltimore) 2017;96:e6174. [PMID: 28207557 DOI: 10.1097/MD.0000000000006174] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
243 Juez I, Rubio C, Figueras J. Multidisciplinary approach of colorectal liver metastases. Clin Transl Oncol. 2011;13:721-727. [PMID: 21975333 DOI: 10.1007/s12094-011-0722-x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
244 Vigano L, De Rosa G, Toso C, Andres A, Ferrero A, Roth A, Sperti E, Majno P, Rubbia-brandt L. Reversibility of chemotherapy-related liver injury. Journal of Hepatology 2017;67:84-91. [DOI: 10.1016/j.jhep.2017.02.031] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 7.2] [Reference Citation Analysis]
245 Mohammad WM, Balaa FK. Surgical management of colorectal liver metastases. Clin Colon Rectal Surg. 2009;22:225-232. [PMID: 21037813 DOI: 10.1055/s-0029-1242462.] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
246 Jourabchi N, Sauk S, Hoffman C, Lee EW, Kee ST. Intercostal artery pseudoaneurysm formation after irinotecan transarterial chemoembolization of a spinal metastasis from colorectal cancer. Case Rep Radiol 2012;2012:146540. [PMID: 23316405 DOI: 10.1155/2012/146540] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
247 Lang H, Baumgart J, Heinrich S, Tripke V, Passalaqua M, Maderer A, Galle PR, Roth W, Kloth M, Moehler M. Extended Molecular Profiling Improves Stratification and Prediction of Survival After Resection of Colorectal Liver Metastases. Ann Surg. 2019;270:799-805. [PMID: 31634180 DOI: 10.1097/sla.0000000000003527] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 9.5] [Reference Citation Analysis]
248 Wang Y, Zhang GY, Xu LC, He XH, Huang HZ, Li GD, Wang YH, Wang GZ, Li WT. Clinical Outcomes and Predictors in Patients With Unresectable Colorectal Cancer Liver Metastases Following Salvage Percutaneous Radiofrequency Ablation: A Single Center Preliminary Experience. Technol Cancer Res Treat 2020;19:1533033820963662. [PMID: 33034276 DOI: 10.1177/1533033820963662] [Reference Citation Analysis]
249 Watkins DJ, Chau I, Cunningham D, Mudan SS, Karanjia N, Brown G, Ashley S, Norman AR, Gillbanks A. Defining patient outcomes in stage IV colorectal cancer: a prospective study with baseline stratification according to disease resectability status. Br J Cancer 2010;102:255-61. [PMID: 20087355 DOI: 10.1038/sj.bjc.6605508] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
250 Eveno C, Karoui M, Gayat E, Luciani A, Auriault ML, Kluger MD, Baumgaertner I, Baranes L, Laurent A, Tayar C, Azoulay D, Cherqui D. Liver resection for colorectal liver metastases with peri-operative chemotherapy: oncological results of R1 resections. HPB (Oxford) 2013;15:359-64. [PMID: 23458567 DOI: 10.1111/j.1477-2574.2012.00581.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
251 Tanaka K, Ichikawa Y, Endo I. Liver resection for advanced or aggressive colorectal cancer metastases in the era of effective chemotherapy: a review. Int J Clin Oncol. 2011;16:452-463. [PMID: 21786210 DOI: 10.1007/s10147-011-0291-6] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
252 Nesbitt C, Glendinning RJ, Byrne C, Poston GJ. Factors that influence treatment strategies in advanced colorectal cancer. Eur J Surg Oncol 2007;33 Suppl 2:S88-94. [PMID: 18023553 DOI: 10.1016/j.ejso.2007.09.019] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
253 Gurusamy KS, Ramamoorthy R, Imber C, Davidson BR. Surgical resection versus non-surgical treatment for hepatic node positive patients with colorectal liver metastases. Cochrane Database Syst Rev 2010;:CD006797. [PMID: 20091607 DOI: 10.1002/14651858.CD006797.pub2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
254 Pessaux P, Chenard MP, Bachellier P, Jaeck D. Consequences of chemotherapy on resection of colorectal liver metastases. J Visc Surg. 2010;147:e193-e201. [PMID: 20655821 DOI: 10.1016/j.jviscsurg.2010.06.004] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 2.4] [Reference Citation Analysis]
255 Guye ML, Schoellhammer HF, Chiu LW, Kim J, Lai LL, Singh G. Designing liver resections and pushing the envelope with resections for hepatic colorectal metastases. Indian J Surg Oncol 2013;4:349-55. [PMID: 24426756 DOI: 10.1007/s13193-013-0256-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
256 Wakiya T, Kudo D, Ishido K, Kimura N, Yakoshi Y, Toyoki Y, Kijima H, Hakamada K. Effect of age on the development of chemotherapy-associated liver injury in colorectal cancer liver metastasis. Mol Clin Oncol 2017;7:200-4. [PMID: 28781785 DOI: 10.3892/mco.2017.1314] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
257 Grothey A. Medical treatment of advanced colorectal cancer in 2009. Ther Adv Med Oncol 2009;1:55-68. [PMID: 21789113 DOI: 10.1177/1758834009343302] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
258 Zendel A, Lahat E, Dreznik Y, Zakai BB, Eshkenazy R, Ariche A. "Vanishing liver metastases"-A real challenge for liver surgeons. Hepatobiliary Surg Nutr. 2014;3:295-302. [PMID: 25392841 DOI: 10.3978/j.issn.2304-3881.2014.09.13] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
259 Shubert CR, Habermann EB, Bergquist JR, Thiels CA, Thomsen KM, Kremers WK, Kendrick ML, Cima RR, Nagorney DM. A NSQIP Review of Major Morbidity and Mortality of Synchronous Liver Resection for Colorectal Metastasis Stratified by Extent of Liver Resection and Type of Colorectal Resection. J Gastrointest Surg. 2015;19:1982-1994. [PMID: 26239515 DOI: 10.1007/s11605-015-2895-z] [Cited by in Crossref: 36] [Cited by in F6Publishing: 31] [Article Influence: 5.1] [Reference Citation Analysis]
260 Stang A, Oldhafer KJ, Weilert H, Keles H, Donati M. Selection criteria for radiofrequency ablation for colorectal liver metastases in the era of effective systemic therapy: a clinical score based proposal. BMC Cancer 2014;14:500. [PMID: 25016394 DOI: 10.1186/1471-2407-14-500] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
261 Wada Y, Takami Y, Tateishi M, Ryu T, Mikagi K, Saitsu H. Efficacy of surgical treatment using microwave coagulo-necrotic therapy for unresectable multiple colorectal liver metastases. Onco Targets Ther 2016;9:937-43. [PMID: 26955286 DOI: 10.2147/OTT.S97824] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
262 Tan KK, Hong CC, Zhang J, Liu JZ, Sim R. Surgery for perforated colorectal malignancy in an Asian population: an institution’s experience over 5 years. Int J Colorectal Dis. 2010;25:989-995. [PMID: 20390285 DOI: 10.1007/s00384-010-0945-2] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
263 Lin Q, Ye Q, Zhu D, Wei Y, Ren L, Zheng P, Xu P, Ye L, Lv M, Fan J, Xu J. Comparison of minimally invasive and open colorectal resections for patients undergoing simultaneous R0 resection for liver metastases: a propensity score analysis. Int J Colorectal Dis. 2015;30:385-395. [PMID: 25503803 DOI: 10.1007/s00384-014-2089-2] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 3.0] [Reference Citation Analysis]
264 Kawamura J, Yazawa T, Sumida K, Kida Y, Ogawa R, Tani M, Kawasoe J, Yamamoto M, Harada H, Yamamoto H, Zaima M. Clinical efficacy of liver resection after downsizing systemic chemotherapy for initially unresectable liver metastases. World J Surg Oncol 2016;14:56. [PMID: 26911142 DOI: 10.1186/s12957-016-0807-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
265 Basso M, Dadduzio V, Ardito F, Lombardi P, Strippoli A, Vellone M, Orlandi A, Rossi S, Cerchiaro E, Cassano A, Giuliante F, Barone C. Conversion Chemotherapy for Technically Unresectable Colorectal Liver Metastases: A Retrospective, STROBE-Compliant, Single-Center Study Comparing Chemotherapy Alone and Combination Chemotherapy With Cetuximab or Bevacizumab. Medicine (Baltimore) 2016;95:e3722. [PMID: 27196492 DOI: 10.1097/MD.0000000000003722] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 2.4] [Reference Citation Analysis]
266 Bertolini F, Malavasi N, Scarabelli L, Fiocchi F, Bagni B, Del Giovane C, Colucci G, Gerunda GE, Depenni R, Zironi S, Fontana A, Pettorelli E, Luppi G, Conte PF. FOLFOX6 and bevacizumab in non-optimally resectable liver metastases from colorectal cancer. Br J Cancer 2011;104:1079-84. [PMID: 21386839 DOI: 10.1038/bjc.2011.43] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 2.5] [Reference Citation Analysis]
267 Mitsuyama Y, Shiba H, Haruki K, Fujiwara Y, Furukawa K, Iida T, Hayashi T, Ogawa M, Ishida Y, Misawa T, Kashiwagi H, Yanaga K. Carcinoembryonic antigen and carbohydrate antigen 19-9 are prognostic predictors of colorectal cancer with unresectable liver metastasis. Oncol Lett 2012;3:767-71. [PMID: 22740990 DOI: 10.3892/ol.2012.574] [Cited by in Crossref: 1] [Cited by in F6Publishing: 7] [Article Influence: 0.1] [Reference Citation Analysis]
268 Narita M, Oussoultzoglou E, Jaeck D, Fuchschuber P, Rosso E, Pessaux P, Marzano E, Bachellier P. Two-stage hepatectomy for multiple bilobar colorectal liver metastases. Br J Surg. 2011;98:1463-1475. [PMID: 21710481 DOI: 10.1002/bjs.7580] [Cited by in Crossref: 97] [Cited by in F6Publishing: 85] [Article Influence: 8.8] [Reference Citation Analysis]
269 Pereira PL. Actual role of radiofrequency ablation of liver metastases. Eur Radiol 2007;17:2062-70. [PMID: 17429644 DOI: 10.1007/s00330-007-0587-0] [Cited by in Crossref: 73] [Cited by in F6Publishing: 57] [Article Influence: 4.9] [Reference Citation Analysis]
270 Kawaguchi Y, De Bellis M, Panettieri E, Duwe G, Vauthey JN. Debate: Improvements in Systemic Therapies for Liver Metastases Will Increase the Role of Locoregional Treatments. Surg Oncol Clin N Am 2021;30:205-18. [PMID: 33220806 DOI: 10.1016/j.soc.2020.08.009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
271 Riby D, Mazzotta AD, Bergeat D, Verdure L, Sulpice L, Bourien H, Lièvre A, Rolland Y, Garin E, Boudjema K, Edeline J. Downstaging with Radioembolization or Chemotherapy for Initially Unresectable Intrahepatic Cholangiocarcinoma. Ann Surg Oncol 2020;27:3729-37. [PMID: 32472411 DOI: 10.1245/s10434-020-08486-7] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
272 Lévi F, Karaboué A, Saffroy R, Desterke C, Boige V, Smith D, Hebbar M, Innominato P, Taieb J, Carvalho C, Guimbaud R, Focan C, Bouchahda M, Adam R, Ducreux M, Milano G, Lemoine A. Pharmacogenetic determinants of outcomes on triplet hepatic artery infusion and intravenous cetuximab for liver metastases from colorectal cancer (European trial OPTILIV, NCT00852228). Br J Cancer 2017;117:965-73. [PMID: 28817838 DOI: 10.1038/bjc.2017.278] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
273 Bertolini F, Malavasi N, Scarabelli L, Fiocchi F, Bagni B, Del Giovane C, Colucci G, Gerunda GE, Depenni R, Zironi S. FOLFOX6 and bevacizumab in non-optimally resectable liver metastases from colorectal cancer. Br J Cancer. 2011;104:1079-1084. [PMID: 21386839 DOI: 10.1038/bjc.2011] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
274 Harty G, Jarrett J, Jofre-Bonet M. Consequences of Biomarker Analysis on the Cost-Effectiveness of Cetuximab in Combination with FOLFIRI as a First-Line Treatment of Metastatic Colorectal Cancer: Personalised Medicine at Work. Appl Health Econ Health Policy 2018;16:515-25. [PMID: 29948926 DOI: 10.1007/s40258-018-0395-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
275 Dijkstra M, Nieuwenhuizen S, Puijk RS, Geboers B, Timmer FEF, Schouten EAC, Scheffer HJ, de Vries JJJ, Ket JCF, Versteeg KS, Meijerink MR, van den Tol MP. The Role of Neoadjuvant Chemotherapy in Repeat Local Treatment of Recurrent Colorectal Liver Metastases: A Systematic Review and Meta-Analysis. Cancers (Basel) 2021;13:378. [PMID: 33561088 DOI: 10.3390/cancers13030378] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
276 Katz M, Vauthey JN. Potentially curable metastatic colorectal cancer. Curr Oncol Rep 2008;10:225-31. [PMID: 18765153 DOI: 10.1007/s11912-008-0035-6] [Reference Citation Analysis]
277 Sato Y, Ohnuma H, Nobuoka T, Hirakawa M, Sagawa T, Fujikawa K, Takahashi Y, Shinya M, Katsuki S, Takahashi M, Maeda M, Okagawa Y, Naoki U, Kikuch S, Okamoto K, Miyamoto H, Shimada M, Takemasa I, Kato J, Takayama T. Conversion therapy for inoperable advanced gastric cancer patients by docetaxel, cisplatin, and S-1 (DCS) chemotherapy: a multi-institutional retrospective study. Gastric Cancer 2017;20:517-26. [PMID: 27553665 DOI: 10.1007/s10120-016-0633-1] [Cited by in Crossref: 28] [Cited by in F6Publishing: 34] [Article Influence: 4.7] [Reference Citation Analysis]
278 Janne d'Othée B, Sofocleous CT, Hanna N, Lewandowski RJ, Soulen MC, Vauthey JN, Cohen SJ, Venook AP, Johnson MS, Kennedy AS, Murthy R, Geschwind JF, Kee ST. Development of a research agenda for the management of metastatic colorectal cancer: proceedings from a multidisciplinary research consensus panel. J Vasc Interv Radiol 2012;23:153-63. [PMID: 22264550 DOI: 10.1016/j.jvir.2011.12.003] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
279 Lévi F, Focan C, Karaboué A, de la Valette V, Focan-Henrard D, Baron B, Kreutz F, Giacchetti S. Implications of circadian clocks for the rhythmic delivery of cancer therapeutics. Adv Drug Deliv Rev. 2007;59:1015-1035. [PMID: 17692427 DOI: 10.1016/j.addr.2006.11.001] [Cited by in Crossref: 108] [Cited by in F6Publishing: 87] [Article Influence: 7.2] [Reference Citation Analysis]
280 Untereiner X, Cagniet A, Memeo R, Tzedakis S, Piardi T, Severac F, Mutter D, Kianmanesh R, Marescaux J, Sommacale D, Pessaux P. Laparoscopic hepatectomy versus open hepatectomy for colorectal cancer liver metastases: comparative study with propensity score matching. Hepatobiliary Surg Nutr 2016;5:290-9. [PMID: 27500141 DOI: 10.21037/hbsn.2015.12.06] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
281 Pawlik TM, Scoggins CR, Zorzi D, Abdalla EK, Andres A, Eng C, Curley SA, Loyer EM, Muratore A, Mentha G, Capussotti L, Vauthey JN. Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases. Ann Surg 2005;241:715-22, discussion 722-4. [PMID: 15849507 DOI: 10.1097/01.sla.0000160703.75808.7d] [Cited by in Crossref: 730] [Cited by in F6Publishing: 664] [Article Influence: 42.9] [Reference Citation Analysis]
282 Bonney GK, Chew CA, Lodge P, Hubbard J, Halazun KJ, Trunecka P, Muiesan P, Mirza DF, Isaac J, Laing RW, Iyer SG, Chee CE, Yong WP, Muthiah MD, Panaro F, Sanabria J, Grothey A, Moodley K, Chau I, Chan ACY, Wang CC, Menon K, Sapisochin G, Hagness M, Dueland S, Line PD, Adam R. Liver transplantation for non-resectable colorectal liver metastases: the International Hepato-Pancreato-Biliary Association consensus guidelines. Lancet Gastroenterol Hepatol 2021;6:933-46. [PMID: 34506756 DOI: 10.1016/S2468-1253(21)00219-3] [Reference Citation Analysis]
283 Wicherts DA, de Haas RJ, Sebagh M, Ciacio O, Lévi F, Paule B, Giacchetti S, Guettier C, Azoulay D, Castaing D, Adam R. Regenerative nodular hyperplasia of the liver related to chemotherapy: impact on outcome of liver surgery for colorectal metastases. Ann Surg Oncol 2011;18:659-69. [PMID: 20976564 DOI: 10.1245/s10434-010-1385-5] [Cited by in Crossref: 39] [Cited by in F6Publishing: 30] [Article Influence: 3.3] [Reference Citation Analysis]
284 de Meijer VE, Verhoef C, Kuiper JW, Alwayn IP, Kazemier G, Ijzermans JN. Radiofrequency ablation in patients with primary and secondary hepatic malignancies. J Gastrointest Surg 2006;10:960-73. [PMID: 16843866 DOI: 10.1016/j.gassur.2006.03.003] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 1.9] [Reference Citation Analysis]
285 Ito K, Govindarajan A, Ito H, Fong Y. Surgical treatment of hepatic colorectal metastasis: evolving role in the setting of improving systemic therapies and ablative treatments in the 21st century. Cancer J. 2010;16:103-110. [PMID: 20404606 DOI: 10.1097/ppo.0b013e3181d7e8e5] [Cited by in Crossref: 55] [Cited by in F6Publishing: 26] [Article Influence: 4.6] [Reference Citation Analysis]
286 Huiskens J, van Gulik TM, van Lienden KP, Engelbrecht MR, Meijer GA, van Grieken NC, Schriek J, Keijser A, Mol L, Molenaar IQ, Verhoef C, de Jong KP, Dejong KH, Kazemier G, Ruers TM, de Wilt JH, van Tinteren H, Punt CJ. Treatment strategies in colorectal cancer patients with initially unresectable liver-only metastases, a study protocol of the randomised phase 3 CAIRO5 study of the Dutch Colorectal Cancer Group (DCCG). BMC Cancer 2015;15:365. [PMID: 25943574 DOI: 10.1186/s12885-015-1323-9] [Cited by in Crossref: 38] [Cited by in F6Publishing: 32] [Article Influence: 5.4] [Reference Citation Analysis]
287 Sangha BS, Nimeiri H, Hickey R, Salem R, Lewandowski RJ. Radioembolization as a Treatment Strategy for Metastatic Colorectal Cancer to the Liver: What Can We Learn from the SIRFLOX Trial? Curr Treat Options Oncol 2016;17:26. [PMID: 27098532 DOI: 10.1007/s11864-016-0402-8] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 2.4] [Reference Citation Analysis]
288 Nieuwenhuizen S, Puijk RS, van den Bemd B, Aldrighetti L, Arntz M, van den Boezem PB, Bruynzeel AME, Burgmans MC, de Cobelli F, Coolsen MME, Dejong CHC, Derks S, Diederik A, van Duijvendijk P, Eker HH, Engelsman AF, Erdmann JI, Fütterer JJ, Geboers B, Groot G, Haasbeek CJA, Janssen JJ, de Jong KP, Kater GM, Kazemier G, Kruimer JWH, Leclercq WKG, van der Leij C, Manusama ER, Meier MAJ, van der Meijs BB, Melenhorst MCAM, Nielsen K, Nijkamp MW, Potters FH, Prevoo W, Rietema FJ, Ruarus AH, Ruiter SJS, Schouten EAC, Serafino GP, Sietses C, Swijnenburg RJ, Timmer FEF, Versteeg KS, Vink T, de Vries JJJ, de Wilt JHW, Zonderhuis BM, Scheffer HJ, van den Tol PMP, Meijerink MR. Resectability and Ablatability Criteria for the Treatment of Liver Only Colorectal Metastases: Multidisciplinary Consensus Document from the COLLISION Trial Group.Cancers (Basel). 2020;12. [PMID: 32635230 DOI: 10.3390/cancers12071779] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
289 Zorzi D, Laurent A, Pawlik TM, Lauwers GY, Vauthey JN, Abdalla EK. Chemotherapy-associated hepatotoxicity and surgery for colorectal liver metastases. Br J Surg. 2007;94:274-286. [PMID: 17315288 DOI: 10.1002/bjs.5719] [Cited by in Crossref: 340] [Cited by in F6Publishing: 296] [Article Influence: 22.7] [Reference Citation Analysis]
290 Adam R. Colorectal cancer with synchronous liver metastases. British Journal of Surgery 2007;94:129-31. [DOI: 10.1002/bjs.5764] [Cited by in Crossref: 64] [Cited by in F6Publishing: 56] [Article Influence: 4.3] [Reference Citation Analysis]
291 Devaud N, Kanji ZS, Dhani N, Grant RC, Shoushtari H, Serrano PE, Nanji S, Greig PD, McGilvray I, Moulton CA, Wei A, Gallinger S, Cleary SP. Liver resection after chemotherapy and tumour downsizing in patients with initially unresectable colorectal cancer liver metastases. HPB (Oxford) 2014;16:475-80. [PMID: 23927606 DOI: 10.1111/hpb.12159] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
292 Makowiec F, Möhrle S, Neeff H, Drognitz O, Illerhaus G, Opitz OG, Hopt UT, zur Hausen A. Chemotherapy, Liver Injury, and Postoperative Complications in Colorectal Liver Metastases. J Gastrointest Surg 2011;15:153-64. [DOI: 10.1007/s11605-010-1368-7] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 2.1] [Reference Citation Analysis]
293 Smith MD, Mccall JL. Systematic review of tumour number and outcome after radical treatment of colorectal liver metastases. British Journal of Surgery 2009;96:1101-13. [DOI: 10.1002/bjs.6735] [Cited by in Crossref: 71] [Cited by in F6Publishing: 63] [Article Influence: 5.5] [Reference Citation Analysis]
294 Ivorra P, Sabater L, Calvete J, Camps B, Cervantes A, Bosch A, Plazzotta C, Cassinello N, Arlandis P, Lledó S. [Effect of neoadjuvant chemotherapy on the results of resection of colorectal liver metastases]. Cir Esp 2007;82:166-71. [PMID: 17916288 DOI: 10.1016/s0009-739x(07)71693-7] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
295 Kanat O. Current treatment options for patients with initially unresectable isolated colorectal liver metastases. World J Clin Oncol 2016; 7(1): 9-14 [PMID: 26862487 DOI: 10.5306/wjco.v7.i1.9] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
296 Wesdorp NJ, Hellingman T, Jansma EP, van Waesberghe JTM, Boellaard R, Punt CJA, Huiskens J, Kazemier G. Advanced analytics and artificial intelligence in gastrointestinal cancer: a systematic review of radiomics predicting response to treatment. Eur J Nucl Med Mol Imaging 2021;48:1785-94. [PMID: 33326049 DOI: 10.1007/s00259-020-05142-w] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
297 Vickers M, Samson B, Colwell B, Cripps C, Jalink D, El-Sayed S, Chen E, Porter G, Goel R, Villeneuve J, Sundaresan S, Asselah J, Biagi J, Jonker D, Dawson L, Letourneau R, Rother M, Maroun J, Thirlwell M, Hussein M, Tehfe M, Perrin N, Michaud N, Hammad N, Champion P, Rajan R, Burkes R, Barrette S, Welch S, Yarom N, Asmis T. Eastern Canadian Colorectal Cancer Consensus Conference: setting the limits of resectable disease. Curr Oncol 2010;17:70-7. [PMID: 20651901 DOI: 10.3747/co.v17i3.610] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
298 Wicherts DA, de Haas RJ, Andreani P, Sotirov D, Salloum C, Castaing D, Adam R, Azoulay D. Impact of portal vein embolization on long-term survival of patients with primarily unresectable colorectal liver metastases. Br J Surg. 2010;97:240-250. [PMID: 20087967 DOI: 10.1002/bjs.6756] [Cited by in Crossref: 86] [Cited by in F6Publishing: 74] [Article Influence: 7.2] [Reference Citation Analysis]
299 D'Alterio C, Nasti G, Polimeno M, Ottaiano A, Conson M, Circelli L, Botti G, Scognamiglio G, Santagata S, De Divitiis C, Nappi A, Napolitano M, Tatangelo F, Pacelli R, Izzo F, Vuttariello E, Botti G, Scala S. CXCR4-CXCL12-CXCR7, TLR2-TLR4, and PD-1/PD-L1 in colorectal cancer liver metastases from neoadjuvant-treated patients. Oncoimmunology. 2016;5:e1254313. [PMID: 28123896 DOI: 10.1080/2162402x.2016.1254313] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
300 O'reilly D, Chaudhari M, Ballal M, Ghaneh P, Wu A, Poston G. The Oncosurge strategy for the management of colorectal liver metastases – An external validation study. European Journal of Surgical Oncology (EJSO) 2008;34:538-40. [DOI: 10.1016/j.ejso.2007.04.013] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
301 Lewis AM, Martin RC. The Treatment of Hepatic Metastases in Colorectal Carcinoma. The American Surgeon 2006;72:466-73. [DOI: 10.1177/000313480607200602] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
302 Hammond JS, Guha IN, Beckingham IJ, Lobo DN. Prediction, prevention and management of postresection liver failure. British Journal of Surgery 2011;98:1188-200. [DOI: 10.1002/bjs.7630] [Cited by in Crossref: 115] [Cited by in F6Publishing: 107] [Article Influence: 10.5] [Reference Citation Analysis]
303 Baird DLH, Kontovounisios C, Simillis C, Pellino G, Rasheed S, Tekkis PP. Factors associated with metachronous metastases and survival in locally advanced and recurrent rectal cancer. BJS Open 2020. [PMID: 32856767 DOI: 10.1002/bjs5.50341] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
304 Ramia-Angel JM, Plaza RDL, Quiñones JE. Complete clinical response of liver metastasis after chemotherapy: To resect or not? World J Gastrointest Oncol 2011; 3(7): 107-110 [PMID: 21860686 DOI: 10.4251/wjgo.v3.i7.107] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
305 Chan G, Chee CE. Perioperative Chemotherapy for Liver Metastasis of Colorectal Cancer. Cancers (Basel) 2020;12:E3535. [PMID: 33256170 DOI: 10.3390/cancers12123535] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
306 Lee RC, Kanhere H, Trochsler M, Broadbridge V, Maddern G, Price TJ. Pancreatic, periampullary and biliary cancer with liver metastases: Should we consider resection in selected cases? World J Gastrointest Oncol 2018; 10(8): 211-220 [PMID: 30147847 DOI: 10.4251/wjgo.v10.i8.211] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
307 Vauthey JN, Dixon E, Abdalla EK, Helton WS, Pawlik TM, Taouli B, Brouquet A, Adams RB; American Hepato-Pancreato-Biliary Association; Society of Surgical Oncology; Society for Surgery of the Alimentary Tract. Pretreatment assessment of hepatocellular carcinoma: expert consensus statement. HPB (Oxford). 2010;12:289-299. [PMID: 20590901 DOI: 10.1111/j.1477-2574.2010.00181.x] [Cited by in Crossref: 111] [Cited by in F6Publishing: 99] [Article Influence: 10.1] [Reference Citation Analysis]
308 Adam R, Aloia T, Krissat J, Bralet MP, Paule B, Giacchetti S, Delvart V, Azoulay D, Bismuth H, Castaing D. Is liver resection justified for patients with hepatic metastases from breast cancer? Ann Surg 2006;244:897-907; discussion 907-8. [PMID: 17122615 DOI: 10.1097/01.sla.0000246847.02058.1b] [Cited by in Crossref: 235] [Cited by in F6Publishing: 155] [Article Influence: 15.7] [Reference Citation Analysis]
309 Bidard FC, Kiavue N, Ychou M, Cabel L, Stern MH, Madic J, Saliou A, Rampanou A, Decraene C, Bouché O, Rivoire M, Ghiringhelli F, Francois E, Guimbaud R, Mineur L, Khemissa-Akouz F, Mazard T, Moussata D, Proudhon C, Pierga JY, Stanbury T, Thézenas S, Mariani P. Circulating Tumor Cells and Circulating Tumor DNA Detection in Potentially Resectable Metastatic Colorectal Cancer: A Prospective Ancillary Study to the Unicancer Prodige-14 Trial. Cells 2019;8:E516. [PMID: 31142037 DOI: 10.3390/cells8060516] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 8.0] [Reference Citation Analysis]
310 Hur H, Kim NK, Kim HG, Min BS, Lee KY, Shin SJ, Cheon JH, Choi SH. Adenosine triphosphate-based chemotherapy response assay-guided chemotherapy in unresectable colorectal liver metastasis. Br J Cancer. 2012;106:53-60. [PMID: 22068817 DOI: 10.1038/bjc.2011.469] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
311 Adam R, Aloia T, Lévi F, Wicherts DA, de Haas RJ, Paule B, Bralet MP, Bouchahda M, Machover D, Ducreux M. Hepatic resection after rescue cetuximab treatment for colorectal liver metastases previously refractory to conventional systemic therapy. J Clin Oncol. 2007;25:4593-4602. [PMID: 17925554 DOI: 10.1200/jco.2007.10.8126] [Cited by in Crossref: 154] [Cited by in F6Publishing: 35] [Article Influence: 10.3] [Reference Citation Analysis]
312 Adam R, Miller R, Pitombo M, Wicherts DA, de Haas RJ, Bitsakou G, Aloia T. Two-stage Hepatectomy Approach for Initially Unresectable Colorectal Hepatic Metastases. Surgical Oncology Clinics of North America 2007;16:525-36. [DOI: 10.1016/j.soc.2007.04.016] [Cited by in Crossref: 78] [Cited by in F6Publishing: 59] [Article Influence: 5.2] [Reference Citation Analysis]
313 Suetsugu T, Matsuhashi N, Takahashi T, Tanahashi T, Matsui S, Imai H, Tanaka Y, Yamaguchi K, Yoshida K. Pathological complete response to mFOLFOX6 plus cetuximab therapy for unresectable colon cancer with multiple paraaortic lymph node metastases. Mol Clin Oncol 2018;9:587-91. [PMID: 30546885 DOI: 10.3892/mco.2018.1742] [Reference Citation Analysis]
314 Tzeng CD, Aloia TA. Colorectal Liver Metastases. J Gastrointest Surg 2013;17:195-202. [DOI: 10.1007/s11605-012-2022-3] [Cited by in Crossref: 46] [Cited by in F6Publishing: 41] [Article Influence: 4.6] [Reference Citation Analysis]
315 Rodríguez-López JL, Toro-Bahamonde AM, Santiago-Méndez RJ, González-Cancel IF, Vélez-Cortés HA. An Unusual Case of Colorectal Adenocarcinoma Presenting as an Anterior Mediastinal Mass. Clin Colorectal Cancer 2018;17:e115-9. [PMID: 29169975 DOI: 10.1016/j.clcc.2017.10.009] [Reference Citation Analysis]
316 Goéré D, Farges O, Leporrier J, Sauvanet A, Vilgrain V, Belghiti J. Chemotherapy does not impair hypertrophy of the left liver after right portal vein obstruction. J Gastrointest Surg. 2006;10:365-370. [PMID: 16504881 DOI: 10.1016/j.gassur.2005.09.001] [Cited by in Crossref: 92] [Cited by in F6Publishing: 69] [Article Influence: 5.8] [Reference Citation Analysis]
317 Brouquet A, Overman MJ, Kopetz S, Maru DM, Loyer EM, Andreou A, Cooper A, Curley SA, Garrett CR, Abdalla EK, Vauthey JN. Is resection of colorectal liver metastases after a second-line chemotherapy regimen justified? Cancer 2011;117:4484-92. [PMID: 21446046 DOI: 10.1002/cncr.26036] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 1.9] [Reference Citation Analysis]
318 Golubnitschaja O, Sridhar KC. Liver metastatic disease: new concepts and biomarker panels to improve individual outcomes. Clin Exp Metastasis 2016;33:743-55. [PMID: 27541751 DOI: 10.1007/s10585-016-9816-8] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 4.3] [Reference Citation Analysis]
319 Chan DL, Cheung M, Earle CC, Coburn N, Mittmann N, Rahman F, Liu N, Singh S. Are We Choosing Surveillance Imaging in Gastric and Pancreatic Cancers Wisely? A Population-Based Study. J Gastrointest Cancer 2020;51:189-95. [PMID: 30972631 DOI: 10.1007/s12029-019-00235-8] [Reference Citation Analysis]
320 Imai K, Allard MA, Castro Benitez C, Vibert E, Sa Cunha A, Cherqui D, Castaing D, Bismuth H, Baba H, Adam R. Nomogram for prediction of prognosis in patients with initially unresectable colorectal liver metastases. Br J Surg 2016;103:590-9. [PMID: 26780341 DOI: 10.1002/bjs.10073] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 2.5] [Reference Citation Analysis]
321 Nakai T, Okuno K, Kitaguchi H, Ishikawa H, Yamasaki M. Unresectable colorectal liver metastases: the safety and efficacy of conversion therapy using hepatic arterial infusion immunochemotherapy with 5-fluorouracil and polyethylene glycol-interferon α-2a. World J Surg 2013;37:1919-26. [PMID: 23564218 DOI: 10.1007/s00268-013-2043-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
322 Kim SH, Kim JH, Jung SH. Comparison of oncologic outcomes of metastatic rectal cancer patients with or without neoadjuvant chemoradiotherapy.Int J Colorectal Dis. 2015;30:1193-1199. [PMID: 26072129 DOI: 10.1007/s00384-015-2272-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
323 McAuliffe JC, Qadan M, D'Angelica MI. Hepatic resection, hepatic arterial infusion pump therapy, and genetic biomarkers in the management of hepatic metastases from colorectal cancer. J Gastrointest Oncol 2015;6:699-708. [PMID: 26697204 DOI: 10.3978/j.issn.2078-6891.2015.081] [Cited by in F6Publishing: 12] [Reference Citation Analysis]
324 Imai K, Allard M, Castro Benitez C, Vibert E, Sa Cunha A, Cherqui D, Castaing D, Baba H, Adam R. Long-term outcomes of radiofrequency ablation combined with hepatectomy compared with hepatectomy alone for colorectal liver metastases. British Journal of Surgery 2017;104:570-9. [DOI: 10.1002/bjs.10447] [Cited by in Crossref: 42] [Cited by in F6Publishing: 36] [Article Influence: 8.4] [Reference Citation Analysis]
325 Dede K, Mersich T, Besznyák I, Zaránd A, Salamon F, Baranyai ZS, Landherr L, Jakab F, Bursics A. Bevacizumab treatment before resection of colorectal liver metastases: safety, recovery of liver function, pathologic assessment. Pathol Oncol Res. 2013;19:501-508. [PMID: 23420304 DOI: 10.1007/s12253-013-9608-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
326 Hacker U, Hallek M, Kubicka S. [Multimodality therapy of colorectal cancer]. Internist (Berl) 2010;51:1366-73. [PMID: 20967408 DOI: 10.1007/s00108-010-2671-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
327 Pavel MC, Casanova R, Estalella L, Memba R, Llàcer-Millán E, Achalandabaso M, Julià E, Geoghegan J, Jorba R. The effect of preoperative chemotherapy on liver regeneration after portal vein embolization/ligation or liver resection in patients with colorectal liver metastasis: a systematic review protocol. Syst Rev 2020;9:279. [PMID: 33276812 DOI: 10.1186/s13643-020-01545-w] [Reference Citation Analysis]
328 Tamandl D, Gruenberger B, Herberger B, Schoppmann S, Bodingbauer M, Schindl M, Puhalla H, Fleischmann E, Schima W, Jakesz R, Laengle F, Gruenberger T. Selective resection of colorectal liver metastases. Eur J Surg Oncol 2007;33:174-82. [PMID: 17046194 DOI: 10.1016/j.ejso.2006.09.008] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 1.7] [Reference Citation Analysis]
329 Abdalla EK. Resection of colorectal liver metastases. J Gastrointest Surg. 2011;15:416-419. [PMID: 21301986 DOI: 10.1007/s11605-011-1429-6] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 1.7] [Reference Citation Analysis]
330 Khan K, Wale A, Brown G, Chau I. Colorectal cancer with liver metastases: Neoadjuvant chemotherapy, surgical resection first or palliation alone? World J Gastroenterol 2014; 20(35): 12391-12406 [PMID: 25253940 DOI: 10.3748/wjg.v20.i35.12391] [Cited by in CrossRef: 35] [Cited by in F6Publishing: 26] [Article Influence: 4.4] [Reference Citation Analysis]
331 Ruers T, Van Coevorden F, Punt CJ, Pierie JE, Borel-Rinkes I, Ledermann JA, Poston G, Bechstein W, Lentz MA, Mauer M, Folprecht G, Van Cutsem E, Ducreux M, Nordlinger B; European Organisation for Research and Treatment of Cancer (EORTC); Gastro-Intestinal Tract Cancer Group; Arbeitsgruppe Lebermetastasen und tumoren in der Chirurgischen Arbeitsgemeinschaft Onkologie (ALM-CAO); National Cancer Research Institute Colorectal Clinical Study Group (NCRI CCSG). Local Treatment of Unresectable Colorectal Liver Metastases: Results of a Randomized Phase II Trial. J Natl Cancer Inst. 2017;109. [PMID: 28376151 DOI: 10.1093/jnci/djx015] [Cited by in Crossref: 197] [Cited by in F6Publishing: 192] [Article Influence: 39.4] [Reference Citation Analysis]
332 Baimas-George M, Thompson KJ, Watson MD, Iannitti DA, Martinie JB, Baker EH, Levi D, Vrochides D. The technical aspects of ex vivo hepatectomy with autotransplantation: a systematic review and meta-analysis. Langenbecks Arch Surg 2021. [PMID: 33591451 DOI: 10.1007/s00423-021-02093-0] [Reference Citation Analysis]
333 Verghese M, Pathak S, Poston GJ. Increasing long-term survival in advanced colorectal cancer. Eur J Surg Oncol 2007;33 Suppl 2:S1-4. [PMID: 18036766 DOI: 10.1016/j.ejso.2007.09.020] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
334 Hriesik C, Ramanathan RK, Hughes SJ. Update for surgeons: recent and noteworthy changes in therapeutic regimens for cancer of the colon and rectum. J Am Coll Surg 2007;205:468-78 (Quiz 524). [PMID: 17765164 DOI: 10.1016/j.jamcollsurg.2007.04.032] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
335 O'Leary MP, Wang C, Sandhu J, Malhotra GK, Thornblade LW, Lau C, Melstrom LG, Fong Y, Singh G, Fakih MG. Salvage regional therapy using hepatic artery infusion pump in unresectable chemotherapy resistant colorectal liver metastases. Am J Surg 2021:S0002-9610(21)00625-5. [PMID: 34696847 DOI: 10.1016/j.amjsurg.2021.10.032] [Reference Citation Analysis]
336 Angelsen JH, Viste A, Løes IM, Eide GE, Hoem D, Sorbye H, Horn A. Predictive factors for time to recurrence, treatment and post-recurrence survival in patients with initially resected colorectal liver metastases. World J Surg Oncol 2015;13:328. [PMID: 26631156 DOI: 10.1186/s12957-015-0738-8] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 2.6] [Reference Citation Analysis]
337 Rubbia-Brandt L, Giostra E, Brezault C, Roth AD, Andres A, Audard V, Sartoretti P, Dousset B, Majno PE, Soubrane O, Chaussade S, Mentha G, Terris B. Importance of histological tumor response assessment in predicting the outcome in patients with colorectal liver metastases treated with neo-adjuvant chemotherapy followed by liver surgery. Ann Oncol. 2007;18:299-304. [PMID: 17060484 DOI: 10.1093/annonc/mdl386] [Cited by in Crossref: 332] [Cited by in F6Publishing: 291] [Article Influence: 20.8] [Reference Citation Analysis]
338 Barimani D, Kauppila JH, Sturesson C, Sparrelid E. Imaging in disappearing colorectal liver metastases and their accuracy: a systematic review. World J Surg Oncol 2020;18:264. [PMID: 33032620 DOI: 10.1186/s12957-020-02037-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
339 Sobrero A, Pastorino A. State of the art: colorectal liver metastases. Future Oncol 2014;10:29-32. [PMID: 25478763 DOI: 10.2217/fon.14.219] [Reference Citation Analysis]
340 Padmanabhan C, Parikh A. Perioperative chemotherapy for resectable colorectal hepatic metastases-What does the EORTC 40983 trial update mean? Hepatobiliary Surg Nutr 2015;4:80-3. [PMID: 25713808 DOI: 10.3978/j.issn.2304-3881.2014.08.05] [Reference Citation Analysis]
341 Lin Q, Ye Q, Zhu D, Wei Y, Ren L, Ye L, Feng Q, Xu P, Zheng P, Lv M, Fan J, Xu J. Determinants of long-term outcome in patients undergoing simultaneous resection of synchronous colorectal liver metastases. PLoS One 2014;9:e105747. [PMID: 25162714 DOI: 10.1371/journal.pone.0105747] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
342 Van Cutsem E, Nordlinger B, Adam R, Köhne CH, Pozzo C, Poston G, Ychou M, Rougier P. Towards a pan-European consensus on the treatment of patients with colorectal liver metastases. Eur J Cancer. 2006;42:2212-2221. [PMID: 16904315 DOI: 10.1016/j.ejca.2006.04.012] [Cited by in Crossref: 326] [Cited by in F6Publishing: 318] [Article Influence: 20.4] [Reference Citation Analysis]
343 Vatandoust S, Price TJ, Karapetis CS. Colorectal cancer: Metastases to a single organ. World J Gastroenterol 2015; 21(41): 11767-11776 [PMID: 26557001 DOI: 10.3748/wjg.v21.i41.11767] [Cited by in CrossRef: 112] [Cited by in F6Publishing: 100] [Article Influence: 16.0] [Reference Citation Analysis]
344 Wu Y, Li C, Zhao J, Yang L, Liu F, Zheng H, Wang Z, Xu Y. Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios predict chemotherapy outcomes and prognosis in patients with colorectal cancer and synchronous liver metastasis. World J Surg Oncol 2016;14:289. [PMID: 27852294 DOI: 10.1186/s12957-016-1044-9] [Cited by in Crossref: 38] [Cited by in F6Publishing: 44] [Article Influence: 6.3] [Reference Citation Analysis]
345 Stubbs RS. Portal Hypertension and Liver Surgery Following Selective Internal Radiation Therapy With 90 Yttrium Microspheres. JCO 2006;24:e15-e15. [DOI: 10.1200/jco.2005.05.2118] [Cited by in Crossref: 21] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
346 Kim YW, Kim IY. The Role of Surgery for Asymptomatic Primary Tumors in Unresectable Stage IV Colorectal Cancer. Ann Coloproctol 2013;29:44-54. [PMID: 23700570 DOI: 10.3393/ac.2013.29.2.44] [Cited by in Crossref: 23] [Cited by in F6Publishing: 30] [Article Influence: 2.6] [Reference Citation Analysis]
347 Ogata S, Belghiti J, Varma D, Sommacale D, Maeda A, Dondero F, Sauvanet A. Two hundred liver hanging maneuvers for major hepatectomy: a single-center experience. Ann Surg 2007;245:31-5. [PMID: 17197962 DOI: 10.1097/01.sla.0000224725.40979.0a] [Cited by in Crossref: 91] [Cited by in F6Publishing: 66] [Article Influence: 6.1] [Reference Citation Analysis]
348 Park J, Lee SD, Han SS, Kim SH, Park SJ, Oh JH, Joo J. Repeat hepatectomy for recurred colorectal liver metastasis: is it justified? Ann Surg Treat Res 2019;97:7-14. [PMID: 31297347 DOI: 10.4174/astr.2019.97.1.7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
349 Desjardin M, Bonhomme B, Le Bail B, Evrard S, Brouste V, Desolneux G, Fonck M, Bécouarn Y, Béchade D. Hepatotoxicities Induced by Neoadjuvant Chemotherapy in Colorectal Cancer Liver Metastases: Distinguishing the True From the False. Clin Med Insights Oncol 2019;13:1179554918825450. [PMID: 30718969 DOI: 10.1177/1179554918825450] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
350 Bork U, Koch M, Büchler MW, Weitz J. [Surgery of hepatobiliary tumors]. Chirurg 2010;81:111-16. [PMID: 20076936 DOI: 10.1007/s00104-009-1812-y] [Cited by in Crossref: 3] [Article Influence: 0.3] [Reference Citation Analysis]
351 Turley MC, Moore C, Creasy JM, Sharib J, Lan B, Thacker JKM, Migaly J, Zani S, Allen PJ, Mantyh CR, Lidsky ME. Combined Primary Resection with Hepatic Artery Infusion Pump Implantation Is Safe for Unresectable Colorectal Liver Metastases. J Gastrointest Surg 2021. [PMID: 34820727 DOI: 10.1007/s11605-021-05195-8] [Reference Citation Analysis]
352 Akgül Ö, Çetinkaya E, Ersöz Ş, Tez M. Role of surgery in colorectal cancer liver metastases. World J Gastroenterol. 2014;20:6113-6122. [PMID: 24876733 DOI: 10.3748/wjg.v20.i20.6113.] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
353 Kumamoto K, Kuwabara K, Tajima Y, Amano K, Hatano S, Ohsawa T, Okada N, Ishibashi K, Haga N, Ishida H. Thymidylate synthase and thymidine phosphorylase mRNA expression in primary lesions using laser capture microdissection is useful for prediction of the efficacy of FOLFOX treatment in colorectal cancer patients with liver metastasis. Oncol Lett. 2012;3:983-989. [PMID: 22783377 DOI: 10.3892/ol.2012.598] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.7] [Reference Citation Analysis]
354 Lévi F. Chronotherapeutics: the relevance of timing in cancer therapy. Cancer Causes Control 2006;17:611-21. [PMID: 16596317 DOI: 10.1007/s10552-005-9004-7] [Cited by in Crossref: 76] [Cited by in F6Publishing: 62] [Article Influence: 4.8] [Reference Citation Analysis]
355 Ardito F, Vellone M, Cassano A, De Rose AM, Pozzo C, Coppola A, Federico B, Giovannini I, Barone C, Nuzzo G. Chance of cure following liver resection for initially unresectable colorectal metastases: analysis of actual 5-year survival. J Gastrointest Surg. 2013;17:352-359. [PMID: 23225196 DOI: 10.1007/s11605-012-2103-3] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 2.4] [Reference Citation Analysis]
356 Lu Z, Peng J, Wang Z, Pan Z, Yuan Y, Wan D, Li B. High preoperative serum CA19-9 level is predictive of poor prognosis for patients with colorectal liver oligometastases undergoing hepatic resection. Med Oncol 2016;33:121. [PMID: 27722895 DOI: 10.1007/s12032-016-0838-5] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
357 Allard MA, Malka D. Place of hepatic intra-arterial chemotherapy in the treatment of colorectal liver metastases. J Visc Surg 2014;151 Suppl 1:S21-4. [PMID: 24636278 DOI: 10.1016/j.jviscsurg.2013.12.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
358 Khatri VP, Chee KG, Petrelli NJ. Modern multimodality approach to hepatic colorectal metastases: solutions and controversies. Surg Oncol 2007;16:71-83. [PMID: 17532622 DOI: 10.1016/j.suronc.2007.05.001] [Cited by in Crossref: 59] [Cited by in F6Publishing: 48] [Article Influence: 3.9] [Reference Citation Analysis]
359 Berri RN, Abdalla EK. Curable metastatic colorectal cancer: recommended paradigms. Curr Oncol Rep 2009;11:200-8. [PMID: 19336012 DOI: 10.1007/s11912-009-0029-z] [Cited by in Crossref: 33] [Cited by in F6Publishing: 18] [Article Influence: 2.5] [Reference Citation Analysis]
360 Oki E, Emi Y, Yamanaka T, Uetake H, Muro K, Takahashi T, Nagasaka T, Hatano E, Ojima H, Manaka D, Kusumoto T, Katayose Y, Fujiwara T, Yoshida K, Unno M, Hyodo I, Tomita N, Sugihara K, Maehara Y. Randomised phase II trial of mFOLFOX6 plus bevacizumab versus mFOLFOX6 plus cetuximab as first-line treatment for colorectal liver metastasis (ATOM trial). Br J Cancer 2019;121:222-9. [PMID: 31285591 DOI: 10.1038/s41416-019-0518-2] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 3.7] [Reference Citation Analysis]
361 Nair VJ, Pantarotto JR. Treatment of metastatic liver tumors using stereotactic ablative radiotherapy. World J Radiol 2014; 6(2): 18-25 [PMID: 24578789 DOI: 10.4329/wjr.v6.i2.18] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
362 Imai K, Allard MA, Baba H, Adam R. Optimal patient selection for successful two-stage hepatectomy of bilateral colorectal liver metastases. Ann Gastroenterol Surg 2021;5:634-8. [PMID: 34585048 DOI: 10.1002/ags3.12465] [Reference Citation Analysis]
363 Kim HK, Cho JH, Lee HY, Lee J, Kim J. Pulmonary metastasectomy for colorectal cancer: How many nodules, how many times? World J Gastroenterol 2014; 20(20): 6133-6145 [PMID: 24876735 DOI: 10.3748/wjg.v20.i20.6133] [Cited by in CrossRef: 35] [Cited by in F6Publishing: 36] [Article Influence: 4.4] [Reference Citation Analysis]
364 Neumann UP, Seehofer D, Neuhaus P. The surgical treatment of hepatic metastases in colorectal carcinoma. Dtsch Arztebl Int. 2010;107:335-342. [PMID: 20532128 DOI: 10.3238/arztebl.2010.0335] [Cited by in Crossref: 2] [Cited by in F6Publishing: 13] [Article Influence: 0.2] [Reference Citation Analysis]
365 Nieuwenhuijs VB, De Bruijn MT, Padbury RT, Barritt GJ. Hepatic ischemia-reperfusion injury: roles of Ca2+ and other intracellular mediators of impaired bile flow and hepatocyte damage. Dig Dis Sci. 2006;51:1087-1102. [PMID: 16865576 DOI: 10.1007/s10620-006-8014-y] [Cited by in Crossref: 41] [Cited by in F6Publishing: 39] [Article Influence: 2.6] [Reference Citation Analysis]
366 Homayounfar K, Bleckmann A, Helms HJ, Lordick F, Rüschoff J, Conradi LC, Sprenger T, Ghadimi M, Liersch T. Discrepancies between medical oncologists and surgeons in assessment of resectability and indication for chemotherapy in patients with colorectal liver metastases. Br J Surg 2014;101:550-7. [PMID: 24756914 DOI: 10.1002/bjs.9436] [Cited by in Crossref: 27] [Cited by in F6Publishing: 21] [Article Influence: 3.4] [Reference Citation Analysis]
367 Wu H, Liu GJ, Zhang ZY, Wu W, Meng YF, Wang S, Yang W, Yan K. Nomogram including chemotherapy response for prediction of intrahepatic progression-free survival in patients with colorectal liver metastasis through chemotherapy followed by radiofrequency ablation. Int J Hyperthermia 2021;38:633-9. [PMID: 33882789 DOI: 10.1080/02656736.2021.1912415] [Reference Citation Analysis]
368 Imai K, Adam R, Baba H. How to increase the resectability of initially unresectable colorectal liver metastases: A surgical perspective. Ann Gastroenterol Surg 2019;3:476-86. [PMID: 31549007 DOI: 10.1002/ags3.12276] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
369 Capussotti L, Muratore A, Mulas MM, Massucco P, Aglietta M. Neoadjuvant chemotherapy and resection for initially irresectable colorectal liver metastases. Br J Surg 2006;93:1001-6. [PMID: 16739103 DOI: 10.1002/bjs.5386] [Cited by in Crossref: 62] [Cited by in F6Publishing: 47] [Article Influence: 3.9] [Reference Citation Analysis]
370 Barone C, Nuzzo G, Cassano A, Basso M, Schinzari G, Giuliante F, D’Argento E, Trigila N, Astone A, Pozzo C. Final analysis of colorectal cancer patients treated with irinotecan and 5-fluorouracil plus folinic acid neoadjuvant chemotherapy for unresectable liver metastases. Br J Cancer. 2007;97:1035-1039. [PMID: 17895897 DOI: 10.1038/sj.bjc.6603988] [Cited by in Crossref: 95] [Cited by in F6Publishing: 69] [Article Influence: 6.3] [Reference Citation Analysis]
371 Boilève A, De Cuyper A, Larive A, Mahjoubi L, Najdawi M, Tazdait M, Gelli M, Tselikas L, Smolenschi C, Malka D, Pignon JP, Ducreux M, Boige V. Hepatic arterial infusion of oxaliplatin plus systemic chemotherapy and targeted therapy for unresectable colorectal liver metastases. Eur J Cancer 2020;138:89-98. [PMID: 32871526 DOI: 10.1016/j.ejca.2020.07.022] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
372 Osterlund P, Salminen T, Soveri LM, Kallio R, Kellokumpu I, Lamminmäki A, Halonen P, Ristamäki R, Lantto E, Uutela A, Osterlund E, Ovissi A, Nordin A, Heervä E, Lehtomäki K, Räsänen J, Murashev M, Aroviita L, Jekunen A, Lindvall-Andersson R, Nyandoto P, Kononen J, Lepistö A, Poussa T, Muhonen T, Ålgars A, Isoniemi H; Members of The RAXO study group are collaborators of this study and are listed in Appendix Table 4B. Repeated centralized multidisciplinary team assessment of resectability, clinical behavior, and outcomes in 1086 Finnish metastatic colorectal cancer patients (RAXO): A nationwide prospective intervention study. Lancet Reg Health Eur 2021;3:100049. [PMID: 34557799 DOI: 10.1016/j.lanepe.2021.100049] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
373 Cassar N, Geoghegan J, Hoti E. Shifting concepts in the management of colorectal liver metastases. Surgeon 2022:S1479-666X(21)00200-6. [PMID: 34998701 DOI: 10.1016/j.surge.2021.12.005] [Reference Citation Analysis]
374 Boostrom SY, Nagorney DM, Donohue JH, Harmsen S, Thomsen K, Que F, Kendrick M, Reid-Lombardo KM. Impact of neoadjuvant chemotherapy with FOLFOX/FOLFIRI on disease-free and overall survival of patients with colorectal metastases. J Gastrointest Surg. 2009;13:2003-9; discussion 2009. [PMID: 19760306 DOI: 10.1007/s11605-009-1007-3] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
375 de'Angelis N, Baldini C, Brustia R, Pessaux P, Sommacale D, Laurent A, Le Roy B, Tacher V, Kobeiter H, Luciani A, Paillaud E, Aparicio T, Canuï-Poitrine F, Liuu E. Surgical and regional treatments for colorectal cancer metastases in older patients: A systematic review and meta-analysis. PLoS One 2020;15:e0230914. [PMID: 32320417 DOI: 10.1371/journal.pone.0230914] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
376 Chun YS, Vauthey JN, Ribero D, Donadon M, Mullen JT, Eng C, Madoff DC, Chang DZ, Ho L, Kopetz S. Systemic chemotherapy and two-stage hepatectomy for extensive bilateral colorectal liver metastases: perioperative safety and survival. J Gastrointest Surg. 2007;11:1498-1504; discussion 1504-1505. [PMID: 17849166 DOI: 10.1007/s11605-007-0272-2] [Cited by in Crossref: 117] [Cited by in F6Publishing: 94] [Article Influence: 7.8] [Reference Citation Analysis]
377 Neuberg M, Triantafyllidis I, Lefevre M, Bennamoun M, Sarran A, Beaussier M, Louvet C, Gayet B, Fuks D. Does Chemotherapy-Induced Liver Injury Impair Postoperative Outcomes After Laparoscopic Liver Resection for Colorectal Metastases? J Gastrointest Surg 2021;25:1203-11. [PMID: 32410180 DOI: 10.1007/s11605-020-04636-0] [Reference Citation Analysis]
378 Behl AS, Goddard KA, Flottemesch TJ, Veenstra D, Meenan RT, Lin JS, Maciosek MV. Cost-effectiveness analysis of screening for KRAS and BRAF mutations in metastatic colorectal cancer. J Natl Cancer Inst 2012;104:1785-95. [PMID: 23197490 DOI: 10.1093/jnci/djs433] [Cited by in Crossref: 72] [Cited by in F6Publishing: 57] [Article Influence: 7.2] [Reference Citation Analysis]
379 Kobayashi A, Miyagawa S. Advances in therapeutics for liver metastasis from colorectal cancer. World J Gastrointest Oncol 2010; 2(10): 380-389 [PMID: 21160889 DOI: 10.4251/wjgo.v2.i10.380] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
380 Yang Q, Liao F, Huang Y, Jiang C, Liu S, He W, Kong P, Zhang B, Xia L. Longterm effects of palliative local treatment of incurable metastatic lesions in colorectal cancer patients. Oncotarget 2016;7:21034-45. [PMID: 26992234 DOI: 10.18632/oncotarget.8090] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
381 Milito P, Sorrentino L, Pietrantonio F, Di Russo A, Citterio D, Mazzaferro V, Cosimelli M. No benefit after neoadjuvant chemoradiation in stage IV rectal cancer: A propensity score-matched analysis on a real-world population. Dig Liver Dis 2021;53:1041-7. [PMID: 33487580 DOI: 10.1016/j.dld.2021.01.013] [Reference Citation Analysis]
382 Bonfill T, Dotor E, Darnell A, Casalots A, Bombardó J, Saigí E, Pericay C. Synchronous isolated adrenal metastasis from rectum adenocarcinoma. Clin Transl Oncol 2009;11:257-8. [PMID: 19380305 DOI: 10.1007/s12094-009-0350-x] [Reference Citation Analysis]
383 Allard MA, Adam R, Giuliante F, Lapointe R, Hubert C, Ijzermans JNM, Mirza DF, Elias D, Laurent C, Gruenberger T, Poston G, Letoublon C, Isoniemi H, Lucidi V, Popescu I, Figueras J. Long-term outcomes of patients with 10 or more colorectal liver metastases. Br J Cancer. 2017;117:604-611. [PMID: 28728167 DOI: 10.1038/bjc.2017.218] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 5.2] [Reference Citation Analysis]
384 Braat MN, Samim M, van den Bosch MA, Lam MG. The role of 90Y-radioembolization in downstaging primary and secondary hepatic malignancies: a systematic review. Clin Transl Imaging 2016;4:283-95. [PMID: 27512689 DOI: 10.1007/s40336-016-0172-0] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 3.3] [Reference Citation Analysis]
385 Grundmann RT. Current state of surgical treatment of liver metastases from colorectal cancer. World J Gastrointest Surg 2011; 3(12): 183-196 [PMID: 22224173 DOI: 10.4240/wjgs.v3.i12.183] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 17] [Article Influence: 1.7] [Reference Citation Analysis]
386 Navarro-Freire F, Navarro-Sánchez P, García-Agua N, Pérez-Cabrera B, Palomeque-Jiménez A, Jiménez-Rios JA, García-López PA, García-Ruiz AJ. Effectiveness of surgery in liver metastasis from colorectal cancer: experience and results of a continuous improvement process. Clin Transl Oncol 2015;17:547-56. [PMID: 25775916 DOI: 10.1007/s12094-015-1277-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
387 Gulec SA, Suthar RR, Barot TC, Pennington K. The prognostic value of functional tumor volume and total lesion glycolysis in patients with colorectal cancer liver metastases undergoing 90Y selective internal radiation therapy plus chemotherapy. Eur J Nucl Med Mol Imaging. 2011;38:1289-1295. [PMID: 21461737 DOI: 10.1007/s00259-011-1758-4] [Cited by in Crossref: 56] [Cited by in F6Publishing: 56] [Article Influence: 5.1] [Reference Citation Analysis]
388 Ellis LM, Curley SA, Grothey A. Surgical resection after downsizing of colorectal liver metastasis in the era of bevacizumab. J Clin Oncol. 2005;23:4853-4855. [PMID: 16051943 DOI: 10.1200/jco.2005.23.754] [Cited by in Crossref: 135] [Cited by in F6Publishing: 34] [Article Influence: 7.9] [Reference Citation Analysis]
389 Kotaka M, Ikeda F, Tsujie M, Yoshioka S, Nakamoto Y, Ishii T, Kyogoku T, Kato T, Tsuji A, Kobayashi M. Observational cohort study focused on treatment continuity of patients administered XELOX plus bevacizumab for previously untreated metastatic colorectal cancer. Onco Targets Ther 2016;9:4113-20. [PMID: 27468238 DOI: 10.2147/OTT.S104140] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
390 Vauthey JN, Pawlik TM, Ribero D, Wu TT, Zorzi D, Hoff PM, Xiong HQ, Eng C, Lauwers GY, Mino-Kenudson M, Risio M, Muratore A, Capussotti L, Curley SA, Abdalla EK. Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases. J Clin Oncol 2006;24:2065-72. [PMID: 16648507 DOI: 10.1200/JCO.2005.05.3074] [Cited by in Crossref: 932] [Cited by in F6Publishing: 327] [Article Influence: 58.3] [Reference Citation Analysis]
391 Folprecht G, Grothey A, Alberts S, Raab HR, Köhne CH. Neoadjuvant treatment of unresectable colorectal liver metastases: correlation between tumour response and resection rates. Ann Oncol. 2005;16:1311-1319. [PMID: 15870084 DOI: 10.1093/annonc/mdi246] [Cited by in Crossref: 461] [Cited by in F6Publishing: 378] [Article Influence: 27.1] [Reference Citation Analysis]
392 Pathak S, Poston GJ. Colorectal liver metastases; the current scenario. Indian J Surg Oncol 2010;1:350-5. [PMID: 22693391 DOI: 10.1007/s13193-011-0066-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
393 Labori KJ, Schulz A, Drolsum A, Guren MG, Kløw NE, Bjørnbeth BA. Radiofrequency ablation of unresectable colorectal liver metastases: trends in management and outcome during a decade at a single center. Acta Radiol Open. 2015;4:2058460115580877. [PMID: 26346740 DOI: 10.1177/2058460115580877] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
394 Guo M, Jin N, Pawlik T, Cloyd JM. Neoadjuvant chemotherapy for colorectal liver metastases: A contemporary review of the literature. World J Gastrointest Oncol 2021; 13(9): 1043-1061 [PMID: 34616511 DOI: 10.4251/wjgo.v13.i9.1043] [Reference Citation Analysis]
395 Mohammad WM, Balaa FK. Surgical management of colorectal liver metastases. Clin Colon Rectal Surg 2009;22:225-32. [PMID: 21037813 DOI: 10.1055/s-0029-1242462] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
396 Clark ME, Smith RR. Liver-directed therapies in metastatic colorectal cancer. J Gastrointest Oncol. 2014;5:374-387. [PMID: 25276410 DOI: 10.3978/j.issn.2078-6891.2014.064] [Cited by in F6Publishing: 20] [Reference Citation Analysis]
397 Bilchik AJ, Poston G, Curley SA, Strasberg S, Saltz L, Adam R, Nordlinger B, Rougier P, Rosen LS. Neoadjuvant chemotherapy for metastatic colon cancer: a cautionary note. J Clin Oncol. 2005;23:9073-9078. [PMID: 16361615 DOI: 10.1200/jco.2005.03.2334] [Cited by in Crossref: 110] [Cited by in F6Publishing: 28] [Article Influence: 6.9] [Reference Citation Analysis]
398 Fiorentini G, Aliberti C, Sarti D, Coschiera P, Tilli M, Mulazzani L, Giordani P, Graziano F, Gonzalez AM, Marcos RG, Mugnoz FG, Cantore M, Ricci S, Catalano V, Mambrini A. Locoregional therapy and systemic cetuximab to treat colorectal liver metastases. World J Gastrointest Oncol 2015; 7(6): 47-54 [PMID: 26090075 DOI: 10.4251/wjgo.v7.i6.47] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 10] [Article Influence: 2.1] [Reference Citation Analysis]
399 Saiura A, Yamamoto J, Hasegawa K, Koga R, Sakamoto Y, Hata S, Makuuchi M, Kokudo N. Liver Resection for Multiple Colorectal Liver Metastases with Surgery Up-front Approach: Bi-institutional Analysis of 736 Consecutive Cases. World J Surg 2012;36:2171-8. [DOI: 10.1007/s00268-012-1616-y] [Cited by in Crossref: 43] [Cited by in F6Publishing: 40] [Article Influence: 4.3] [Reference Citation Analysis]
400 Kim KH, Yoon YS, Yu CS, Kim TW, Kim HJ, Kim PN, Ha HK, Kim JC. Comparative analysis of radiofrequency ablation and surgical resection for colorectal liver metastases. J Korean Surg Soc. 2011;81:25-34. [PMID: 22066097 DOI: 10.4174/jkss.2011.81.1.25] [Cited by in Crossref: 79] [Cited by in F6Publishing: 69] [Article Influence: 7.2] [Reference Citation Analysis]
401 Pini S, Pinto C, Angelelli B, Giampalma E, Blotta A, Di Fabio F, Santini D, Golfieri R, Martoni AA. Multimodal Sequential Approach in Colorectal Cancer Liver Metastases: Hepatic Resection after Yttrium-90 Selective Internal Radiation Therapy and Cetuximab Rescue Treatment. Tumori 2010;96:157-9. [DOI: 10.1177/030089161009600126] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
402 Luz JHM, Luz PM, Bilhim T, Martin HS, Gouveia HR, Coimbra É, Gomes FV, Souza RR, Faria IM, de Miranda TN. Portal vein embolization with n-butyl-cyanoacrylate through an ipsilateral approach before major hepatectomy: single center analysis of 50 consecutive patients. Cancer Imaging 2017;17:25. [PMID: 28931429 DOI: 10.1186/s40644-017-0127-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
403 Mahar AL, Compton C, Halabi S, Hess KR, Weiser MR, Groome PA. Personalizing prognosis in colorectal cancer: A systematic review of the quality and nature of clinical prognostic tools for survival outcomes. J Surg Oncol. 2017;116:969-982. [PMID: 28767139 DOI: 10.1002/jso.24774] [Cited by in Crossref: 36] [Cited by in F6Publishing: 37] [Article Influence: 7.2] [Reference Citation Analysis]
404 Van Bael K, Jansen Y, Seremet T, Engels B, Delvaux G, Neyns B. A Case Report of Long-Term Survival following Hepatic Arterial Infusion of L-Folinic Acid Modulated 5-Fluorouracil Combined with Intravenous Irinotecan and Cetuximab Followed by Hepatectomy in a Patient with Initially Unresectable Colorectal Liver Metastases. Case Rep Oncol Med 2015;2015:472037. [PMID: 26064730 DOI: 10.1155/2015/472037] [Reference Citation Analysis]
405 Robles-Campos R, Brusadin R, López-Conesa A, López-López V, Navarro-Barrios Á, López-Espín JJ, Arévalo-Pérez J, Parrilla P. Long-Term Outcome After Conventional Two-Stage Hepatectomy Versus Tourniquet-ALPPS in Colorectal Liver Metastases: A Propensity Score Matching Analysis. World J Surg 2019;43:2281-9. [PMID: 31119359 DOI: 10.1007/s00268-019-05031-w] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
406 Dai S, Ye Y, Kong X, Li J, Ding K. A predictive model for early recurrence of colorectal-cancer liver metastases based on clinical parameters. Gastroenterol Rep (Oxf) 2021;9:241-51. [PMID: 34316374 DOI: 10.1093/gastro/goaa092] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
407 Shimada Y, Muneoka Y, Nagahashi M, Ichikawa H, Tajima Y, Hirose Y, Ando T, Nakano M, Sakata J, Kameyama H, Takii Y, Ling Y, Okuda S, Takabe K, Wakai T. BRAF V600E and SRC mutations as molecular markers for predicting prognosis and conversion surgery in Stage IV colorectal cancer. Sci Rep 2019;9:2466. [PMID: 30792536 DOI: 10.1038/s41598-019-39328-6] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
408 Figueras J, Lopez-Ben S, Alsina M, Soriano J, Hernandez-Yagüe X, Albiol M, Guardeño R, Codina-Barreras A, Queralt B. Preoperative treatment with bevacizumab in combination with chemotherapy in patients with unresectable metastatic colorectal carcinoma. Clin Transl Oncol 2013;15:460-6. [PMID: 23143951 DOI: 10.1007/s12094-012-0952-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
409 Parks R, Gonen M, Kemeny N, Jarnagin W, D’Angelica M, DeMatteo R, Garden OJ, Blumgart LH, Fong Y. Adjuvant chemotherapy improves survival after resection of hepatic colorectal metastases: analysis of data from two continents. J Am Coll Surg. 2007;204:753-761; discussion 761-763. [PMID: 17481478 DOI: 10.1016/j.jamcollsurg.2006.12.036] [Cited by in Crossref: 133] [Cited by in F6Publishing: 106] [Article Influence: 8.9] [Reference Citation Analysis]
410 Patel V, Sanyal AJ. Drug-induced steatohepatitis. Clin Liver Dis 2013;17:533-46, vii. [PMID: 24099016 DOI: 10.1016/j.cld.2013.07.012] [Cited by in Crossref: 41] [Cited by in F6Publishing: 37] [Article Influence: 4.6] [Reference Citation Analysis]
411 Robinson SM, Wilson CH, Burt AD, Manas DM, White SA. Chemotherapy-associated liver injury in patients with colorectal liver metastases: a systematic review and meta-analysis. Ann Surg Oncol. 2012;19:4287-4299. [PMID: 22766981 DOI: 10.1245/s10434-012-2438-8] [Cited by in Crossref: 114] [Cited by in F6Publishing: 103] [Article Influence: 11.4] [Reference Citation Analysis]
412 Tranchart H, Chirica M, Faron M, Balladur P, Lefevre LB, Svrcek M, de Gramont A, Tiret E, Paye F. Prognostic Impact of Positive Surgical Margins After Resection of Colorectal Cancer Liver Metastases: Reappraisal in the Era of Modern Chemotherapy. World J Surg 2013;37:2647-54. [DOI: 10.1007/s00268-013-2186-3] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 4.0] [Reference Citation Analysis]
413 Tanaka K, Shimada H, Ueda M, Matsuo K, Endo I, Sekido H, Togo S. Perioperative complications after hepatectomy with or without intra-arterial chemotherapy for bilobar colorectal cancer liver metastases. Surgery 2006;139:599-607. [PMID: 16701091 DOI: 10.1016/j.surg.2005.09.023] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 0.9] [Reference Citation Analysis]
414 Goéré D, Malka D, Tzanis D, Gava V, Boige V, Eveno C, Maggiori L, Dumont F, Ducreux M, Elias D. Is there a possibility of a cure in patients with colorectal peritoneal carcinomatosis amenable to complete cytoreductive surgery and intraperitoneal chemotherapy? Ann Surg 2013;257:1065-71. [PMID: 23299520 DOI: 10.1097/SLA.0b013e31827e9289] [Cited by in Crossref: 166] [Cited by in F6Publishing: 49] [Article Influence: 18.4] [Reference Citation Analysis]
415 Tsukioka T, Nishiyama N, Iwata T, Nagano K, Izumi N, Mizuguchi S, Morita R, Inoue K, Suehiro S. Pulmonary metastasis from colorectal carcinoma with hepatic metastasis. Gen Thorac Cardiovasc Surg 2007;55:455-60. [PMID: 18049853 DOI: 10.1007/s11748-007-0165-z] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
416 Sotelo MJ, García-Paredes B, Aguado C, Sastre J, Díaz-Rubio E. Role of cetuximab in first-line treatment of metastatic colorectal cancer. World J Gastroenterol 2014; 20(15): 4208-4219 [PMID: 24764659 DOI: 10.3748/wjg.v20.i15.4208] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
417 Chan KM, Wu TH, Cheng CH, Lee WC, Chiang JM, Chen JS, Wang JY. Prognostic significance of the number of tumors and aggressive surgical approach in colorectal cancer hepatic metastasis. World J Surg Oncol. 2014;12:155. [PMID: 24885967 DOI: 10.1186/1477-7819-12-155] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 2.9] [Reference Citation Analysis]
418 Gur I, Diggs BS, Wagner JA, Vaccaro GM, Lopez CD, Sheppard BC, Orloff SL, Billingsley KG. Safety and outcomes following resection of colorectal liver metastases in the era of current perioperative chemotherapy. J Gastrointest Surg 2013;17:2133-42. [PMID: 24091909 DOI: 10.1007/s11605-013-2295-1] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
419 Hinz S, Egberts J, Pauser U, Schafmayer C, Fändrich F, Tepel J. Electrolytic ablation is as effective as radiofrequency ablation in the treatment of artificial liver metastases in a pig model: Electrolytic Ablation in a Pig Model. J Surg Oncol 2008;98:135-8. [DOI: 10.1002/jso.21088] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
420 Tamaoki Y, Beppu T, Sakamoto Y, Imai K, Hayashi H, Nitta H, Hashimoto D, Miyamoto Y, Tsuruta Y, Chikamoto A, Baba H. A 5-year recurrence-free survivor with over ten colorectal liver metastases undergoing FOLFOX plus bevacizumab followed by two-stage hepatectomy. Surg Case Rep 2015;1:111. [PMID: 26943435 DOI: 10.1186/s40792-015-0113-6] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
421 Wicherts DA, de Haas RJ, Andreani P, Ariche A, Salloum C, Pascal G, Castaing D, Adam R, Azoulay D. Short- and long-term results of extended left hepatectomy for colorectal metastases. HPB (Oxford). 2011;13:536-543. [PMID: 21762296 DOI: 10.1111/j.1477-2574.2011.00321.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
422 Engledow AH, Skipworth JR, Pakzad F, Imber C, Ell PJ, Groves AM. The role of 18FDG PET/CT in the management of colorectal liver metastases. HPB (Oxford). 2012;14:20-25. [PMID: 22151447 DOI: 10.1111/j.1477-2574.2011.00378.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
423 Lordick F, Knödler M, Hacker U, Bartels M. [Neoadjuvant chemotherapy or primary surgery for colorectal liver metastases. Pro adjuvant chemotherapy]. Chirurg 2014;85:11-6. [PMID: 24292192 DOI: 10.1007/s00104-013-2564-2] [Reference Citation Analysis]
424 Urdzik J, Vildhede A, Wiśniewski JR, Duraj F, Haglund U, Artursson P, Norén A. Global Proteome Changes in Liver Tissue 6 Weeks after FOLFOX Treatment of Colorectal Cancer Liver Metastases. Proteomes 2016;4:E30. [PMID: 28248240 DOI: 10.3390/proteomes4040030] [Reference Citation Analysis]
425 Siriwardena AK, Mason JM, Mullamitha S, Hancock HC, Jegatheeswaran S. Management of colorectal cancer presenting with synchronous liver metastases. Nat Rev Clin Oncol 2014;11:446-59. [DOI: 10.1038/nrclinonc.2014.90] [Cited by in Crossref: 75] [Cited by in F6Publishing: 67] [Article Influence: 9.4] [Reference Citation Analysis]
426 Folprecht G. Introduction: Advances in treatment of metastatic colorectal cancer. Cancer Treatment Reviews 2008;34:S1-2. [DOI: 10.1016/s0305-7372(08)70001-x] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
427 Riedesser JE, Ebert MP, Betge J. Precision medicine for metastatic colorectal cancer in clinical practice. Ther Adv Med Oncol 2022;14:175883592110727. [DOI: 10.1177/17588359211072703] [Reference Citation Analysis]
428 Han MH, Park YY, Pratap S, Han YD, Cho MS, Hur H, Min BS, Lee KY, Kim NK. Short-term Outcomes After Upfront Chemotherapy Followed by Curative Surgery in Metastatic Colon Cancer: A Comparison With Upfront Surgery Patients. Ann Coloproctol 2019;35:327-34. [PMID: 31937072 DOI: 10.3393/ac.2019.03.04.1] [Reference Citation Analysis]
429 Hisatsune Y, Nakano H, Mihara Y, Tobe N, Ishibashi K, Shimamura T, Tanaka K, Aida Y, Otsubo T. A patient who showed a pathologically complete response after undergoing treatment with XELOX plus bevacizumab for synchronous liver metastasis of grade H2 from sigmoid colon cancer. J Gastrointest Oncol. 2013;4:E5-E10. [PMID: 23730524 DOI: 10.3978/j.issn.2078-6891.2012.060] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
430 D'Angelica MI, Correa-Gallego C, Paty PB, Cercek A, Gewirtz AN, Chou JF, Capanu M, Kingham TP, Fong Y, DeMatteo RP. Phase II trial of hepatic artery infusional and systemic chemotherapy for patients with unresectable hepatic metastases from colorectal cancer: conversion to resection and long-term outcomes. Ann Surg. 2015;261:353-360. [PMID: 24646562 DOI: 10.1097/sla.0000000000000614] [Cited by in Crossref: 101] [Cited by in F6Publishing: 34] [Article Influence: 14.4] [Reference Citation Analysis]
431 Abdel-Rahman O, Cheung WY. Integrating Systemic Therapies into the Multimodality Treatment of Resectable Colorectal Liver Metastases. Gastroenterol Res Pract 2018;2018:4326082. [PMID: 30034465 DOI: 10.1155/2018/4326082] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
432 Strnad BS, Ludwig DR, Gilcrease-Garcia B, Fraum TJ, Shetty AS, Doyle MBM, Mellnick VM. Contemporary Imaging of the Surgically Placed Hepatic Arterial Infusion Chemotherapy Pump. AJR Am J Roentgenol 2021;217:633-43. [PMID: 33025806 DOI: 10.2214/AJR.20.24437] [Reference Citation Analysis]
433 Behrenbruch C, Prabhakaran S, Udayasiri D D, Michael M, Hollande F, Hayes I, Heriot AG, Knowles B, Thomson BN. Association between imaging response and survival following neoadjuvant chemotherapy in patients with resectable colorectal liver metastases: A cohort study. J Surg Oncol 2021;123:1263-73. [PMID: 33524184 DOI: 10.1002/jso.26400] [Reference Citation Analysis]
434 Levi Sandri GB, Santoro R, Vennarecci G, Lepiane P, Colasanti M, Ettorre GM. Two-stage hepatectomy, a 10 years experience. Updates Surg. 2015;67:401-405. [PMID: 26534726 DOI: 10.1007/s13304-015-0332-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
435 Pawlik TM, Olino K, Gleisner AL, Torbenson M, Schulick R, Choti MA. Preoperative Chemotherapy for Colorectal Liver Metastases: Impact on Hepatic Histology and Postoperative Outcome. J Gastrointest Surg 2007;11:860-8. [DOI: 10.1007/s11605-007-0149-4] [Cited by in Crossref: 179] [Cited by in F6Publishing: 148] [Article Influence: 11.9] [Reference Citation Analysis]
436 Sugarbaker PH. Colorectal cancer: Prevention and management of metastatic disease. Biomed Res Int. 2014;2014:782890. [PMID: 24783222 DOI: 10.1155/2014/782890] [Cited by in Crossref: 32] [Cited by in F6Publishing: 23] [Article Influence: 4.0] [Reference Citation Analysis]
437 Nakagawa K, Tanaka K, Nojiri K, Kumamoto T, Takeda K, Ueda M, Endo I. The modified Glasgow prognostic score as a predictor of survival after hepatectomy for colorectal liver metastases. Ann Surg Oncol. 2014;21:1711-1718. [PMID: 24452408 DOI: 10.1245/s10434-013-3342-6] [Cited by in Crossref: 36] [Cited by in F6Publishing: 37] [Article Influence: 4.5] [Reference Citation Analysis]
438 Braat AJ, Huijbregts JE, Molenaar IQ, Borel Rinkes IH, van den Bosch MA, Lam MG. Hepatic radioembolization as a bridge to liver surgery. Front Oncol. 2014;4:199. [PMID: 25126539 DOI: 10.3389/fonc.2014.00199] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
439 Adam R. Developing Strategies for Liver Metastases From Colorectal Cancer. Seminars in Oncology 2007;34:S7-S11. [DOI: 10.1053/j.seminoncol.2007.01.003] [Cited by in Crossref: 40] [Cited by in F6Publishing: 33] [Article Influence: 2.7] [Reference Citation Analysis]
440 Curley SA. One Surgeon's Unabashedly Biased View on Liver Resection. JCO 2005;23:8286-8. [DOI: 10.1200/jco.2005.08.009] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
441 Takeda D, Nitta H, Takahara T, Hasegawa Y, Itou N, Wakabayashi G. Effect of preoperative chemotherapy on postoperative liver regeneration following hepatic resection as estimated by liver volume. World J Surg Oncol 2013;11:65. [PMID: 23497123 DOI: 10.1186/1477-7819-11-65] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
442 Akgül &, Çetinkaya E, Ersöz Ş, Tez M. Role of surgery in colorectal cancer liver metastases. World J Gastroenterol 2014; 20(20): 6113-6122 [PMID: 24876733 DOI: 10.3748/wjg.v20.i20.6113] [Cited by in CrossRef: 86] [Cited by in F6Publishing: 82] [Article Influence: 10.8] [Reference Citation Analysis]
443 Procopio F, Viganò L, Cimino M, Donadon M, Del Fabbro D, Torzilli G. Does KRAS mutation status impact the risk of local recurrence after R1 vascular resection for colorectal liver metastasis? An observational cohort study. Eur J Surg Oncol 2020;46:818-24. [PMID: 31839435 DOI: 10.1016/j.ejso.2019.12.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
444 Mahadevan A, Blanck O, Lanciano R, Peddada A, Sundararaman S, D'Ambrosio D, Sharma S, Perry D, Kolker J, Davis J. Stereotactic Body Radiotherapy (SBRT) for liver metastasis - clinical outcomes from the international multi-institutional RSSearch® Patient Registry. Radiat Oncol 2018;13:26. [PMID: 29439707 DOI: 10.1186/s13014-018-0969-2] [Cited by in Crossref: 58] [Cited by in F6Publishing: 43] [Article Influence: 14.5] [Reference Citation Analysis]
445 Vibert E, Canedo L, Adam R. Strategies to treat primary unresectable colorectal liver metastases. Semin Oncol. 2005;32:33-39. [PMID: 16360011 DOI: 10.1053/j.seminoncol.2005.07.015] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 1.4] [Reference Citation Analysis]
446 González HD, Figueras J. Practical questions in liver metastases of colorectal cancer: general principles of treatment. HPB (Oxford) 2007;9:251-8. [PMID: 18345300 DOI: 10.1080/13651820701457992] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 2.2] [Reference Citation Analysis]
447 Kingham TP, Pak LM, Simpson AL, Leung U, Doussot A, D'Angelica MI, DeMatteo RP, Allen PJ, Jarnagin WR. 3D image guidance assisted identification of colorectal cancer liver metastases not seen on intraoperative ultrasound: results from a prospective trial. HPB (Oxford) 2018;20:260-7. [PMID: 28935452 DOI: 10.1016/j.hpb.2017.08.035] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
448 Gangi A, Lu SC. Chemotherapy-associated liver injury in colorectal cancer. Therap Adv Gastroenterol 2020;13:1756284820924194. [PMID: 32547639 DOI: 10.1177/1756284820924194] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
449 Che LH, Liu JW, Huo JP, Luo R, Xu RM, He C, Li YQ, Zhou AJ, Huang P, Chen YY, Ni W, Zhou YX, Liu YY, Li HY, Zhou R, Mo H, Li JM. A single-cell atlas of liver metastases of colorectal cancer reveals reprogramming of the tumor microenvironment in response to preoperative chemotherapy. Cell Discov 2021;7:80. [PMID: 34489408 DOI: 10.1038/s41421-021-00312-y] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
450 Powell AGMT, Bevan V, Brown C, Lewis WG. Altmetric Versus Bibliometric Perspective Regarding Publication Impact and Force. World J Surg 2018;42:2745-56. [PMID: 29536144 DOI: 10.1007/s00268-018-4579-9] [Cited by in Crossref: 26] [Cited by in F6Publishing: 18] [Article Influence: 6.5] [Reference Citation Analysis]
451 Resende Salgado L, Hsu H, Du K. Outcomes of rectal cancer with liver oligometastases. J Gastrointest Oncol 2014;5:414-20. [PMID: 25436119 DOI: 10.3978/j.issn.2078-6891.2014.078] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
452 Stremitzer S, Stift J, Gruenberger B, Tamandl D, Aschacher T, Wolf B, Wrba F, Gruenberger T. KRAS status and outcome of liver resection after neoadjuvant chemotherapy including bevacizumab. British Journal of Surgery 2012;99:1575-82. [DOI: 10.1002/bjs.8909] [Cited by in Crossref: 55] [Cited by in F6Publishing: 55] [Article Influence: 5.5] [Reference Citation Analysis]
453 Adam R, De Gramont A, Figueras J, Guthrie A, Kokudo N, Kunstlinger F, Loyer E, Poston G, Rougier P, Rubbia-Brandt L, Sobrero A, Tabernero J, Teh C, Van Cutsem E;  Jean-Nicolas Vauthey of the EGOSLIM (Expert Group on OncoSurgery management of LIver Metastases) group. The oncosurgery approach to managing liver metastases from colorectal cancer: a multidisciplinary international consensus. Oncologist. 2012;17:1225-1239. [PMID: 22962059 DOI: 10.1634/theoncologist.2012-0121] [Cited by in Crossref: 284] [Cited by in F6Publishing: 255] [Article Influence: 28.4] [Reference Citation Analysis]
454 Nagata K, Shinto E, Shiraishi T, Yamadera M, Kajiwara Y, Mochizuki S, Okamoto K, Einama T, Kishi Y, Ueno H. Mesothelin Expression is Correlated with Chemoresistance in Stage IV Colorectal Cancer. Ann Surg Oncol 2021. [PMID: 34318385 DOI: 10.1245/s10434-021-10507-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
455 Chun YS, Vauthey JN. Extending the frontiers of resectability in advanced colorectal cancer. Eur J Surg Oncol 2007;33 Suppl 2:S52-8. [PMID: 18006265 DOI: 10.1016/j.ejso.2007.09.026] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 2.0] [Reference Citation Analysis]
456 Blackham AU, Swett K, Levine EA, Shen P. Surgical management of colorectal cancer metastases to the liver: multimodality approach and a single institutional experience. Colorectal Cancer 2013;2:73-88. [PMID: 25110522 DOI: 10.2217/crc.12.80] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
457 Tsai S, Marques HP, de Jong MC, Mira P, Ribeiro V, Choti MA, Schulick RD, Barroso E, Pawlik TM. Two-stage strategy for patients with extensive bilateral colorectal liver metastases. HPB (Oxford). 2010;12:262-269. [PMID: 20590896 DOI: 10.1111/j.1477-2574.2010.00161.x] [Cited by in Crossref: 67] [Cited by in F6Publishing: 63] [Article Influence: 5.6] [Reference Citation Analysis]
458 Kishi Y, Hasegawa K, Sugawara Y, Kokudo N. Hepatocellular carcinoma: current management and future development-improved outcomes with surgical resection. Int J Hepatol. 2011;2011:728103. [PMID: 21994868 DOI: 10.4061/2011/728103] [Cited by in Crossref: 35] [Cited by in F6Publishing: 39] [Article Influence: 3.2] [Reference Citation Analysis]
459 Adams RB, Aloia TA, Loyer E, Pawlik TM, Taouli B, Vauthey JN; Americas Hepato-Pancreato-Biliary Association; Society of Surgical Oncology; Society for Surgery of the Alimentary Tract. Selection for hepatic resection of colorectal liver metastases: expert consensus statement. HPB (Oxford). 2013;15:91-103. [PMID: 23297719 DOI: 10.1111/j.1477-2574.2012.00557.x] [Cited by in Crossref: 180] [Cited by in F6Publishing: 155] [Article Influence: 20.0] [Reference Citation Analysis]
460 Hagihara S, Shimizu T, Inoue Y, Asakuma M, Hirokawa F, Taniguchi K, Hayashi M, Uchiyama K. A complete response to capecitabine and oxaliplatin chemotherapy in primary duodenal carcinoma with liver and nodal metastases: a case report. Surg Case Rep 2018;4:125. [PMID: 30269236 DOI: 10.1186/s40792-018-0532-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
461 Townsend A, Price T, Karapetis C. Selective internal radiation therapy for liver metastases from colorectal cancer. Cochrane Database Syst Rev 2009;:CD007045. [PMID: 19821394 DOI: 10.1002/14651858.CD007045.pub2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
462 Loupakis F, Schirripa M, Caparello C, Funel N, Pollina L, Vasile E, Cremolini C, Salvatore L, Morvillo M, Antoniotti C, Marmorino F, Masi G, Falcone A. Histopathologic evaluation of liver metastases from colorectal cancer in patients treated with FOLFOXIRI plus bevacizumab. Br J Cancer 2013;108:2549-56. [PMID: 23703247 DOI: 10.1038/bjc.2013.245] [Cited by in Crossref: 38] [Cited by in F6Publishing: 40] [Article Influence: 4.2] [Reference Citation Analysis]
463 Afonso S, Viani G, Afonso V, Stefano E, Afonso S. Surgical removal of metastases after successful treatment containing bevacizumab in metastatic colorectal cancer. Anticancer Drugs 2011;22 Suppl 2:S21-3. [PMID: 21768794 DOI: 10.1097/01.cad.0000398730.53214.12] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
464 Brudvik KW, Bains SJ, Seeberg LT, Labori KJ, Waage A, Taskén K, Aandahl EM, Bjørnbeth BA. Aggressive treatment of patients with metastatic colorectal cancer increases survival: a scandinavian single-center experience. HPB Surg 2013;2013:727095. [PMID: 23840074 DOI: 10.1155/2013/727095] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
465 Griggs RKL, Pathak S, Poston G. An Overview of the Current Management of Bilobar Colorectal Liver Metastases. Indian J Surg Oncol 2017;8:600-6. [PMID: 29203994 DOI: 10.1007/s13193-017-0686-6] [Reference Citation Analysis]
466 Fujimoto Y, Akasu T, Yamamoto S, Fujita S, Moriya Y. Long-term results of hepatectomy after hepatic arterial infusion chemotherapy for initially unresectable hepatic colorectal metastases. J Gastrointest Surg 2009;13:1643-50. [PMID: 19582514 DOI: 10.1007/s11605-009-0966-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
467 Pfannschmidt J, Dienemann H, Hoffmann H. Surgical resection of pulmonary metastases from colorectal cancer: a systematic review of published series. Ann Thorac Surg. 2007;84:324-338. [PMID: 17588454 DOI: 10.1016/j.athoracsur.2007.02.093] [Cited by in Crossref: 366] [Cited by in F6Publishing: 326] [Article Influence: 24.4] [Reference Citation Analysis]
468 Elfrink AKE, Kok NFM, van der Werf LR, Krul MF, Marra E, Wouters MWJM, Verhoef C, Kuhlmann KFD, den Dulk M, Swijnenburg RJ, Te Riele WW, van den Boezem PB, Leclercq WKG, Lips DJ, Nieuwenhuijs VB, Gobardhan PD, Hartgrink HH, Buis CI, Grünhagen DJ, Klaase JM; Dutch Hepato Biliary Audit Group., Collaborators. Population-based study on practice variation regarding preoperative systemic chemotherapy in patients with colorectal liver metastases and impact on short-term outcomes. Eur J Surg Oncol 2020;46:1742-55. [PMID: 32303416 DOI: 10.1016/j.ejso.2020.03.221] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
469 Mukai T, Uehara K, Aiba T, Nakamura H, Ebata T, Nagino M. Outcomes of stage IV patients with colorectal cancer treated in a single institution: What is the key to the long-term survival? J Anus Rectum Colon 2018;2:16-24. [PMID: 31583318 DOI: 10.23922/jarc.2017-021] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
470 Baba K, Oshita A, Kohyama M, Inoue S, Kuroo Y, Yamaguchi T, Nakamura H, Sugiyama Y, Tazaki T, Sasaki M, Imamura Y, Daimaru Y, Ohdan H, Nakamitsu A. Successful treatment of conversion chemotherapy for initially unresectable synchronous colorectal liver metastasis. World J Gastroenterol 2015; 21(6): 1982-1988 [PMID: 25684967 DOI: 10.3748/wjg.v21.i6.1982] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
471 Ozawa H, Kotake K, Kobayashi H, Sugihara K. Prognostic factors for peritoneal carcinomatosis originating from colorectal cancer: an analysis of 921 patients from a multi-institutional database. Surg Today 2014;44:1643-50. [DOI: 10.1007/s00595-013-0735-x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 2.0] [Reference Citation Analysis]
472 Flood M, Narasimhan V, Wilson K, Lim WM, Ramsay R, Michael M, Heriot A. Organoids as a Robust Preclinical Model for Precision Medicine in Colorectal Cancer: A Systematic Review. Ann Surg Oncol 2021. [PMID: 34596795 DOI: 10.1245/s10434-021-10829-x] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
473 Marchiò S, Soster M, Cardaci S, Muratore A, Bartolini A, Barone V, Ribero D, Monti M, Bovino P, Sun J, Giavazzi R, Asioli S, Cassoni P, Capussotti L, Pucci P, Bugatti A, Rusnati M, Pasqualini R, Arap W, Bussolino F. A complex of α6 integrin and E-cadherin drives liver metastasis of colorectal cancer cells through hepatic angiopoietin-like 6. EMBO Mol Med 2012;4:1156-75. [PMID: 23070965 DOI: 10.1002/emmm.201101164] [Cited by in Crossref: 35] [Cited by in F6Publishing: 29] [Article Influence: 3.5] [Reference Citation Analysis]
474 Zorzi D, Mullen JT, Abdalla EK, Pawlik TM, Andres A, Muratore A, Curley SA, Mentha G, Capussotti L, Vauthey JN. Comparison between hepatic wedge resection and anatomic resection for colorectal liver metastases. J Gastrointest Surg 2006;10:86-94. [PMID: 16368496 DOI: 10.1016/j.gassur.2005.07.022] [Cited by in Crossref: 111] [Cited by in F6Publishing: 91] [Article Influence: 6.9] [Reference Citation Analysis]
475 Misiakos EP, Karidis NP, Kouraklis G. Current treatment for colorectal liver metastases. World J Gastroenterol 2011; 17(36): 4067-4075 [PMID: 22039320 DOI: 10.3748/wjg.v17.i36.4067] [Cited by in CrossRef: 102] [Cited by in F6Publishing: 95] [Article Influence: 9.3] [Reference Citation Analysis]
476 Hu H, Wang K, Huang M, Kang L, Wang W, Wang H, Qiu M, Lin R, Zhang H, Lan P, Wu X, Liu G, Wan Y, Liu M, Zhou Z, Huang Y, Li F, Zhang J, Cai Y, Ma T, Zhou J, Wang H, Ling J, Cai Y, Wu Z, Luo S, Ling L, Deng Y. Modified FOLFOXIRI With or Without Cetuximab as Conversion Therapy in Patients with RAS/BRAF Wild-Type Unresectable Liver Metastases Colorectal Cancer: The FOCULM Multicenter Phase II Trial. Oncologist 2021;26:e90-8. [PMID: 33400355 DOI: 10.1634/theoncologist.2020-0563] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
477 Vera R, Gomez Dorronsoro M, Lopez-Ben S, Viudez A, Queralt B, Hernandez I, Ortiz-Duran MR, Zazpe C, Soriano J, Amat I, Herrera Cabezón J, Diaz E, Codina-Barreras A, Hernandez-Yagüe X, Quera A, Figueras J. Retrospective analysis of pathological response in colorectal cancer liver metastases following treatment with bevacizumab. Clin Transl Oncol 2014;16:739-45. [PMID: 24338508 DOI: 10.1007/s12094-013-1142-x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
478 Evrard S, Mathoulin-pelissier S. Controversies between surgical and percutaneous radiofrequency ablation. European Journal of Surgical Oncology (EJSO) 2006;32:3-5. [DOI: 10.1016/j.ejso.2005.09.002] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
479 Tzeng CW, Aloia TA. Colorectal liver metastases. J Gastrointest Surg. 2013;17:195-201; quiz 201-202. [PMID: 23054896 DOI: 10.1007/s11605-012-2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
480 Benoist S, Brouquet A, Penna C, Julié C, El Hajjam M, Chagnon S, Mitry E, Rougier P, Nordlinger B. Complete response of colorectal liver metastases after chemotherapy: does it mean cure? J Clin Oncol 2006;24:3939-45. [PMID: 16921046 DOI: 10.1200/JCO.2006.05.8727] [Cited by in Crossref: 409] [Cited by in F6Publishing: 116] [Article Influence: 25.6] [Reference Citation Analysis]
481 Xu J, Wei Y, Zhong Y, Fan J, Zhou J, Qin L, Ren L, Qin X. Hepatectomy for liver metastasis of colorectal cancer. Int J Colorectal Dis 2009;24:419-25. [PMID: 19096855 DOI: 10.1007/s00384-008-0619-5] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
482 Padmanabhan C, Nussbaum DP, D'Angelica M. Surgical Management of Colorectal Cancer Liver Metastases. Surg Oncol Clin N Am 2021;30:1-25. [PMID: 33220799 DOI: 10.1016/j.soc.2020.09.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
483 Dijkstra M, Nieuwenhuizen S, Puijk RS, Timmer FEF, Geboers B, Schouten EAC, Opperman J, Scheffer HJ, de Vries JJJ, Versteeg KS, Lissenberg-Witte BI, Meijerink MR, van den Tol MP. Repeat Local Treatment of Recurrent Colorectal Liver Metastases, the Role of Neoadjuvant Chemotherapy: An Amsterdam Colorectal Liver Met Registry (AmCORE) Based Study. Cancers (Basel) 2021;13:4997. [PMID: 34638481 DOI: 10.3390/cancers13194997] [Reference Citation Analysis]
484 Adam R, Kitano Y. Multidisciplinary approach of liver metastases from colorectal cancer. Ann Gastroenterol Surg. 2019;3:50-56. [PMID: 30697610 DOI: 10.1002/ags3.12227] [Cited by in Crossref: 43] [Cited by in F6Publishing: 38] [Article Influence: 14.3] [Reference Citation Analysis]
485 Aloysius MM, Zaitoun AM, Beckingham IJ, Neal KR, Aithal GP, Bessell EM, Lobo DN. The pathological response to neoadjuvant chemotherapy with FOLFOX-4 for colorectal liver metastases: a comparative study. Virchows Arch. 2007;451:943-948. [PMID: 17805566 DOI: 10.1007/s00428-007-0497-1] [Cited by in Crossref: 34] [Cited by in F6Publishing: 30] [Article Influence: 2.3] [Reference Citation Analysis]
486 Haddad AJ, Bani Hani M, Pawlik TM, Cunningham SC. Colorectal liver metastases. Int J Surg Oncol 2011;2011:285840. [PMID: 22312501 DOI: 10.1155/2011/285840] [Cited by in Crossref: 12] [Cited by in F6Publishing: 20] [Article Influence: 1.1] [Reference Citation Analysis]
487 Qi J, Fong Y, Saltz L, D'Angelica MI, Kemeny NE, Gonen M, Shia J, Shukla-Dave A, Jarnagin WR, Do RK, Schwartz LH, Koutcher JA, Zakian KL. Serial measurement of hepatic lipids during chemotherapy in patients with colorectal cancer: a 1 H MRS study. NMR Biomed 2013;26:204-12. [PMID: 22961714 DOI: 10.1002/nbm.2837] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
488 Hakoda K, Yoshimitsu M, Emi M, Omori I, Kohashi T, Kaneko M, Ohdan H, Hirabayashi N. Complete pathological response of multiple huge liver metastases of colon cancer: a case report. Oxf Med Case Reports 2017;2017:omx016. [PMID: 28580153 DOI: 10.1093/omcr/omx016] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
489 Covey AM, Brown KT, Jarnagin WR, Brody LA, Schwartz L, Tuorto S, Sofocleous CT, D’Angelica M, Getrajdman GI, DeMatteo R. Combined portal vein embolization and neoadjuvant chemotherapy as a treatment strategy for resectable hepatic colorectal metastases. Ann Surg. 2008;247:451-455. [PMID: 18376189 DOI: 10.1097/sla.0b013e31815ed693] [Cited by in Crossref: 130] [Cited by in F6Publishing: 48] [Article Influence: 9.3] [Reference Citation Analysis]
490 Wicherts DA, Miller R, de Haas RJ, Bitsakou G, Vibert E, Veilhan LA, Azoulay D, Bismuth H, Castaing D, Adam R. Long-term results of two-stage hepatectomy for irresectable colorectal cancer liver metastases. Ann Surg. 2008;248:994-1005. [PMID: 19092344 DOI: 10.1097/sla.0b013e3181907fd9] [Cited by in Crossref: 248] [Cited by in F6Publishing: 79] [Article Influence: 19.1] [Reference Citation Analysis]
491 Figueras J, Burdio F, Ramos E, Torras J, Llado L, Lopez-Ben S, Codina-Barreras A, Mojal S. Effect of subcentimeter nonpositive resection margin on hepatic recurrence in patients undergoing hepatectomy for colorectal liver metastases. Evidences from 663 liver resections. Ann Oncol. 2007;18:1190-1195. [PMID: 17434896 DOI: 10.1093/annonc/mdm106] [Cited by in Crossref: 87] [Cited by in F6Publishing: 77] [Article Influence: 5.8] [Reference Citation Analysis]
492 Lalmahomed ZS, Mostert B, Onstenk W, Kraan J, Ayez N, Gratama JW, Grünhagen D, Verhoef C, Sleijfer S. Prognostic value of circulating tumour cells for early recurrence after resection of colorectal liver metastases. Br J Cancer. 2015;112:556-561. [PMID: 25562435 DOI: 10.1038/bjc.2014.651] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 2.7] [Reference Citation Analysis]
493 Chan G, Hassanain M, Chaudhury P, Vrochides D, Neville A, Cesari M, Kavan P, Marcus V, Metrakos P. Pathological response grade of colorectal liver metastases treated with neoadjuvant chemotherapy. HPB (Oxford) 2010;12:277-84. [PMID: 20590898 DOI: 10.1111/j.1477-2574.2010.00170.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 22] [Article Influence: 1.5] [Reference Citation Analysis]
494 Sartore-Bianchi A, Amatu A, Bonazzina E, Stabile S, Giannetta L, Cerea G, Schiavetto I, Bencardino K, Funaioli C, Ricotta R, Cipani T, Schirru M, Gambi V, Palmeri L, Carlo-Stella G, Rusconi F, Di Bella S, Burrafato G, Cassingena A, Valtorta E, Lauricella C, Pazzi F, Gambaro A, Ghezzi S, Marrapese G, Tarenzi E, Veronese S, Truini M, Vanzulli A, Siena S. Pooled Analysis of Clinical Outcome of Patients with Chemorefractory Metastatic Colorectal Cancer Treated within Phase I/II Clinical Studies Based on Individual Biomarkers of Susceptibility: A Single-Institution Experience. Target Oncol 2017;12:525-33. [PMID: 28669023 DOI: 10.1007/s11523-017-0505-6] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
495 Hao CY, Ji JF. Surgical treatment of liver metastases of colorectal cancer: Strategies and controversies in 2006. Eur J Surg Oncol 2006;32:473-83. [PMID: 16580172 DOI: 10.1016/j.ejso.2006.02.016] [Cited by in Crossref: 39] [Cited by in F6Publishing: 34] [Article Influence: 2.4] [Reference Citation Analysis]
496 Adam R, Imai K, Castro Benitez C, Allard MA, Vibert E, Sa Cunha A, Cherqui D, Baba H, Castaing D. Outcome after associating liver partition and portal vein ligation for staged hepatectomy and conventional two-stage hepatectomy for colorectal liver metastases. Br J Surg. 2016;103:1521-1529. [PMID: 27517369 DOI: 10.1002/bjs.10256] [Cited by in Crossref: 59] [Cited by in F6Publishing: 53] [Article Influence: 9.8] [Reference Citation Analysis]
497 Kleespies A, Füessl KE, Seeliger H, Eichhorn ME, Müller MH, Rentsch M, Thasler WE, Angele MK, Kreis ME, Jauch KW. Determinants of morbidity and survival after elective non-curative resection of stage IV colon and rectal cancer. Int J Colorectal Dis. 2009;24:1097-1109. [PMID: 19495779 DOI: 10.1007/s00384-009-0734-y] [Cited by in Crossref: 78] [Cited by in F6Publishing: 62] [Article Influence: 6.0] [Reference Citation Analysis]
498 Kataoka K, Kanazawa A, Nakajima A, Yamaguchi A, Arimoto A, Kohno Y. Feasibility and potential benefit of preoperative chemotherapy for colorectal liver metastasis (CLM): a single-centered retrospective study. Surg Today 2013;43:1154-61. [PMID: 23139049 DOI: 10.1007/s00595-012-0410-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
499 Aloia T, Sebagh M, Plasse M, Karam V, Lévi F, Giacchetti S, Azoulay D, Bismuth H, Castaing D, Adam R. Liver histology and surgical outcomes after preoperative chemotherapy with fluorouracil plus oxaliplatin in colorectal cancer liver metastases. J Clin Oncol. 2006;24:4983-4990. [PMID: 17075116 DOI: 10.1200/jco.2006.05.8156] [Cited by in Crossref: 384] [Cited by in F6Publishing: 119] [Article Influence: 24.0] [Reference Citation Analysis]
500 Yamamoto M, Yoshida M, Furuse J, Sano K, Ohtsuka M, Yamashita S, Beppu T, Iwashita Y, Wada K, Nakajima TE, Sakamoto K, Hayano K, Mori Y, Asai K, Matsuyama R, Hirashita T, Hibi T, Sakai N, Tabata T, Kawakami H, Takeda H, Mizukami T, Ozaka M, Ueno M, Naito Y, Okano N, Ueno T, Hijioka S, Shikata S, Ukai T, Strasberg S, Sarr MG, Jagannath P, Hwang TL, Han HS, Yoon YS, Wang HJ, Luo SC, Adam R, Gimenez M, Scatton O, Oh DY, Takada T. Clinical practice guidelines for the management of liver metastases from extrahepatic primary cancers 2021. J Hepatobiliary Pancreat Sci 2021;28:1-25. [PMID: 33200538 DOI: 10.1002/jhbp.868] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
501 Kobayashi H, Kotake K, Sugihara K. Prognostic scoring system for stage IV colorectal cancer: is the AJCC sub-classification of stage IV colorectal cancer appropriate? Int J Clin Oncol. 2013;18:696-703. [PMID: 22692571 DOI: 10.1007/s10147-012-0433-5] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 2.6] [Reference Citation Analysis]
502 Adam R, Wicherts DA, de Haas RJ, Aloia T, Lévi F, Paule B, Guettier C, Kunstlinger F, Delvart V, Azoulay D, Castaing D. Complete Pathologic Response After Preoperative Chemotherapy for Colorectal Liver Metastases: Myth or Reality? JCO 2008;26:1635-41. [DOI: 10.1200/jco.2007.13.7471] [Cited by in Crossref: 217] [Cited by in F6Publishing: 61] [Article Influence: 15.5] [Reference Citation Analysis]
503 Lupinacci RM, Paye F, Coelho FF, Kruger JA, Herman P. Lymphatic drainage of the liver and its implications in the management of colorectal cancer liver metastases. Updates Surg 2014;66:239-45. [PMID: 25168641 DOI: 10.1007/s13304-014-0265-0] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 1.9] [Reference Citation Analysis]
504 Mahfud M, Breitenstein S, El-Badry AM, Puhan M, Rickenbacher A, Samaras P, Pessaux P, Lopez-Ben S, Jaeck D, Figueras J. Impact of preoperative bevacizumab on complications after resection of colorectal liver metastases: case-matched control study. World J Surg. 2010;34:92-100. [PMID: 19838754 DOI: 10.1007/s00268-009-0251-8] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 2.5] [Reference Citation Analysis]
505 Posner MC, Niedzwiecki D, Venook AP, Hollis DR, Kindler HL, Martin EW, Schilsky RL, Goldberg RM, Mayer RJ. A phase II prospective multi-institutional trial of adjuvant active specific immunotherapy following curative resection of colorectal cancer hepatic metastases: cancer and leukemia group B study 89903. Ann Surg Oncol. 2008;15:158-164. [PMID: 18008108 DOI: 10.1245/s10434-007-9654-7] [Cited by in Crossref: 27] [Cited by in F6Publishing: 18] [Article Influence: 1.8] [Reference Citation Analysis]
506 Vera R, González-Flores E, Rubio C, Urbano J, Valero Camps M, Ciampi-Dopazo JJ, Orcajo Rincón J, Morillo Macías V, Gomez Braco MA, Suarez-Artacho G. Multidisciplinary management of liver metastases in patients with colorectal cancer: a consensus of SEOM, AEC, SEOR, SERVEI, and SEMNIM.Clin Transl Oncol. 2020;22:647-662. [PMID: 31359336 DOI: 10.1007/s12094-019-02182-z] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 5.3] [Reference Citation Analysis]
507 Khatri VP. Synchronous colorectal liver metastases: triumph of prospective randomized trials over observational bias leads to paradigm shift. Ann Surg Oncol 2009;16:1762-4. [PMID: 19290493 DOI: 10.1245/s10434-009-0369-9] [Reference Citation Analysis]
508 van Vledder MG, de Jong MC, Pawlik TM, Schulick RD, Diaz LA, Choti MA. Disappearing colorectal liver metastases after chemotherapy: should we be concerned? J Gastrointest Surg. 2010;14:1691-1700. [PMID: 20839072 DOI: 10.1007/s11605-010-1348-y] [Cited by in Crossref: 79] [Cited by in F6Publishing: 61] [Article Influence: 6.6] [Reference Citation Analysis]
509 Mitin T, Enestvedt CK, Thomas CR Jr. Management of oligometastatic rectal cancer: is liver first? J Gastrointest Oncol 2015;6:201-7. [PMID: 25830039 DOI: 10.3978/j.issn.2078-6891.2014.086] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
510 Sotiropoulos GC, Lang H. Clinical scoring systems for predicting outcome after surgery for colorectal liver metastases: towards a better multidisciplinary approach. Liver International 2009;29:6-9. [DOI: 10.1111/j.1478-3231.2008.01923.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
511 Yoshidome H, Kimura F, Shimizu H, Ohtsuka M, Kato A, Yoshitomi H, Furukawa K, Mitsuhashi N, Takeuchi D, Iida A, Miyazaki M. Interval period tumor progression: does delayed hepatectomy detect occult metastases in synchronous colorectal liver metastases? J Gastrointest Surg. 2008;12:1391-1398. [PMID: 18491195 DOI: 10.1007/s11605-008-0540-9] [Cited by in Crossref: 33] [Cited by in F6Publishing: 25] [Article Influence: 2.4] [Reference Citation Analysis]
512 Nordlinger B, Van Cutsem E, Rougier P, Köhne CH, Ychou M, Sobrero A, Adam R, Arvidsson D, Carrato A, Georgoulias V. Does chemotherapy prior to liver resection increase the potential for cure in patients with metastatic colorectal cancer? A report from the European Colorectal Metastases Treatment Group. Eur J Cancer. 2007;43:2037-2045. [PMID: 17766104 DOI: 10.1016/j.ejca.2007.07.017] [Cited by in Crossref: 178] [Cited by in F6Publishing: 153] [Article Influence: 11.9] [Reference Citation Analysis]
513 Nishioka Y, Shindoh J, Yoshioka R, Gonoi W, Abe H, Okura N, Yoshida S, Oba M, Hashimoto M, Watanabe G, Hasegawa K, Kokudo N. Radiological Morphology of Colorectal Liver Metastases after Preoperative Chemotherapy Predicts Tumor Viability and Postoperative Outcomes. J Gastrointest Surg. 2015;19:1653-1661. [PMID: 25917536 DOI: 10.1007/s11605-015-2836-x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 2.6] [Reference Citation Analysis]
514 Chen EY, Mayo SC, Sutton T, Kearney MR, Kardosh A, Vaccaro GM, Billingsley KG, Lopez CD. Effect of Time to Surgery of Colorectal Liver Metastases on Survival. J Gastrointest Cancer 2021;52:169-76. [PMID: 32086781 DOI: 10.1007/s12029-020-00372-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
515 Fakih M. The role of targeted therapy in the treatment of advanced colorectal cancer. Curr Treat Options Oncol 2008;9:357-74. [PMID: 19238551 DOI: 10.1007/s11864-009-0089-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
516 Garlipp B, Gibbs P, Van Hazel GA, Jeyarajah R, Martin RCG, Bruns CJ, Lang H, Manas DM, Ettorre GM, Pardo F, Donckier V, Benckert C, van Gulik TM, Goéré D, Schoen M, Pratschke J, Bechstein WO, de la Cuesta AM, Adeyemi S, Ricke J, Seidensticker M. Secondary technical resectability of colorectal cancer liver metastases after chemotherapy with or without selective internal radiotherapy in the randomized SIRFLOX trial.Br J Surg. 2019;106:1837-1846. [PMID: 31424576 DOI: 10.1002/bjs.11283] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
517 Dervenis C, Xynos E, Sotiropoulos G, Gouvas N, Boukovinas I, Agalianos C, Androulakis N, Athanasiadis A, Christodoulou C, Chrysou E, Emmanouilidis C, Georgiou P, Karachaliou N, Katopodi O, Kountourakis P, Kyriazanos I, Makatsoris T, Papakostas P, Papamichael D, Pechlivanides G, Pentheroudakis G, Pilpilidis I, Sgouros J, Tekkis P, Triantopoulou C, Tzardi M, Vassiliou V, Vini L, Xynogalos S, Ziras N, Souglakos J. Clinical practice guidelines for the management of metastatic colorectal cancer: a consensus statement of the Hellenic Society of Medical Oncologists (HeSMO). Ann Gastroenterol 2016;29:390-416. [PMID: 27708505 DOI: 10.20524/aog.2016.0050] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
518 Ishida K, Uesugi N, Hasegawa Y, Sugimoto R, Takahara T, Otsuka K, Nitta H, Kawasaki T, Wakabayashi G, Sugai T. Proposal for novel histological findings of colorectal liver metastases with preoperative chemotherapy. Pathol Int 2015;65:367-73. [PMID: 25940915 DOI: 10.1111/pin.12300] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
519 Bilchik AJ, Hecht JR. Perioperative risks of bevacizumab and other biologic agents for hepatectomy: theoretical or evidence based? J Clin Oncol. 2008;26:1786-1788. [PMID: 18398144 DOI: 10.1200/jco.2007.15.6380] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
520 Bergeat D, Rayar M, Mouchel Y, Merdrignac A, Meunier B, Lièvre A, Boudjema K, Sulpice L. Preoperative bevacizumab and surgery for colorectal liver metastases: a propensity score analysis. Langenbecks Arch Surg 2017;402:57-67. [DOI: 10.1007/s00423-017-1551-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
521 Aussilhou B, Lesurtel M, Sauvanet A, Farges O, Dokmak S, Goasguen N, Sibert A, Vilgrain V, Belghiti J. Right portal vein ligation is as efficient as portal vein embolization to induce hypertrophy of the left liver remnant. J Gastrointest Surg. 2008;12:297-303. [PMID: 18060468 DOI: 10.1007/s11605-007-0410-x] [Cited by in Crossref: 112] [Cited by in F6Publishing: 103] [Article Influence: 7.5] [Reference Citation Analysis]
522 Mima K, Beppu T, Chikamoto A, Miyamoto Y, Nakagawa S, Kuroki H, Okabe H, Hayashi H, Sakamoto Y, Watanabe M, Kikuchi K, Baba H. Hepatic resection combined with radiofrequency ablation for initially unresectable colorectal liver metastases after effective chemotherapy is a safe procedure with a low incidence of local recurrence. Int J Clin Oncol 2013;18:847-55. [DOI: 10.1007/s10147-012-0471-z] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
523 Masi G, Loupakis F, Pollina L, Vasile E, Cupini S, Ricci S, Brunetti IM, Ferraldeschi R, Naso G, Filipponi F, Pietrabissa A, Goletti O, Baldi G, Fornaro L, Andreuccetti M, Falcone A. Long-Term Outcome of Initially Unresectable Metastatic Colorectal Cancer Patients Treated with 5-Fluorouracil/Leucovorin, Oxaliplatin, and Irinotecan (FOLFOXIRI) Followed by Radical Surgery of Metastases. Annals of Surgery 2009;249:420-5. [DOI: 10.1097/sla.0b013e31819a0486] [Cited by in Crossref: 169] [Cited by in F6Publishing: 59] [Article Influence: 13.0] [Reference Citation Analysis]
524 Winter H, Rassam J, Virdee PS, Goldin R, Pitcheshwar P, Weaver K, Primrose J, Berry DP, Wasan HS, Sharma RA. Hepatic Resection Following Selective Internal Radiation Therapy for Colorectal Cancer Metastases in the FOXFIRE Clinical Trial: Clinical Outcomes and Distribution of Microspheres. Cancers (Basel) 2019;11:E1155. [PMID: 31408970 DOI: 10.3390/cancers11081155] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
525 Wicherts DA, de Haas RJ, Sebagh M, Saenz Corrales E, Gorden DL, Lévi F, Paule B, Azoulay D, Castaing D, Adam R. Impact of bevacizumab on functional recovery and histology of the liver after resection of colorectal metastases. Br J Surg 2011;98:399-407. [PMID: 21254017 DOI: 10.1002/bjs.7368] [Cited by in Crossref: 39] [Cited by in F6Publishing: 35] [Article Influence: 3.3] [Reference Citation Analysis]
526 Hammond WA, Swaika A, Mody K. Pharmacologic resistance in colorectal cancer: a review. Ther Adv Med Oncol. 2016;8:57-84. [PMID: 26753006 DOI: 10.1177/1758834015614530] [Cited by in Crossref: 203] [Cited by in F6Publishing: 194] [Article Influence: 33.8] [Reference Citation Analysis]
527 Dendy MS, Ludwig JM, Kim HS. Predictors and prognosticators for survival with Yttrium-90 radioembolization therapy for unresectable colorectal cancer liver metastasis. Oncotarget 2017;8:37912-22. [PMID: 28415671 DOI: 10.18632/oncotarget.16007] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
528 Figueras J. Metástasis hepáticas masivas de cáncer colorrectal. Cirugía Española 2005;77:313-4. [DOI: 10.1016/s0009-739x(05)70862-9] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]